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ABSTRACT 
Ivan Gwilym Sabath: Characterization of Factors Required for 3’ End Processing                         
of Histone pre-mRNAs                                                                                                                                      
(Under the direction of Dr. Zbigniew Dominski) 
 
Metazoan replication dependent histone mRNAs form their 3’ end by endonucleolytic 
cleavage of the pre-mRNA transcript without the subsequent addition of a poly(A) tail. These are 
the only cellular mRNAs that are not polyadenylated but instead end in a highly conserved stem-
loop. Analogous to the poly(A) tail of canonical mRNAs, the terminal 3’ stem-loop of histone 
mRNAs is a crucial regulatory feature that provides an interface for mechanisms coupling the 
mRNA to cell-cycle regulation, stability, and translation. Histone pre-mRNA 3’ end processing 
requires the U7 snRNP, which interacts with a purine rich sequence called the histone 
downstream element (HDE) located about 10 nts 3’ of the cleavage site.  The U7 snRNP is 
composed of a small 60 nucleotide snRNA bound with a U7 specific heptameric ring resembling 
that of splicesomal snRNPs except that  SmD1 and SmD2 are replaced by Lsm10 and Lsm11, 
respectively.   Unlike other Lsm proteins, Lsm11 has an extended N-terminal domain, which 
interacts with FLASH. The interaction between the N-terminus of Lsm11 and FLASH is 
essential for processing. My research shows that the native U7 snRNP has a larger, more 
complex, composite structure than previously described.  The Lsm11/FLASH complex in the U7 
snRNP stably associates with a subset of polyadenylation factors termed the histone pre-mRNA 
cleavage complex (HCC). This composite U7 snRNP can be isolated from mammalian nuclear 
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extracts in a single step biochemical purification. Mammalian HCC consists of all six subunits of 
CPSF in addition to symplekin and CstF64. Association of the U7 snRNP with the HCC is 
absolutely dependent on a highly conserved LDLY motif in FLASH. I define the region of 
Lsm11 required for binding FLASH and identify the region of Lsm11 in the context of an 
Lsm11/FLASH complex necessary to recruit the HCC. Additionally, my work identified the 
Drosophila HCC, which has a similar composition to the mammalian HCC but lacks two CPSF 
subunits, Fip1 and CPSF30.  Using extracts prepared from Drosophila cultured cells with 
FLASH knocked down by RNA interference, I also determined the critical elements in FLASH 
necessary to support histone pre-mRNA processing in vitro.   
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CHAPTER 1: INTRODUCTION 
ROLE OF HISTONES 
The eukaryotic genome is packaged in a tightly and highly ordered arrangement of nucleo-
protein units called nucleosomes. These repeating units form the basis of chromatin. At the 
center of the nucleosome is an octameric core formed from two copies each of the four histone 
proteins H2A, H2B, H3 and H4. At the center of the core, H3 and H4 exist as dual heterodimers 
with two H2A/H2B heterodimers on either side of the H3/H4 tetramer. There are 147 base pairs 
of DNA wrapped 1.67 helical turns around each octamer with a stretch of linker DNA 
approximately 10-80 base pairs between nucleosomes. While the ordered core of the histone 
proteins in the nucleosome make direct contact with the DNA, a significant portion of the histone 
proteins protrude out beyond the nucleosome as less ordered N-terminal tails available for a 
variety of regulatory post-translational modifications collectively termed the histone code (Strahl 
and Allis, 2000). The core nucleosome particle also interacts with the histone H1 linker protein. 
H1 binds the linker DNA to the octamer at the point at which 5’ and 3’ ends of the wrapped 
DNA make contact with the core nucleosome. H1 promotes compaction of nucleosomes to form 
a dense chromatin structure. This chromatin environment serves two critical functions: protecting 
the integrity of the genome and providing complex architecture for regulation of gene 
expression.
 There are two classes of histones in multicellular eukaryotes: those that are replication-
dependent (RD) and those that are replication-independent. RD histone genes encode the major 
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core histone proteins H2A, H2B, H3, H4 and H1 that form the nucleosome. Expressed only 
when DNA is replicated, these five histones form the primary bulk of proteins constituting 
chromatin. Their expression is tightly coupled to cell-cycle progression and coordinated with 
DNA replication during S-phase when there is a need to package newly synthesized DNA. RD 
histone mRNA levels peak during S-phase with a 30 fold induction of available mRNA when the 
demand for histone proteins is greatest. In vertebrates, regulation of mRNA levels is the result of 
changes in rates and efficiency of transcription, mRNA 3’ end formation, and mRNA stability 
with 3’ end formation playing the most significant role (Fig. 1).  In metazoans, RD histone 
mRNAs are the only messenger RNAs (mRNAs) that do not have poly(A) tails. Furthermore, 
their precursor messenger RNA (pre-mRNA) transcripts are monocistronic and lack introns. 
Replication-independent histones, or histone replacement variants, are not cell-cycle 
regulated but instead expressed constitutively at basal levels throughout the cell-cycle. They are 
expressed from genes scattered through the genome and can substitute for RD histones under a 
number of circumstances including transcriptional activation, kinetochore assembly, and DNA 
repair (Sarma and Reinberg, 2005). A significant difference from the RD genes is that pre-
mRNA transcripts from replication-independent genes often contain introns and the mRNAs are 
polyadenylated.  
 
ORGANIZATION OF HISTONE GENES AND NUCLEAR BODIES 
In general, metazoan RD histone genes exist in the genome as large clusters of either tandem 
repeats or jumbled clusters. The human RD histone genes are found in three clusters distributed 
between chromosome 1 and chromosome 6. The HIST1 cluster on chromosome 6 consists of 55 
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histone genes: 49 for the core histones and 6 for the linker H1. Two smaller clusters, HIST2 and 
HIST3, lie on chromosome 1 and contain 6 and 3 histone genes respectively (Marzluff et al., 
2002).  In contrast, histone genes in Drosophila melanogaster are located at just one locus on 
chromosome 2L 39DE (Lifton et al., 1978). These genes are organized in 100 tandem 5.1kB 
repeating units each encoding one copy of all five RD histones (Fig. 2).  The Drosophila H3 and 
H4 genes, and the H2a and H2b genes, are in pairs with divergent transcription from shared 
promoters while the histone H1 gene has its own promoter.  Grouping large numbers of histone 
genes into distinct clusters is an evolutionary conserved feature unique to RD histone genes, 
unlike many other large copy number gene families that are found scattered throughout the 
genome. This clustered arrangement is ideal for localizing cis-acting transcription and pre-
mRNA processing factors at concentrations sufficient for increased transcription rates and 
efficient biosynthesis of RD histone pre-mRNA during S-phase.   
Eukaryotes have evolved a complex system of cellular compartmentalization in order to 
regulate and ensure the efficiency of distinct biochemical processes. While some of these 
compartments such as mitochondria, the nuclear envelope, lysosomes, peroxisomes, and the 
endoplasmic reticulum, are clearly defined by membranes, others, like the nucleolus, can be 
characterized by protein-protein and RNA-protein interactions that bring together factors in a 
macromolecular body lacking a membrane but still possessing a specialized function. Since these 
bodies lack a lipid membrane, constituent components can rapidly exchange between the 
macromolecular structure and its surrounding nucleoplasm or cytoplasm environment. 
A particularly well studied nuclear body present in multicellular organisms is the Cajal 
Body (CB), described by Ramon y Cajal over 100 years ago. One of the first discovered and 
most abundant proteins in CBs is p80 coilin, a 576 amino acid protein that has an organizational 
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role in the formation of the bodies (Liu et al., 2009) and which is used as a marker to identify 
CBs. These bodies play a key role in the biogenesis and organization of RNA processing 
machinery. Despite not being a center for splicing activity, the U1, U2, U4, U5 and U6 small 
nuclear RNAs (snRNAs) and their associated proteins that together form the splicesomal small 
nuclear ribonucleoprotein particles (snRNPs) can be found in CBs. Although the connection 
between CBs and splicing snRNPs is not completely understood, there are indications that upon 
return to the nucleus and association with CBs, the assembled snRNPs are subject to further 
modification. For example, the CB-specific RNA (scaRNA) U85 contains a C/D and H/ACA 
motif similar to that found in small nucleolar RNAs (snoRNAs) and in conjunction with the 
methyltransferase fibrillarin and pseudouridine synthase dyskerin/NAP57/CBF5 complex has 
been shown to guide 2′-O-methylation and pseudouridylation respectively of distinct nucleotide 
ribose moieties on the U5 snRNA (Matera and Ward, 1993; Almond and Carmo-fonseca, 1993). 
This could be considered analogous to the way ribosomal RNAs (rRNAs) are modified in the 
nucleolus by snoRNAs. 
Work in Xenopus oocytes revealed the U7 snRNA, a snRNA specific to RD histone 
biogenesis, as a component of CBs (Wu and Gall, 1993). However, additional observations in 
mammals and Drosophila suggested not all CBs contained U7 snRNA and that in fact there were 
at least two different bodies forming. In situ hybridization showed a portion of U7 snRNA 
positive CBs localized to the histone gene loci on chromosomes 1 and 6 in humans (Frey and 
Matera, 1995) and that in Drosophila all U7 snRNA positive CBs co-localized to the histone 
genes on chromosome 2L (Liu et al., 2006). These specialized bodies were named histone locus 
bodies (HLB) due to their vicinity to the histone genes and are identifiable during G1, G2, and S-
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phase. Harmony Salzler showed the bi-directional promoter region located between H3 and H4 is 
sufficient to promote assembly of ectopic HLBs in Drosophila (Salzler et al., 2013). 
The protein p220 nuclear protein ataxia-telengiectasia locus (NPAT) is also found 
constitutively in HLBs. It is required for the G1 to S-phase transition (Ma et al., 2000) and 
expression of histone genes during S-phase (Zhao et al., 2000). The C-terminal half of NPAT 
contains domains critical for G1 to S-phase transition. During the start of S-phase, NPAT is a 
substrate of cyclin E-cyclin dependent kinase 2 (CDK2/cyclin E) and is phosphorylated at five 
sites within its C-terminal half resulting in an increased level of histone gene expression (Ma et 
al., 2000). Regions in the N-terminal portion of NPAT are critical for its role as a histone gene 
co-activator.  NPAT contains an approximately 30 amino acid LisH domain at its N-terminus, 
which is known to be essential for histone gene transcription. Mutations at conserved residues in 
this region block histone gene transcription but do not prevent localization to the HLB (Wei et 
al., 2003).  NPAT has also been shown to bind histone nuclear factor P (HiNF-P), a transcription 
factor for H4 genes, and disrupting this interaction inhibits the transcription of the H4 gene at the 
G1 to S-phase transition (Miele et al., 2005).   
 
CANONICAL PRE-MRNA 3’ END PROCESSING 
The vast majority of mRNAs are polyadenylated at the 3’ end in a two-stage reaction. In the first 
stage, the cleavage and polyadenylation machinery recognizes a conserved AAUAAA 
hexanucleotide sequence called the poly(A) signal (PAS) and a G/U rich element 3′ of PAS. 
Cleavage occurs between these two cis-acting elements before proceeding to a tightly coupled 
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second reaction where the cleaved pre-mRNA 3’ end is appended with a poly(A) tail of 
approximately 200-250 adenosines added cotranscriptionally by poly(A) polymerase (PAP).   
Cleavage coupled to polyadenylation requires at least five multi-subunit protein 
complexes to proceed including cleavage polyadenylation specificity factor (CPSF), cleavage 
stimulation factor (CstF), cleavage factor I (CF Im), cleavage factor II (CF IIm), in addition to 
symplekin, PAP. CPSF consists of six protein subunits: CPSF30, CPSF73, CPSF100, CPSF160, 
Fip1, and WDR33. The CPSF complex recognizes the AAUAAA poly(A) signal through an 
interaction with CPSF160 (Mandel et al., 2008). The endonuclease that cleaves the transcript 
after a CA dinucleotide is CPSF73 (Mandel et al., 2006). CPSF30 binds a uridine rich sequence 
5’ of the PAS (Barabino et al., 2000). Fip1 was identified as a member of CPSF that binds 
several cleavage and polyadenylation factors including CPSF30 and CstF77 (Helmling et al., 
2001) and CPSF160 (Kaufmann et al., 2004). CPSF100, the catalytically inactive homologue of 
CPSF73, forms a heterodimer with the endonuclease (Dominski et al., 2005; Kolev et al., 2008). 
The protein WDR33 was also found to bind CPSF73 and co-purify with the CPSF complex (Shi 
et al., 2009). 
CstF is a heterotrimeric RNA binding complex consisting of CstF77, CstF50, and CstF64 
which recognizes and binds the downstream G/U rich element through an RNA binding domain 
(RBD) in CstF64 (Takagaki and Manley, 1997).  CstF77 was shown to interact with both CstF64 
and CstF50 in addition to self-associating through its C-terminus. CstF50 can also form a 
homodimer through its N-terminus. CstF77 binds symplekin, an essential processing factor that 
likely bridges the CPSF and CstF complexes, potentially serving a crucial role as a scaffolding 
protein (Hatton et al., 2000). CstF64 also binds symplekin. The ability of CstF64 to interact with 
CstF77 or symplekin is mutually exclusive as increasing amounts of symplekin protein in vitro 
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inhibits the efficiency of CstF77 binding to CstF64, and the same region of CstF64 binds both 
CstF77 and symplekin.  
In higher eukaryotes, CF Im is necessary for stimulating cleavage and polyadenylation 
(Brown and Gilmartin, 2003). CF Im is a heterodimer consisting of eithera 59, 68, or 72 kDa 
subunit (CF Im 68) and a 25 kDa subunit (CF Im 25) (Rüegsegger et al., 1998). CF Im 68 contains 
an N-terminal RNA recognition motif (RRM) that mediates its interaction with CF Im 25 and 
enhances the ability of the CF Im 25 RBD to bind a UGUA sequence element located 5’ of the 
PAS. Evidence indicates CF Im plays a role in recognition of canonical and non-canonical 
poly(A) sites (Venkataraman et al., 2005) and a role for CF Im in inhibiting usage of proximal 
polyadenylation sites  has been described as a mechanism for regulating alternative 
polyadenylation (Gruber et al., 2014).  
The CF IIm heterodimer comprised of Clp1 and Pcf11 is also required for cleavage and 
polyadenylation in higher eukaryotes.  Clp1 is an RNA kinase that has been shown to be 
essential for cleavage but dispensable for polyadenylation. Pcf11 binds pre-mRNA in proximity 
to the PAS (Kim et al., 2004) and associates with the C-terminal domain (CTD) of RNA 
Polymerase II (Pol II) (Sadowski et al., 2003), linking transcription and 3’ end processing of 
canonical mRNAs. Mutations that affect the ability of Pcf11 to interact with the CTD result in 
transcription termination defects and are lethal yet do not impact normal 3’ end formation.  The 
CF IIm complex co-purifies in relatively low amounts with the rest of the cleavage and 
polyadenylation machinery and is not stably associated with a complex assembled on pre-
mRNA, suggesting that it may play a regulatory role in 3’ end processing of pre-mRNAs. 
Taken altogether, the protein components of the polyadenylation machinery form an 
extended network of interactions that ultimately position the cleavage site for precise 
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endonucleolytic cleavage of the pre-mRNA (Fig 4). After the cleavage of the pre-mRNA, PAP 
generates the poly(A) tail that is essential for nuclear export, translational regulation, and the 
general stability of the mRNA. It is entirely possible that additional unknown protein factors that 
participate in 3’ end processing of canonical pre-mRNAs yet remain to be discovered. 
   
EARLY INSIGHTS INTO HISTONE PRE-MRNA 3’ END PROCESSING 
Similar to other eukaryotic mRNAs, histone mRNAs have a 7-methylguanosine cap and require 
two cis-acting sequence elements in the pre-mRNA for efficient formation of the mature 
transcript 3’ end. But the similarities end there. Unlike other eukaryotic mRNAs, histone 
mRNAs lack introns and could not be purified by binding to poly(dT)-cellulose suggesting that 
this class of mRNA lacked a poly(A) tail. The RD histone pre-mRNA sequence elements 
necessary for 3’ end processing are a stem-loop structure 5’ of the cleavage site and a purine-rich 
element 3’ of the cleavage site named the histone downstream element (HDE) (Fig. 3). These 
two elements differ drastically from those required for canonical pre-mRNA 3’ end formation.  
Cloning of the tandem repeat histone genes in sea urchins (Cohn et al., 1976) led to the 
discovery of a common nucleotide sequence near the end of replication-dependent histone genes. 
This sequence contains a 16 nucleotide stem-loop structure present at the 3’ end of the mature 
mRNA and a separate purine rich HDE 3′ of the stem-loop that is absolutely conserved in sea 
urchin histone genes but more loosely defined in vertebrates (Birnstiel et al., 1985). Additional 
cloning of RD histone genes in other organisms indicated the stem-loop is a highly conserved 
feature of metazoa with several features being invariant including sequences in the stem and 
nucleotides immediately pre and post stem-loop (Birchmeier et al., 1982). Only in C. elegans 
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does the 3’ end of H1 mRNA lack the stem-loop and is instead polyadenylated. Because of 
similarities to bacterial transcriptional termination signals, researchers initially thought the stem-
loop structure might function as a transcription terminator. However, experiments using 
synthetic chicken H2b histone pre-mRNA injected into Xenopus oocytes indicated the 3’ ends of 
mature histone mRNAs were formed by a processing reaction as opposed to transcription 
termination (Krieg and Melton, 1984).   
The mechanism of histone pre-mRNA processing was first investigated using a 
biochemical complementation assay. When injected into Xenopus oocytes, sea urchin histone 
genes are all expressed and properly processed with the exception of H3. Properly processed H3 
histone mRNA was only formed if injected into the Xenopus oocyte in conjunction with extract 
from sea urchin embryos. Sucrose gradient fractionation of sea urchin embryo extract identified a 
fraction sedimenting at 12S that could restore normal processing to H3 pre-mRNA when co-
injected into Xenopus oocytes, suggesting a key factor missing in the Xenopus oocyte was 
present in this fraction. The specific RNA molecule required to catalyze correct formation of H3 
3’ ends was isolated by deproteinizing the poly(A)- RNAs of the 12S fraction and preparing a 
second sucrose gradient from this pool. A small RNA of approximately 60 nucleotides in the 4S 
fraction was identified by S1 protection assays using 32P labeled RNAs to identify protected 
regions of histone pre-mRNA (Strub and Birnstiel, 1986).  
A more detailed analysis of histone pre-mRNA processing was possible after the 
development of efficient in vitro processing assays using mammalian   nuclear extracts. In vitro 
transcribed and 7-methylguanosine capped mouse H4 histone pre-mRNA was incubated with 
HeLa nuclear extracts to show that histone mRNA maturation depended on endonucleolytic 
cleavage between the stem-loop structure and the HDE (Gick et al., 1986; Mowry and Steitz, 
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1987). Cleavage occurred about 4-5 nucleotides 3′ of the stem-loop and favored a CA 
dinucleotide substrate, similarly to the conditions in canonical cleavage/polyadenylation and 
cleavage occured in 20mM EDTA. Once cleavage occurs, the downstream cleavage product 
(DCP) 3’ of the cleavage site is degraded (Walther et al. 1998) 
 
ROLE OF RNA IN HISTONE PRE-MRNA 3’ END PROCESSING 
 In eukaryotes, a number of small nuclear RNAs (snRNAs) are known to play key roles in RNA 
metabolism. U1, U2, U4, U5 and U6 snRNAs form RNA-protein complexes known as small 
nuclear ribonucleoprotein particles (snRNPs) that participate in the splicing reactions responsible 
for removing introns from pre-mRNA (Jurica and Moore, 2003; Nilsen, 2003). In a number of 
animal species, these snRNPs can be immunoprecipitated using sera from patients suffering from 
the auto-immune disease systemic lupus ertythermatosus. The anti-Sm sera specifically 
recognize the protein component of the snRNP and not the RNA (Lerner and Steitz, 1979; 
Billings et al., 1982). Enrichment of snRNPs from sea urchin ovary extracts using anti-Sm sera 
resulted in the identification of a very low abundance small RNA that migrated at the same size 
as the active one identified in the 4S fraction in the sea urchin/Xenopus biochemical 
complementation assay. When isolated, this RNA stimulated the formation of sea urchin mature 
H3 mRNA 3’ ends in Xenopus oocytes. cDNA copies of the RNA component were cloned for 
sequencing and the unique RNA named U7 snRNA (Strub et al., 1984).  The authors noted that 
the 5’ end of U7 snRNA contained partial sequence complimentary to the conserved 
CAAGAAGAA sequence in the HDE located 3’ from the stem-loop.  
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The importance of sequence complementarity between sea urchin U7 snRNA 5’ end and 
the HDE of histone pre-mRNA was confirmed using complementation assays in Xenopus 
oocytes. Plasmids containing the wild type sea urchin Psammechinus miliaris H3 genes or a 
variety of mutant H3 genes with alterations in the HDE sequence were injected into sea urchin 
Paracentrotus lividus eggs where they are transcribed and subjected to the same regulatory 
pathways as endogenous histone genes after fertilization. Mutations in the HDE of H3 resulted in 
a reduction or loss of correctly processed 3’ ends while compensatory changes in the sequence of 
the U7 snRNA restored processing to wild type levels (Schaufele et al., 1986).   Kim Mowry and 
Joan Steitz identified and sequenced the U7 snRNA from humans.  The region complementary to 
the histone pre-mRNA was identified in human U7 snRNA using HeLa cells to express mouse 
H2A with purine to pyrimidine block substitutions in the HDE, which abolished processing. 
These were then rescued by co-transfection of a synthetic U7 snRNA containing compensatory 
changes complementary to the mutated histone HDE (Bond et al., 1991). 
There are two classes of snRNAs. Sm-class snRNAs have a 5’ trimethylguanosine cap, a 
3′ stem-loop structure proceeded by a Sm site for binding a heptameric ring composed of Sm 
proteins B/B’, D1, D2, F, E, G, and D3.  Sm-class snRNAs include the U1, U2, U4, U5, (U11, 
U12, U4atac). They are transcribed by RNA polymerase II, as suggested by the cap-structure.  A 
second class of snRNAs is transcribed by RNA polymerase III, and hence end in a short oligo(U) 
tail.  Lsm-class snRNAs such as U6 have a 5’ monomethylphosphate cap, a 3′ stem-loop 
structure, and end in a stretch of uridines, which form the Lsm site for binding a heptameric ring 
composed of Lsm proteins 2-8 (Matera et al., 2007). Sm/Lsm proteins contain two Sm sequence 
motifs, Sm1 and Sm2, which form a characteristic Sm-fold. Sm1 is comprised of an α helix and 
three anti-parallel β strands while the Sm2 sequence contributes two additional anti-paralell β 
  
13 
 
strands. Between the two motifs is a linker of variable length. Contacts between the subunits of 
the heptameric ring are primarily mediated by the anti-parallel interactions of the fourth and fifth 
β strands in Sm2 although the α helix and other amino acid residues also contribute at the 
interface of subunits (Khusial et al., 2005).  
The U7 snRNA identified by Schaufle et al. contained a non-canonical Sm binding site 
with consensus of AAUUUGUCUAG  which was similar to but distinct from those found in the 
Sm-class of splicesomal snRNAs (Grimm et al., 1993). The functionality of the Sm binding site 
for binding Sm proteins was confirmed in a series of experiments using plasmids expressing sea 
urchin U7 genes under a Xenopus U2 promoter that were injected into Xenopus oocytes. Anti-Sm 
sera precipitated the sea urchin U7 snRNA and associated proteins while key mutations or 
deletions within the U7 Sm binding site disrupted the formation of the snRNP (Gilmartin et al., 
1988).   
The unique Sm binding site in U7 snRNA associates with an unusual Sm protein ring. In 
order to isolate and identify the protein components of the U7 snRNP, Pillai et al. successfully 
adapted a purification scheme in which Sm-class snRNPs are first enriched from HeLa nuclear 
extracts by immunoprecipitation using anti-trimethylguanosine cap antibodies followed by anion 
exchange column chromotography on a Resource Q column.  After identifying a fraction 
containing U1 and U7 snRNA, a biotinylated anti-sense oligonucleotide complementary to the 
5’end of U7 snRNA was used to affinity purify the U7 snRNP. Although Sm proteins B/B’, D1, 
D2, F, G, and D3 were detected by Western blot analysis in the fraction containing U1 and U7 
snRNA (no E antibody available), D1 and D2 were not present in the U7 anti-sense 
oligonucleotide affinity purified material. Furthermore, a unique peptide band migrating at 14 
kDa in the U7 snRNA column fraction was analyzed by mass spectrometry and identified as a 
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new Sm-like protein termed Lsm10. Lsm10, but not SmD1 or SmD2, was shown to coprecipitate 
with U7 snRNA in mammalian (293T) cells in a manner dependent on the sequence of the Sm-
site (Pillai et al., 2001a). A second peptide band migrating around 50 kDa from an U7 snRNP 
anti-sense oligonucleotide affinity purified fraction was later identified as Lsm11 and shown to 
(Parsons et al.)cross-link directly to U7 snRNA (Pillai et al., 2003). Sequence alignments 
between known Sm/Lsm proteins and Lsm10/Lsm11 indicated key residues are conserved in the 
Sm1 and Sm2 domains. 
The 170 amino acid N-terminal domain of Lsm11 is particular to this specific protein and 
not found in other Sm/Lsm family members. Processing assays in Xenopus oocytes indicated the 
unique N-terminus portion of Lsm11 preceding the two Sm domains was critical for processing. 
In vitro transcribed, capped, and polyadenylated mRNAs encoding a number of various HA-
tagged N-terminal deletions of Lsm11 were injected into the oocytes followed by the subsequent 
injection of a labeled chimeric histone-U7 snRNA substrate (Stefanovic et al., 1995a; Stefanovic 
et al., 1995b). Immunoprecipitiation of cytoplasmic extracts prepared from the oocytes using an 
anti-HA antibody showed removing the first N-terminal 104 amino acids of Lsm11 resulted in a 
marked reduction of cleavage of the chimeric probe (Pillai et al., 2003). Additionally, when 
mouse nuclear extract was incubated with bacterially expressed recombinant N-terminally tagged 
136 amino acids of Lsm11, processing efficiency of the extract diminished significantly 
suggesting a critical role for N-terminal Lsm11 in the functional binding of other factors required 
for 3’ end processing of histone pre-mRNAs.  
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ROLE OF SLBP IN HISTONE PRE-MRNA 3’ END PROCESSING 
The highly conserved stem-loop structure in histone pre-mRNA contains a six base pair stem and 
four nucleotide uridine loop. The 5’ and 3’ single stranded flanking regions are also conserved. 
A 32 kDa protein named the stem-loop binding protein (SLBP) binds the stem-loop and 3’ end 
processing in Drosophila critically depends on this interaction (Dominski et al., 2005b). 
Sequestering SLBP using a stem-loop oligonucleotide competitor completely inhibits processing 
in vitro. In mammals, SLBP stabilizes the base pairing of the U7 snRNP with the HDE and is 
somewhat dispensable if the strength of the duplex formed between the HDE and 5’ end of U7 
snRNA is sufficient in vitro (Dominski et al., 1999). SLBP levels increase with the onset of S-
phase, when it is necessary to promote the upregulation of 3’ end processing (Whitfield et al., 
2000).  After cleavage, SLBP remains bound to the mature message and plays a key role in 
message stability (Zheng et al., 2003), nuclear export (Sullivan et al., 2009a), and translation 
(Gorgoni et al., 2005; Sanchez and Marzluff, 2002). 
 SLBP contains a conserved RBD domain (amino acids 125-200) (Wang et al., 1996) 
comprised of three helices, ɑA, ɑB, and ɑC (Tan et al., 2013). Only helices ɑA and ɑC make 
contacts with the stem-loop, with helix ɑA making contact with the 5’ flanking region. 
Interestingly, SLBP only recognizes one nucleotide on the 5’ arm of the stem and none on the 3’ 
side. Helix ɑC is closest to the stem loop and interacts with a guanine base at the second position 
in the stem. It also contacts the single stranded 5’ flanking sequence previously shown to be 
essential for SLBP binding (Dominski et al., 2003). The 5’ stem and flanking sequence 
interactions occur through residues located in the N-terminus of helix ɑC while the C-terminal 
end of the helix touches a uridine in the loop. Since helix ɑC interacts with three distinct 
positions of the stem-loop (the 5’ flanking region, the 5’ arm of the stem-loop, and the loop), it 
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has been hypothesized it may play the role of a ruler to measure the length of the stem (Tan et 
al., 2013).  
 
IDENTIFICATION OF SYMPLEKIN AS A HEAT LABILE FACTOR AND CPSF73 AS 
THE ENDONUCLEASE 
 
Mildly heating HeLa nuclear extracts blocks histone pre-mRNA 3’ end processing in vitro. A 
heat labile factor (HLF) of at least 40 kDa was inactivated at 48˚C but resistant to micrococcal 
digestion and precipitation by anti-Sm sera suggesting another unique factor is required for 
histone mRNA 3’ end formation (Gick et al., 1987). Fractionation of HeLa nuclear extracts and 
characterization of the fractions containing HLF led to the identification of symplekin as the heat 
sensitive protein required for processing. Surprisingly, a number of other cleavage and 
polyadenylation factors also co-purified with the HLF fraction including five subunits of CPSF 
(CPSF73, CPSF100, CPSF30, Fip1, and CPSF160) and two subunits of CstF (CstF64 and 
CstF77) (Kolev and Steitz, 2005). Symplekin is a protein originally identified in tight junctions 
(Keon et al., 1996) and later shown to be a factor in cleavage and polyadenylation of canonical 
pre-mRNAs, where it has been suggested to play a role as a scaffolding protein (Takagaki and 
Manley, 2000b). But the identification of the specific endonuclease required for cleavage of 
histone pre-mRNA 3’ ends remained elusive. 
CPSF73 was identified as the endonuclease responsible for cleavage of histone pre-
mRNA 3’ ends in our lab by Dr. Zbigniew Dominski. In active nuclear extracts, CPSF73 cross-
links to the cleavage site in histone pre-mRNA substrates during U7-dependent 3′-end processing 
in addition to cross-linking with the downstream cleavage product (DCP) that undergoes 5’ to 3′ 
exonucleolytic degradation after release from the mature mRNA (Dominski et al., 2005c). 
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CPSF73 and its homologue CPSF100 belong to the β-CASP family, a separate group of metallo-
β-lactamase superfamily enzymes (Dominski, 2007; Callebaut et al., 2002). As determined by 
phylogenic sequence comparisons, typical metallo-β-lactamases possess five motifs enriched in 
histidine and aspartic acid residues. In general they coordinate two metal ions, most often 
Zn2+(Aravind, 1999). The metallo-β-lactamase domains in CPSF73 and CPSF100 are lacking the 
fifth motif but contain the three motifs distinct to the β-CASP family. The site required for 
catalytic activity of CPSF73 is located in the cleft between the partial metallo-β-lactamase 
domain and the β-CASP domain. It is possible that CPSF73 may require the formation of a 
heterodimer with CPSF100 for the activation of its catalytic endonuclease activity (Dominski et 
al., 2005a). Recombinant CPSF73 is inactive for in vitro processing. A lack of conserved 
histidine residues in motif B is thought to render CPSF100 catalytically inactive but despite this 
variance it is still required for cleavage of histone pre-mRNA transcripts (Kolev et al., 2008). 
The identification of CPSF73 as the endonuclease in histone pre-mRNA 3’ end processing led to 
work demonstrating it is also the endonuclease in canonical cleavage and polyadenylation 
(Mandel et al., 2006). The precise mechanism by which the endonuclease was recruited to 
histone pre-mRNA remained unknown. 
 
FLASH IS ESSENTIAL FOR HISTONE PRE-MRNA 3’ END PROCESSING 
Through a yeast two-hybrid screen where the extended N-terminal portion of Lsm11 critical for 
processing was used as bait, multiple cDNAs constituting the first 139 amino acids of the 
caspase-8 binding protein FLICE associated huge protein (FLASH) were isolated (Yang et al., 
2009a).  FLASH was originally described as a cytoplasmic pro-apoptotic protein that interacts 
with the adapter protein FADD in conjunction with the ligand bound CD95/FAS receptor. 
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FLASH was shown to be a member of the death inducing signal complex (DISC) (Imai et al., 
1999), an integral complex essential for activation of caspase-8 in FAS mediated extrinsic 
apoptosis. FLASH was also found to be involved in the activation of NF-κB by the TRAF2 
pathway (Choi et al., 2001). Subsequent work clearly showed FLASH to be a mostly nuclear 
protein that localized in punctate dots casting doubt on the earlier characterization of FLASH’s 
cytoplasmic roles (Milovic-Holm et al., 2007; Barcaroli et al., 2006).   
Work by Barcaroli et al. was the first to suggest a role for FLASH in histone gene 
expression. In mammalian cells they showed FLASH was often associated with CBs and 
invariantly co-localized with NPAT at HLBs in a cell-cycle dependent manner. FLASH protein 
levels rise and fall during the cell-cycle with an increase during G1, a clear peak during S-phase 
and decrease in G2 (Barcaroli et al., 2006b). Down regulation of FLASH by short hairpin RNA 
(shRNA) in a variety of mammalian cell types resulted in the accumulation of cells in S-phase. It 
is not unusual for proteins that function in RD histone gene expression to cause cells to be 
blocked in S-phase when their function is impeded. When overexpressed, FLASH stimulated the 
activity of the H4 histone promoter in a luciferase assay while FLASH depleted cells exhibited 
reduced transcription of endogenous RD histone genes. Indeed, chromatin immunoprecipitation 
(ChiP) using anti-HA antibody against exogenously expressed HA-tagged FLASH coprecipitated 
the RD histone H2B, H3, and H4 gene promoters. In mammalian cells, S-phase progression, RD 
histone gene expression, and recruitment of FLASH to the HLB depend on the interaction 
between FLASH and Ars2 (Kiriyama et al., 2009), a protein shown to participate in cellular 
proliferation (Gruber et al. 2009) and biogenesis of microRNAs (Lobbes et al., 2006) 
In mammals, FLASH is a large protein consisting of almost 2000 amino acids yet the N-
terminal 139 amino acids are sufficient to stimulate processing of radio-labeled H2a histone pre-
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mRNA when added in dilute HeLa nuclear extracts. Mutational analysis of this region of FLASH 
identified a highly conserved LDLY motif from amino acids 55 to 58 that is critical for 
processing in vitro (Yang et al., 2009a). The robust interaction between FLASH and the N-
terminus of Lsm11 was confirmed by both directed yeast two-hybrid and in vitro pull down 
assays with GST tagged N-terminal 139 amino acids of FLASH and 35S-labeled Lsm11. In both 
cases deletion of Lsm11 amino acids 1-40 prevented binding with FLASH. An orthologue of 
FLASH was identified in Drosophila and RNA interference (RNAi) using double stranded RNA 
targeting FLASH in S2 cells resulted in a substantial increase in mis-processed histone mRNA. 
These data confirmed FLASH as a newly identified essential histone pre-mRNA 3’ end 
processing factor (Fig. 5). These results had just been published when I joined Dr. Dominski and 
Dr. Marzluff to study histone pre-mRNA 3’ end processing. 
 
SUMMARY 
Histone biogenesis is critical to cell division. RD histone gene expression is invariably linked to 
cell-cycle progression with levels of histones peaking during S-phase and coordinated with DNA 
replication. Although increased transcription and RNA stability contribute to the elevated levels 
of RD histone mRNA in S-phase cells, the U7-dependent endonucleolytic cleavage to form a 
mature 3’ end is the single most significant regulatory step that increases the pool of available 
mRNA for synthesis of histone proteins.  
Several key elements and factors are essential for the formation of histone mRNA 3’ 
ends. Two cis-acting sequence elements in the histone pre-mRNA are critical: the stem-loop and 
the HDE. The stem loop is bound by SLBP, which is absolutely required for processing in 
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Drosophila but somewhat dispensable in mammalian systems. Increases in SLBP levels are 
critical to the upregulation of U7-dependent 3’ end processing in S-phase. The HDE performs a 
critical function by recruiting the U7 snRNP through partial base pairing with the U7 snRNA 5’ 
end. A subset of polyadenylation factors consisting of CPSF73, CPSF100, and symplekin are 
required for processing. CPSF73 is the endonuclease that cleaves the transcript but the specific 
mechanism of recruitment to the cleavage site remained a mystery. 
 
THESIS GOALS 
The goal of this dissertation is to characterize the factors required for histone pre-mRNA 
processing. I focused on examining the composite nature of the U7 snRNP and sequence 
elements of FLASH necessary to recruit the polyadenylation factors required for processing, 
including CPSF100, CPSF73, and symplekin. In chapter 2, I describe biochemical techniques for 
purifying histone pre-mRNA 3’ end processing factors from mammalian nuclear extracts using 
elements unique to U7-dependent processing. I also identify regions of Lsm11 that are essential 
for recruitment of 3’ end processing factors. These studies indicate a subset of cleavage and 
polyadenylation factors, including CPSF73, CPSF100, and symplekin, associate with the U7 
snRNP in a FLASH dependent fashion. This subset of cleavage and polyadenylation factors is 
named the histone pre-mRNA cleavage complex (HCC).  
Although the initial studies were conducted in mammalian systems, much of my research 
effort focused on describing the HCC in Drosophila, using nuclear extracts prepared from Kc 
and S2 cell cultures. Chapter 3 addresses the identification of critical residues in Drosophila 
FLASH required for histone pre-mRNA 3’ end processing and recruitment of a unique 
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Drosophila HCC. It also describes a surprising result that FLASH is required for degradation of 
the downstream cleavage product (DCP), whereas in mammalian systems FLASH is dispensable 
for this reaction. Furthermore, I examine the role of CstF64 in histone processing and describe 
the isolation of a large macromolecular complex comprised of all the major complexes required 
for canonical cleavage and polyadenylation with the exception of CF IIm. This is the first 
instance where these polyadenylation complexes have been purified together in Drosophila. Its 
composition contrasts sharply with the subset of polyadenylation factors that assemble in the 
Drosophila HCC.  
 In addition to these studies, I conducted a yeast-two hybrid screen with the N-terminal 
fragment of Lsm11 (amino acids 1-168) and a human universal tissue library. In this screen, I 
isolated an alternatively spliced variant of FLASH containing its first five exons comprising the 
first 138 amino acids of the protein and the last two exons that represent the 52 amino acids of 
the C-terminus. This alternatively spliced variant of FLASH excluded two huge internal exons 
that together account for a total of 1792 amino acids. Interestingly, while the extreme N-terminal 
region contains all the elements for processing in vitro, the C-terminal region was shown to 
interact with NPAT. This interaction localizes FLASH to the HLB and is described in Chapter 4.  
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Figure 1. Histone mRNA levels peak during S-phase. Expression of RD histone genes is 
tightly coupled to cell-cycle progression with peak levels of available histone mRNA occurring 
during S-phase. Several mechanisms contribute to the increased pool of mRNA and the 
processing of pre-mRNA plays a significant role in this process.  
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Figure 2. Organization of histone genes in Drosophila. RD histone genes in Drosophila are 
located on chromosome 2L and grouped in approximately 100 tandemly repeated units 
consisting of one copy of each core histone gene. H3/H4 and H2a/H2b share divergent 
promoters.  
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Figure 3. 3’ end processing of canonical and histone pre-mRNAs depend on different 
sequence elements. Although both pre-mRNAs have a 7-methylguanosine caps at the 5’ end and 
are cleaved during maturation, the sequence elements required for the two different processing 
reactions lack any similarity. Canonical pre-mRNAs have a highly conserved AAUAAA 
polyadenylation signal 5’ of the cleavage site and a less defined G/U rich element 3’ of the 
cleavage site. Histone pre-mRNAs have a highly conserved stem-loop and a purine rich HDE in 
the corresponding positions. Both pre-mRNAs undergo endonucleolytic cleavage between the 
two cis-acting sequence elements. Eukaryotic histone mRNAs have a unique 3’ end that lacks a 
poly(A) tail and instead ends in a highly conserved stem-loop structure whereas canonical pre-
mRNA is appended at the 3’ end with a poly(A) tail after cleavage.  
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Figure 4. A large network of protein complexes positions the endonuclease in cleavage and 
polyadenylation. Endonucleolytic cleavage of pre-mRNA in cleavage and polyadenylation 
depends on recognition of key sequence elements in the 3’-UTR of pre-mRNAs. CPSF 
recognizes and binds the conserved poly(A) signal AAUAAA while CStF binds a G/U rich 
element 3’ of the cleavage site. Symplekin bridges these two multi-subunit complexes. CF Im has 
been functionally linked to a AUGUA motif 5’ of the poly(A) signal and stimulates cleavage. 
Together this network of interactions juxtaposes endonuclease CPSF73 precisely at the cleavage 
site.  
 
 
 
 
 
 
 
 
 
 
 
 
  
29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
30 
 
Figure 5. Histone pre-mRNA 3’ end processing depends upon a unique set of factors. The 
U7 snRNP is recruited to the histone pre-mRNA through partial complementarity between the 
HDE and 5’ end of the U7 snRNA. SLBP, absolutely required for processing in Drosophila but 
less so in mammalian systems, binds the stem-loop. Lsm11, the largest member of the 
heptameric Lsm ring, interacts with the recently identified histone 3’ end processing factor 
FLASH. The core cleavage complex comprised of the CPSF73, its catalytically inactive 
homologue CPSF100, and symplekin are all necessary for the endonucleolytic cleavage of the 
transcript to form mature mRNA. The accessory proteins accompanying the cleavage complex 
and the precise mechanism by which it is recruited remained unknown. 
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CHAPTER 2: IN MAMMALS, A SUBSET OF CLEAVAGE AND POLYADENYLATION 
FACTORS INCLUDING THE ENDOCUCLEASE CPSF73 ASSOCIATE WITH THE U7 
SNRNP IN A FLASH DEPENDENT MANNER 
 
INTRODUCTION 
The U7 snRNP is essential for histone pre-mRNA 3’ end processing in both mammalian and 
Drosophila cells.  The specificity for histone pre-mRNA processing lies in the U7 snRNA and 
the unusual U7 snRNP heptameric Sm ring, which contains the two unique Sm-like proteins, 
Lsm10 and Lsm11.  These replace the SmD1 and SmD2 proteins found in the canonical 
splicesomal Sm rings. Lsm11 has an extended N-terminus not contained by other Lsm proteins 
that is critical for processing (Pillai et al., 2003; Azzouz et al., 2005). With the discovery of 
CPSF73 as the endonuclease in histone pre-mRNA 3’ end processing (Dominski et al., 2005c), 
and the requirement for at least two other polyadenylation factors, a major remaining question 
was how they are recruited to the pre-mRNA to carry out the cleavage. 
A yeast two-hybrid screen using the N-terminal region of Lsm11 led to the identification 
of FLASH as a binding partner, and it was subsequently shown to be a critical factor for histone 
pre-mRNA processing just before I joined the lab.  In vitro processing assays showed the first 
139 amino acids of N-terminal FLASH were sufficient to stimulate 3’ end pre-mRNA processing 
in HeLa and mouse myeloma nuclear extracts(Yang et al., 2009a). Although limiting in 
mammalian nuclear extracts, supplemented recombinant N-terminal FLASH co-purified with 
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biotinylated histone pre-mRNA incubated in nuclear extracts in a U7 snRNP dependent manner, 
indicating FLASH is associated with the histone 3’ end processing machinery.    
Two regions of N-terminal FLASH are essential to promote a stimulatory effect in the 
processing reaction: the Lsm11 binding site found through amino acids 100-139 and a highly 
conserved LDLY motif at amino acids 55-58.  In mouse myeloma nuclear extracts, removing the 
Lsm11 binding site or altering key residues in this region that prevent binding eliminated the 
stimulatory effect of N-terminal FLASH on processing in vitro. A similar effect was noted when 
the conserved LDLY motif was mutated. Furthermore, the LDLY mutation had a mild inhibitory 
effect on processing when compared to control reactions (Yang et al., 2011). It was theorized this 
was due to the binding of endogenous Lsm11 and sequestration of the U7 snRNP in an inactive 
complex.  
These studies led to the hypothesis that the LDLY motif was critical for the recruitment 
of CPSF73 to histone pre-mRNA in the context of a Lsm11/FLASH interaction. CPSF73 cleaves 
pre-mRNA in histone pre-mRNA 3’ end processing and has been shown to stably associate with 
the two other polyadenylation factors essential for processing, CPSF 100 and symplekin 
(Dominski et al., 2005a; Kolev and Steitz, 2005). In this chapter I present data that show 
CPSF73, CPSF100, and symplekin associate with the Lsm11/FLASH complex, with the critical 
LDLY motif in FLASH fulfilling an essential role for this interaction. These results were 
achieved using a stable complex formed from bacterially expressed N-terminal Lsm11 and 
FLASH, adding it to HeLa or mouse myeloma nuclear extracts, then isolating the material in a 
single step biochemical purification. Surprisingly, a subset of additional polyadenylation factors 
associate with the Lsm11/FLASH platform including the remaining subunits of CPSF and 
CstF64 as the only component of CstF. This unique complex is named the histone pre-mRNA 
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cleavage complex (HCC) and differs from known polyadenylation machinery by the absence of 
CstF50, CstF77, CF Im and CF IIm.  I also map the region of Lsm11 required for binding FLASH 
and examine the other regions of Lsm11 required for interacting with the HCC. The HCC co-
purifies with the U7 snRNP from mammalian nuclear extracts in the presence of recombinant 
FLASH and is recruited to histone pre-mRNA in a U7-dependent fashion under the same 
conditions. Together these data show that at least a portion of the available U7 snRNP exists as a 
stable composite structure containing FLASH and the HCC in nuclear extracts. 
 
MATERIALS AND METHODS 
3’ end processing. The 86-nucleotide mouse H2a pre-mRNA substrate was generated by T7 
RNA polymerase using an appropriate DNA template and was subsequently treated with calf 
intestinal phosphatase (NEB) to remove the 5’ triphosphate. The dephosphorylated H2a pre-
mRNA was labeled at the 5’ end with 32P using T4 polynucleotide kinase (NEB). The 3’ end 
processing reaction was carried out in a nuclear extract prepared from mouse myeloma cells 
(Biovest International, Inc., MN), as previously (Dominski et al., 1995). The H2a/5m pre-
mRNA, anti-U7, and anti-Mock oligonucleotides were synthesized by Dharmacon (Lafayette, 
CO) and had the following sequences:  
H2a/5m (61-mer), 5’-
biotin)(18S)(18S)CUCCCAAAAAGGCUCUUUUCAGAGCCACmCmCmAmCmUGAAUCA
GAUAAAGAGCUGUGACACGGUA-3′; 
 anti-U7 (17-mer), 5’-
mAmAmAmGmAmGmCmUmGmUmAmAmCmAmCmUmU(18S)(18S)(biotin)-3′;  
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anti-Mock (15-mer), 5’-
mCmGmAmGmCmUmCmGmAmUmUmCmGmCmC(18S)(18S)(biotin)-3′.  
Note that in these sequences, “(18S)” represents an 18-atom spacer and “m” represents the 2′-O-
methyl group. 
Mutagenesis and protein expression. Mutations in the N-terminal fragments of FLASH (amino 
acids 29 to 139) and Lsm11 (amino acids 1 to 168) were generated using PCR and appropriately 
altered oligonucleotide primers. FLASH mutants were expressed in bacteria from the pET-42a 
vector, as described previously (Yang et al. 2009), and contained an N-terminal glutathione S-
transferase (GST) tag. I expressed the N-terminal fragment of Lsm11 and its mutant versions in 
bacteria from the pDEST566 vector as fusions with an N-terminal maltose binding protein 
(MBP). Both FLASH and Lsm11 proteins additionally contained a 6×His tag that was used for 
purification on nickel beads (Qiagen), as described by the manufacturer. 
GST pulldown assay. The wild type and various deletion mutants of the N-terminal fragment of 
human Lsm11 (amino acids 1 to 168) were synthesized in the presence of [35S]methionine using 
the TnT kit (Promega), as recommended by the manufacturer. Their ability to interact with 
FLASH was tested using a GST-mediated pulldown assay, as described in detail previously 
(Yang et al., 2009a). Briefly, the 35S-labeled Lsm11 proteins were mixed with the bacterially 
expressed GST-tagged N-terminal FLASH (amino acids 29 to 139) or with GST alone. Proteins 
bound to FLASH were adsorbed on glutathione (GSH) beads, separated on SDS-polyacrylamide 
gels, and detected by autoradiography. 
Binding of nuclear proteins to the Lsm11/FLASH complex. The Lsm11/FLASH complex was 
formed by mixing 100 pmol of each recombinant protein in 100 μl of buffer D (100 mM KCl, 20 
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mM HEPES [pH 7.9], 20% glycerol, 0.2 mM EDTA [pH 8], 0.5 mM dithiothreitol [DTT]). The 
complex was subsequently incubated for 20 min at room temperature with 100 to 300 μl of a 
nuclear extract from HeLa or mouse myeloma cells. Bound proteins were purified on 
glutathione-Sepharose beads via the GST-tagged FLASH, electrophoretically resolved on 8 to 
12% SDS–polyacrylamide gels, and detected by Western blotting and/or staining with either 
Coomassie blue or silver. To identify protein bands that correspond to recombinant FLASH and 
Lsm11, the Lsm11/FLASH complex was bound to glutathione beads in the absence of the 
nuclear extract and electrophoretically separated next to samples containing nuclear proteins. 
Formation of processing complexes and purification of the U7 snRNP. Processing complexes 
were assembled in a final volume of 1 ml containing 750 μl of a highly active mouse myeloma 
nuclear extract, 1.25 μg of the 61-nucleotide H2a/5m pre-mRNA, and 20 mM EDTA. The 
samples were incubated for 5 min at 22°C followed by a 1-h rotation at 4°C. The RNA substrate 
and associated proteins were bound to streptavidin beads, washed several times with buffer D 
containing 20 mM EDTA, and separated on an SDS-polyacrylamide gel. The same method was 
used for the single-step purification of the endogenous U7 snRNP, with the exception that the 
anti-U7 2′-O-methyl oligonucleotide (1 μg) containing biotin at the 3’ end was used instead of 
the H2a/5m pre-mRNA. 
Antibodies. Antibodies against Lsm11 and FLASH were described previously (Yang et al., 
2009a; Yang et al., 2009b). Antibodies against all polyadenylation factors were purchased from 
Bethyl Laboratories. Anti-viral protein R binding protein (anti-VprBP) and anti-damaged DNA 
binding protein 1 (anti-DDB1) were kindly provided by the laboratory of Y. Xiong (University 
of North Carolina at Chapel Hill). 
 
  
37 
 
RESULTS 
Bacterially expressed FLASH and Lsm11 form a tight complex. Although human FLASH 
contains almost 2,000 amino acids, a short N-terminal region encompassing amino acids 52 to 
139 is sufficient to stimulate processing of histone pre-mRNAs in vitro (Yang et al., 2011) (Fig. 
6D, lanes 3 and 4). Amino acids 100 to 135 interact with Lsm11, whereas the highly conserved 
LDLY sequence located between amino acids 55 and 58 plays an essential but undetermined role 
in processing (Fig. 6B). Mutant proteins lacking the LDLY motif inhibit rather than stimulate 
processing in vitro by sequestering Lsm11 (and hence U7 snRNP) into an inactive processing 
complex (Yang et al., 2011) (Fig. 6D, lane 5). The Lsm11 binding site and the LDLY motif are 
functionally conserved in Drosophila FLASH and are essential in vivo (Burch et al., 2011). 
Xiao Yang first tested whether bacterially expressed N-terminal regions of FLASH and 
Lsm11 interact with the same efficiency and specificity as previously shown for radioactively 
labeled proteins generated using in vitro transcription and translation system (TnT) (Yang et al., 
2011; Burch et al., 2011). She bacterially expressed a series of GST-tagged FLASH deletions 
beginning at amino acid 52, 62, 88, 100, or 111 and ending at amino acid 139: FΔ51N, FΔ61N, 
FΔ87N, FΔ99N, and FΔ110N (Fig. 1B and andC).C). Of these FLASH variants, only FΔ28N 
and FΔ51N contain the essential LDLY motif (amino acids 55 to 58) and are active in processing 
(Fig. 6D, lanes 3 and 4) (Yang et al., 2011). I also bacterially expressed Lsm11 (amino acids 1 to 
168) tagged at the N terminus with MBP. With the exception of FΔ110N, which lacks a 
substantial portion of the Lsm11 binding site (Fig. 6C), all of the remaining FLASH deletion 
mutants strongly interact with Lsm11 and the two proteins can be recovered either on glutathione 
beads via the GST tag attached to FLASH or on amylose beads via the MPB tag attached to 
Lsm11. Thus, bacterially expressed N-terminal fragments of FLASH and Lsm11 together form a 
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tight complex and the interaction between these two proteins involves amino acids 100 to 135 of 
FLASH, as previously concluded (Yang et al., 2011). 
Size exclusion chromatography was used to analyze the oligomeric status of bacterially 
expressed N-terminal Lsm11 (amino acids 1 to 168), FΔ51N and their complex. These 
experiments demonstrated that Lsm11 exists in solution as a monomer, while FΔ51N alone 
under the same conditions forms a homo-oligomer, most likely a tetramer. The molecular mass 
of the FΔ51N/Lsm11 complex is consistent with four molecules of FΔ51N interacting with one 
molecule of Lsm11, although further detailed studies are required to confirm this stoichiometry 
in the complex. 
The Lsm11/FLASH complex interacts with multiple polyadenylation factors. Our hypothesis 
was that a complex formed by FLASH and Lsm11 interacts with another processing factor and 
that the LDLY motif is essential for this interaction (Yang et al., 2011). To test this hypothesis, 
Xiao Yang mixed bacterially expressed N-terminal portions of human FLASH and Lsm11 and 
analyzed the ability of the Lsm11/FLASH complex to interact with CPSF73 and/or other 
polyadenylation factors present in nuclear extracts (Fig. 6E). Initially, we used FΔ51N (the 
shortest FLASH active in processing in vitro) either alone or together with Lsm11. The 
recombinant proteins were incubated either alone or with a HeLa nuclear extract for 20 min and 
subsequently collected on glutathione beads via the GST tag attached to FΔ51N. The two 
components of the FΔ51N/Lsm11 complex were recovered on glutathione beads, indicating that 
the presence of the nuclear extract does not interfere with formation of the complex (Fig. 7A, 
compare lanes 2 and 3). The same nuclear extract was also incubated with FΔ51N alone (Fig. 
7A, lane 4). As visualized by silver staining of SDS gels, only a small number of HeLa nuclear 
proteins nonspecifically bind to glutathione beads in the absence of FΔ51N or Lsm11. One of 
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these HeLa proteins migrates slightly slower than FΔ51N (Fig. 7A, lane 1) and comigrates with 
the longer FLASH variant FΔ28N. 
HeLa nuclear proteins bound to the FΔ51N/Lsm11 complex were screened by specific 
antibodies for the presence of CPSF73, CF Im68, and CstF50, each representing a separate class 
of cleavage and polyadenylation factors. Importantly, the FΔ51N/Lsm11 complex interacted 
with readily detectable amounts of CPSF73 but not with CF Im68 or CstF50 (Fig. 7B, lane 4). 
The precipitate also lacked COPS5, a 35 kDa component of the octameric COP9 signalosome 
(Wei et al., 2008), which served as a negative control for protein complexes unrelated to 3’ end 
processing. No CPSF73 bound to FΔ51N alone, emphasizing the requirement for the Lsm11 
partner (Fig. 7B, lane 3). 
Xiao Yang extended this experiment by using FΔ51N and two larger FLASH deletion 
mutants, FΔ61N and FΔ87N (Fig. 6C). We also used more antibodies to look for the presence of 
other polyadenylation factors. No detectable amount of polyadenylation factors accumulated on 
glutathione beads in the presence of Lsm11 alone, which is tagged with MBP and does not bind 
to GSH beads in the absence of GST-tagged FLASH, hence serving as a negative control to 
measure the nonspecific background of nuclear proteins (Fig. 7C, bottom panel, lane 2). Among 
HeLa proteins associated with the complex composed of Lsm11 and the processing-proficient 
FΔ51N FLASH, we identified CPSF73 and all of the remaining CPSF subunits larger than 50 
kDa, including CPSF160, CPSF100, Fip1, and WDR33, although the latter subunit was only 
weakly detected by Western blotting (Fig. 7C, lane 3). CPSF30, which is the smallest subunit of 
CPSF, was detected in independent experiments after resolving proteins in a higher-percentage 
polyacrylamide gel. The bound proteins also included symplekin and CstF64 (Fig. 7C, lane 3). 
Importantly, the binding of all these proteins was abolished when the complex contained the 
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processing-deficient FLASH mutant FΔ61N or FΔ87N (Fig. 7C, lanes 4 and 5). This result 
clearly demonstrates that the strong binding of CPSF73 and other polyadenylation factors to the 
complex is not mediated solely by Lsm11, as the same amounts of Lsm11 were precipitated by 
all three FLASH deletion mutants (Fig. 7C, bottom panel, lanes 3 to 5). 
The material bound to the FΔ51N/Lsm11 complex lacked CF Im68 and CstF50 and 
contained only weakly detectable amounts of CstF77 that were also present when the first 87 
amino acids were deleted from FLASH (Fig. 7C, lanes 3 to 5). Subsequent studies demonstrated 
that CstF77 nonspecifically interacts with Lsm11 and also has a weak affinity for streptavidin 
beads (described below and see Fig. 11A). The complex bound to the FΔ51N/Lsm11 complex 
also did not contain any detectable amounts of CstF64 Tau. This paralogue of CstF64 associates 
with canonical pre-mRNAs (Shi et al., 2009) and can partially substitute for CstF64 in cleavage 
and polyadenylation and in 3’ end processing of histone pre-mRNAs (Ruepp et al., 2011). 
The FΔ51N/Lsm11 complex bound the same set of proteins in a nuclear extract prepared 
from mouse myeloma cells (Fig. 7D, lane 3). Among the mouse proteins bound to the complex, 
WDR33 was readily detectable, as were the two forms of mouse symplekin. Again, with the 
exception of CstF77, the binding of all of the proteins was greatly reduced when the processing-
deficient FΔ87N FLASH mutant was used instead of FΔ51N (Fig. 7D, lane 4). Altogether, the 
results demonstrate that in mammalian nuclear extracts the FΔ51N/Lsm11 complex interacts 
with a specific combination of cleavage and polyadenylation factors: symplekin, all CPSF 
subunits, and CstF64 as the only CStF component. 
The LDLY sequence in FLASH is essential for the efficient recruitment of polyadenylation 
factors. The LDLY motif is absolutely essential for the activity of FLASH in processing (Yang 
et al., 2011), and the above results suggest that this motif might also be critical for binding the 
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multitude of polyadenylation factors to the Lsm11/FLASH complex. To test this assumption, we 
used the processing-deficient LDLY-4A mutant in which the LDLY sequence was replaced with 
4 alanines (Fig. 6C). The mutation was made in the context of the longer FLASH FΔ28N (amino 
acids 29 to 139) fused N terminally to GST. No detectable amounts of polyadenylation factors 
were bound to glutathione beads in the absence of any recombinant protein or in the presence of 
either Lsm11 (amino acids 1 to 168) or FΔ28N alone. The complex of FΔ28N and Lsm11 
efficiently interacted with all the polyadenylation factors previously identified for the 
Lsm11/FΔ51N complex: symplekin, CPSF160, CPSF100, CPSF73, and CPSF30 (Fig. 8A and 
and B). Most strikingly, the complex of Lsm11 and LDLY-4A did not interact with any of these 
proteins (Fig. 8A and B). We conclude that the essential function of the LDLY motif in 
processing is to recruit a subset of polyadenylation factors to histone pre-mRNA. 
To confirm the identity of polyadenylation factors associated with FLASH and Lsm11 
and to potentially identify other interacting proteins, we used mass spectrometry. We assembled 
the complex of Lsm11 (amino acids 1 to 168) and either the FΔ28N FLASH (amino acids 29 to 
139) or its LDLY-4A mutant and incubated each complex with a HeLa nuclear extract. The wild-
type complex interacted with a number of proteins readily detectable in a polyacrylamide gel by 
silver staining as individual bands (Fig. 8C, lane 2). These bands and the remaining parts of the 
same lane and the corresponding regions in the lane containing the mutant complex (Fig. 8C, 
lane 3) were excised and analyzed by mass spectrometry. This analysis fully confirmed the 
results obtained by Western blotting, with the slowest-migrating silver-stained band in the lane 
containing the wild-type complex (Fig. 8C, lane 2) yielding a large number of peptides for 
CPSF160 and WDR33 (band 1). The faster-migrating bands contained symplekin, CPSF100, 
CPSF73, Fip1, and CstF64 (bands 2 to 7). All of these proteins were virtually undetectable in the 
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precipitate bound to the complex of Lsm11 and LDLY-4A (Fig. 8D). Consistent with the results 
of Western blotting, proteomic analysis of the material bound to the wild-type complex did not 
detect any peptides from CstF50 and CF Im68 and only one peptide from CstF77. In addition, no 
traces of other polyadenylation factors, including the Pcf11 subunit of CF IIm, were detected. 
Finally, the complex of the FΔ28N FLASH and Lsm11 does not bind any of previously 
identified proteins specifically involved in 3’ end processing of histone pre-mRNAs, including 
ZFP100 and SLBP. 
Both the wild-type and mutant Lsm11/FLASH complexes bound readily detectable 
amounts of DDB1 (damaged DNA binding protein 1) and its binding partner VprBP (viral 
protein R binding protein) (McCall et al., 2008) that comigrates with CPSF160 and WDR33 
(Fig. 8C, lanes 2 and 3). Subsequent studies revealed that VprBP and DDB1 bind directly to 
Lsm11, and this interaction is not linked to 3’ end processing of histone pre-mRNA in vitro. 
Independent proteomic analyses were conducted using other HeLa nuclear extract 
preparations and a nuclear extract prepared from mouse myeloma cells. The same 
polyadenylation factors invariably bound to the wild-type Lsm11/FLASH complex, regardless of 
whether the extract was very active or poorly active in processing and whether the EDTA was 
omitted or included at the final concentration of 20 mM, as used in the in vitro processing 
reaction. The unique combination of polyadenylation factors bound to the complex of FLASH 
and Lsm11 was also not affected by pretreatment of the nuclear extract with RNase A. 
Regions of Lsm11 required for recruiting polyadenylation factors. Our previous analysis 
indicated that deletion of the first 40 amino acids of Lsm11 (LΔ40N) almost completely 
eliminated its interaction with FLASH  (Yang et al., 2009a). I used the GST-binding assay and 
various 35S-labeled deletion mutants of Lsm11 expressed using the TnT system (Fig. 9A and B) 
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to define the minimal region of Lsm11 required to form a complex with FLASH. A short 
fragment encompassing the first 40 amino acids of Lsm11 (L40N) is not sufficient to interact 
with FΔ28N fused to GST (Fig. 9C, top panel, lane 3). However, extending this region to 65 
amino acids resulted in a minimal Lsm11 (L65N) that interacted with FΔ28N as strongly as the 
entire N-terminal Lsm11 encompassing amino acids 1 to 168 (Fig. 9C, top panels, lanes 6 and 9). 
Further mapping of Lsm11 using 35S-labeled fragments and GST-tagged FΔ28N narrowed the 
region of interaction to between amino acids 19-55 of Lsm11 (L19-55N in Fig. 10 lane 3).   
I bacterially expressed some of the fragments of Lsm11 as fusions with MBP and tested 
their ability to interact with FΔ28N fused to GST and bind polyadenylation factors. As expected, 
only residual amounts of LΔ40N and polyadenylation factors were collected on glutathione 
beads (Fig. 9D, both panels, lane 4), consistent with the virtual inability of this Lsm11 mutant to 
form a complex with FLASH. Importantly, FΔ28N and the L65N mutant, while forming a very 
tight complex, were even less efficient in binding polyadenylation factors (Fig. 9D, both panels, 
lane 5). When the length of Lsm11 was increased from 65 to 130 N-terminal amino acids, the 
corresponding complex was nearly as efficient in binding symplekin, CstF64, and CPSF subunits 
as the wild-type complex containing the entire 168-amino-acid N-terminal Lsm11 (Fig. 9D, both 
panels, compare lanes 3 and 6). Shortening Lsm11 to the first 105 amino acids (L105N in Fig. 
9B) resulted in a significant loss of binding activity by the Lsm11/FLASH complex (Fig. 9E, 
both panels, lanes 3 and 4). Thus, a complex containing the first 130 amino acids of Lsm11 is 
sufficient for binding the polyadenylation factors. 
Polyadenylation factors are present on the endogenous U7 snRNP. We demonstrated that 
large amounts of the recombinant Lsm11/FLASH complex bind a unique combination of 
polyadenylation factors in mammalian nuclear extracts. To determine whether FLASH associates 
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with endogenous Lsm11 in the context of the U7 snRNP, I purified the U7 snRNP on 
streptavidin beads using a 2′-O-methyl oligonucleotide that contains a biotin tag at the 3’ end and 
a sequence complementary to the first 15 nucleotides of the U7 snRNA (anti-U7). I also used a 
3′-biotinylated 2′-O-methyl oligonucleotide with an unrelated sequence that served as a negative 
control (anti-Mock). The experiment was carried out with a nuclear extract from mouse myeloma 
cells, which contains about a 10-fold higher concentration of the U7 snRNP than extracts from 
HeLa cells (unpublished observations). 
As judged by the high enrichment of Lsm11 in the material bound to the anti-U7 
oligonucleotide, this antisense oligonucleotide is very efficient in purifying the U7 snRNP (Fig. 
11A, lane 2). The anti-Mock oligonucleotide did not result in any background of Lsm11, 
indicating that it has no affinity for the U7 snRNA (Fig. 11A, lane 3). Most importantly, readily 
detectable amounts of polyadenylation factors, including several CPSF subunits and CstF64, 
were present in the anti-U7 precipitate but not in the anti-Mock precipitate. Compared with the 
input, the amounts of these proteins were small and this reflects the extremely low concentration 
of endogenous U7 snRNP and FLASH and the large abundance of the polyadenylation factors in 
nuclear extracts. A specific antibody against the N-terminal region of FLASH encompassing 
amino acids 1 to 139 detected a band migrating at about 35 kDa in the anti-U7 precipitate that 
was not present in the control precipitate (Fig. 11A, lanes 2 and 3). This band most likely 
represents a FLASH degradation product encompassing the first ∼300 amino acids of the 
protein, i.e., the region that is sufficient for the interaction with Lsm11 and which contains the 
region used to generate the anti-FLASH antibody (Yang et al., 2009a). 
Only background amounts of CstF77 were detected in both the anti-U7 and anti-Mock 
precipitates, indicating that CstF77 is not part of a complex with CstF64 in the U7 snRNP (Fig. 
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11A, lanes 2 and 3). In agreement with the data obtained for the recombinant Lsm11/FLASH 
complex, the U7 snRNP-bound proteins also did not contain detectable amounts of CstF50 or CF 
Im68. We conclude that in mammalian cells at least a fraction of the U7 snRNP exists as a 
preassembled complex containing the same set of polyadenylation factors that interact with the 
recombinant Lsm11/FLASH complex. 
Addition of recombinant FΔ28N but not the LDLY-4A mutant increased the amount of 
polyadenylation complex bound to the U7 snRNP but had no effect on the amount of CstF77 
detected (Fig. 11B, lanes 2 and 3). Note that lane 3 compared to lane 2 was loaded with a smaller 
amount of U7 snRNP, as indicated by a weaker signal for Lsm11, yet symplekin, CPSF160, 
CPSF73, CPSF30, and CstF64 were clearly more abundant. These results confirm that a fraction 
of the endogenous U7 snRNP is associated with a subset of polyadenylation factors and support 
the notion that these factors are recruited to the U7 snRNP by FLASH interacting with Lsm11. 
Composition of the processing complex assembled on histone pre-mRNA. We next 
investigated whether the same cleavage and polyadenylation factors, including the endonuclease 
CPSF73, can be detected in vitro in a complex assembled on histone pre-mRNA. An obstacle in 
achieving this goal is that the cleavage reaction proceeds very rapidly in nuclear extracts 
incubated at room temperature, causing disruption of the processing complex. Previously, we 
used low concentrations of NP-40 (0.05 to 0.1%) to block the cleavage reaction and to arrest 
processing complexes during the assembly process (Yang et al., 2009a). This strategy allowed us 
to capture SLBP and the U7 snRNP in association with histone pre-mRNA, but we failed to 
detect any polyadenylation factors. One possibility was that while NP-40 blocks processing, it 
does so by destabilizing the interaction of polyadenylation factors with FLASH bound to the U7 
snRNP. 
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To avoid this potential limitation, Dr. Dominski designed a new histone pre-mRNA 
substrate termed H2a/5m in which 5 nucleotides surrounding the major and three minor cleavage 
sites were modified with a 2′-O-methyl group (Fig. 11C). Our previous studies demonstrated that 
2′-O-methyl nucleotides are resistant to hydrolysis by CPSF73 when it acts as a 5’ exonuclease 
(Yang et al., 2009). The H2a/5m substrate also contained two point mutations within the HDE 
that improved its interaction with the U7 snRNA and biotin at the 5’ end for subsequent 
purification of bound nuclear components on streptavidin beads. When incubated in a mouse 
nuclear extract, the H2a/5m pre-mRNA assembled into a stable complex containing highly 
enriched amounts of SLBP and, as judged by the presence of Lsm11, the U7 snRNP. This result 
indicates that the cleavage reaction was at least partially blocked (Fig. 11D, lane 2). 
As determined using specific antibodies, the complex assembled on the H2a/5m pre-
mRNA contained the same polyadenylation factors that associate with the recombinant 
Lsm11/FLASH complex or the U7 snRNP, including symplekin, CPSF subunits, and CstF64 but 
lacking CstF50 and CF Im68 (Fig. 11D, lane 2). Addition of recombinant FLASH (amino acids 
29 to 139) only slightly increased the amount of these factors in the processing complex, 
although the recombinant FLASH was efficiently delivered to the H2a/5m pre-mRNA through 
the interaction with Lsm11. Importantly, blocking the U7 snRNA by a 2′-O-methyl 
oligonucleotide identical to the anti-U7 but lacking the biotin tag prevented the association of the 
U7 snRNP, recombinant FΔ28N, and all of the polyadenylation factors with the pre-mRNA 
substrate without affecting the binding of SLBP (Fig. 11D, lane 4). Again, only very small 
amounts of CstF77 were detected in both the presence and the absence of the anti-U7 
oligonucleotide (Fig. 11D, compare lanes 2 to 4), indicating that this protein nonspecifically 
associates with the substrate and/or streptavidin beads and is not part of the complex with other 
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polyadenylation factors. We conclude that a preassembled U7 snRNP containing the CPSF73 3’ 
endonuclease and multiple polyadenylation factors is delivered to histone pre-mRNA through the 
interaction between the HDE and the U7 snRNA for 3’ end processing (Fig. 11E). 
 
DISCUSSION 
Cleavage of animal replication-dependent histone pre-mRNAs critically depends on the U7 
snRNP that interacts with the histone downstream element (HDE) located several nucleotides 3′ 
of the cleavage site. Histone pre-mRNAs do not share any sequence elements with canonical pre-
mRNAs, and their cleavage is not followed by the polyadenylation step. Previous studies showed 
that 3’ end processing of histone pre-mRNAs requires at least three components of the 
cleavage/polyadenylation machinery: the endonuclease CPSF73, CPSF100, and symplekin 
(Dominski et al., 2005c; Kolev and Steitz 2006; Wagner et al., 2007). For canonical pre-mRNAs, 
the CPSF73 endonuclease is brought to the vicinity of the cleavage site primarily by CPSF160, 
which recognizes the upstream AAUAAA element (Mandel et al., 2008). However, it has not 
been determined how CPSF73 and the two other common subunits are recruited to the 
processing machinery assembled on histone pre-mRNAs. 
A subset of polyadenylation factors interacts with the Lsm11/FLASH complex. Of the 
known components of the U7 snRNP-based processing machinery, Lsm11 was the most likely 
candidate for a protein that either directly or indirectly recruits CPSF73 to histone pre-mRNA. 
First, Lsm11 is the largest component of the U7-specific Sm ring and contains an extended N-
terminal region of about 170 amino acids that is essential for processing (Azzouz et al., 2005). 
Furthermore, this extended region interacts with FLASH (Yang et al., 2009a), a recently 
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identified factor required for endonucleolytic cleavage of histone pre-mRNAs by CPSF73 (Yang 
et al., 2011). Finally, the base pair interaction between the HDE and the 5’ end of the U7 snRNA 
brings Lsm11 near the cleavage site (Yang et al., 2009b). 
In this study, Xiao Yang bacterially expressed the N-terminal fragments of FLASH and 
Lsm11 and showed that these two recombinant proteins interact with each other. Our initial gel 
filtration experiments demonstrated that the Lsm11/FLASH complex is significantly larger than 
a simple heterodimer of the two proteins and suggest that it may consist of four molecules of 
FLASH and one molecule of Lsm11. This conclusion is consistent with the mechanism of 3’ end 
processing in which a single particle of the U7 snRNP interacts with histone pre-mRNA and with 
the observation that FLASH can self-associate through the N-terminal region (Kiriyama et al., 
2009). 
The complex of recombinant FLASH and Lsm11 tightly interacts with a unique 
combination of polyadenylation factors present in mammalian nuclear extracts, whereas FLASH 
and Lsm11 individually are unable to bind the same factors with efficiency. Among nuclear 
proteins associated with the Lsm11/FLASH complex were symplekin, CstF64, and all subunits 
of CPSF, including the recently discovered component WDR33 (Shi et al., 2009) and the 
endonuclease CPSF73. This is the first biochemical demonstration of an interaction between 
proteins specifically devoted to processing of histone pre-mRNAs (FLASH and Lsm11) with 
subunits of the cleavage and polyadenylation machinery. The two other subunits of CStF, CstF77 
and CstF50, as well as the cleavage factors I and II, were absent, indicating that FLASH and 
Lsm11 interact with a specific subset of polyadenylation factors. 
The interaction of the Lsm11/FLASH complex with CPSF subunits, CstF64, and 
symplekin was abolished by mutating the LDLY sequence in FLASH, a highly conserved cluster 
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of amino acids found in FLASH orthologues of both vertebrates and invertebrates. Thus, all of 
these polyadenylation factors likely exist in the cell as a single complex that is specifically 
crafted to directly interact with the Lsm11/FLASH complex. Due to the presence of the CPSF73 
endonuclease, we refer to this complex as the histone pre-mRNA cleavage complex (HCC). The 
LDLY motif is absolutely essential for the activity of FLASH in processing of histone pre-
mRNAs in mammalian nuclear extracts (Yang et al., 2011), and deletion of the corresponding 
LDIY sequence in Drosophila FLASH disrupts 3’ end processing in cultured S2 cells (Burch et 
al., 2011). These results demonstrate that the role of this motif in processing is to recruit the 
CPSF73 endonuclease and other components of the HCC to the Lsm11/FLASH complex. 
The details of the interaction between the Lsm11/FLASH complex and the HCC are not 
known. In human Lsm11, I showed amino acids 19 to 55 interact with FLASH and an additional 
region(s) located between amino acids 66 and 130 is required for binding the HCC by the 
Lsm11/FLASH complex. In the simplest model, the LDLY motif in FLASH and amino acids 66 
to 130 in Lsm11 have individually a weak affinity for one or more components of the HCC. 
When these two sequence elements are juxtaposed together in the Lsm11/FLASH complex, they 
function in a cooperative manner, resulting in a very tight binding of the HCC. An important role 
in binding the HCC may also be played by the interface of the interacting Lsm11 and FLASH 
and/or potential structural rearrangements in each protein triggered by the formation of the 
Lsm11 and FLASH complex. 
Intriguingly, the HCC is very similar in its composition to the heat labile factor (HLF) 
that was identified by Kolev and Steitz in HeLa cell nuclear fractions capable of restoring the 
ability of heat-treated nuclear extracts to process histone pre-mRNAs (Kolev and Steitz, 2005). 
The HLF contains symplekin as the most heat-sensitive component and cofractionated with all of 
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the known CPSF subunits and CstF64. Similar to the complex recruited to histone pre-mRNA, 
the HLF lacks CstF50 and subunits of CF Im and CF IIm but was reported to contain CstF77, 
which we detect as a nonspecific contaminant. An attractive possibility is that the HCC and the 
HLF are identical and CstF77 is not a genuine part of the HLF but simply copurifies as a 
component of a different complex sharing similar chromatographic properties to the HCC. Taken 
together, our findings and the previous results of Kolev and Steitz demonstrate that the 
functional overlap between the canonical cleavage/polyadenylation and 3’ end processing of 
histone pre-mRNAs is much more extensive than previously anticipated, strongly suggesting that 
these two 3’ end processing reactions are evolutionarily related (Gilmartin, 2005). 
U7 snRNP as a preformed 3’ end processing unit. The HCC is also associated with the 
endogenous U7 snRNP in the absence of a pre-mRNA substrate. Based on our experiments with 
recombinant Lsm11 and FLASH, the assembly of this “active” U7 snRNP is dependent on 
FLASH, which is limiting in many nuclear extracts. Indeed, addition of recombinant wild-type 
FLASH, but not the LDLY-4A mutant, to a nuclear extract stimulated the association of the 
polyadenylation complex with the U7 snRNP. Overall, our results reveal an unexpected 
complexity of the U7 snRNP, previously believed to consist solely of the U7 snRNA and the Sm 
ring. 
Previous studies of U7 snRNP purified by several chromatographic steps did not reveal 
novel components of this snRNP other than Lsm10 and Lsm11, suggesting that the entire HCC 
dissociated from U7 snRNP during purification, perhaps as a result of FLASH proteolysis (Pillai 
et al., 2001a; Smith et al., 1991). More recent proteomic studies identified CF Im68 as the only 
polyadenylation factor that associates with the U7 snRNP (Ruepp et al., 2010). We found no 
evidence that this protein is recruited by the Lsm11/FLASH complex or is part of the 
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endogenous U7 snRNP purified by the anti-U7 oligonucleotide. Further studies are required to 
determine the source of this contradiction. 
I also isolated a processing complex assembled on a histone pre-mRNA that was resistant 
to cleavage as a result of the placement of five 2′-O-methyl nucleotides around the cleavage site. 
This processing complex contained SLBP, U7 snRNP, and the same combination of 
polyadenylation factors that bind the Lsm11/FLASH complex, suggesting that the “active” form 
of U7 snRNP carrying the HCC is directly delivered to histone pre-mRNA through a single-step 
base-pairing interaction between the HDE and U7 snRNA. Addition of recombinant FLASH 
only slightly stimulated recruitment of the HCC to the modified histone pre-mRNA, suggesting 
that the interaction between the HCC and the U7 snRNP in the context of the entire processing 
machinery assembled on histone pre-mRNA is intrinsically less stable and/or the modified 
substrate was undergoing limited cleavage in neighboring sites that lack the 2′-O-methyl 
modification. 
Potential roles of components of the HCC in 3’ end processing of histone pre-mRNAs. 
CstF64 was previously shown to interact through overlapping regions with either CstF77 or 
symplekin, but it is unable to interact with these two proteins simultaneously (Takagaki and 
Manley, 2000; Ruepp et al., 2011). The presence of CstF64 and symplekin in the complex bound 
to the Lsm11/FLASH complex likely explains the concomitant lack of CstF77 and CstF50, as 
CstF50 interacts with CstF77 (Takagaki and Manley, 2000; (Bai et al., 2007). Thus, our data 
suggest that the previously puzzling mutually exclusive interaction of CstF64 with either 
symplekin or CstF77 allows formation of two alternative complexes in animal cells: one 
containing all three CStF subunits that functions in cleavage and polyadenylation and the other 
composed of CstF64 and symplekin that operates on histone pre-mRNAs (Fig. 11E). This 
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interpretation is strongly supported by the recent in vivo studies of Schumperli and coworkers 
who in an elegant set of experiments addressed the role of the CstF64-symplekin interaction in 3’ 
end processing of canonical and histone pre-mRNAs. These authors designed a symplekin 
mutant that does not bind CstF64 and tested its ability to substitute for the endogenous 
symplekin depleted from HeLa cells by RNA interference (RNAi) (Ruepp et al., 2011). 
Importantly, this mutant protein could efficiently rescue cleavage/polyadenylation, but formation 
of mature histone mRNAs remained impaired, demonstrating that in vivo the symplekin-CstF64 
interaction is required for 3’ end processing of histone pre-mRNA but not canonical pre-mRNAs. 
Intriguingly, CstF64 is the only known component of the cleavage and polyadenylation 
machinery that is upregulated several fold as cells transit from G0 to S phase (Martincic et al., 
1998). In addition, depletion of CstF64 causes cell-cycle arrest and apoptosis-like cell death 
(Takagaki and Manley, 1998), and this phenotype could be directly related to its role in 
generating mature histone mRNAs. Overall, our results suggest that the biochemical function of 
the CstF64/symplekin heterodimer is to interact with FLASH and Lsm11 and to bring other 
polyadenylation factors, including CPSF73 and CPSF100, to the U7 snRNP. This “active” U7 
snRNP is ultimately recruited to histone pre-mRNA for 3’ end processing. 
With the exception of CPSF73, which contacts the cleavage site in histone pre-mRNA 
and functions as the 3′ endonuclease (Dominski et al., 2005c; Dominski, 2010), the role of the 
remaining CPSF subunits in the U7-dependent processing is largely unknown. CPSF100 is a  
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noncatalytic homologue, binding partner, and perhaps a regulator of CPSF73 (Kolev et al., 2008; 
Dominski). CPSF160, CPSF30, Fip1, and WDR33 may be essential for maintaining the integrity 
of the polyadenylation complex or play regulatory roles in vivo by connecting 3’ end processing 
of histone pre-mRNAs with other cellular processes. However, it is also possible that at least 
some of these subunits are simply passive bystanders that play no role in the U7-dependent 
processing. 
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Figure 6. Biochemical assay to identify proteins interacting with a complex of FLASH and 
Lsm11. (A) The known critical factors in 3’ end processing of histone pre-mRNA (blue line) are 
shown. Vertical lines indicate base paring between the histone downstream element (HDE) and 
the 5’ end of U7 snRNA (gray line). Histone pre-mRNAs are cleaved by CPSF73 typically five 
nucleotides after the stem-loop (arrow). The reaction also requires CPSF100, symplekin, and 
potentially other factors (question mark). (B) Amino acid sequence of the N-terminal region of 
human FLASH (amino acids 1 to 139). The first amino acids of various N-terminal truncations 
are indicated with arrowheads. The Lsm11-binding site is indicated with a double-headed arrow, 
and the LDLY motif is underlined. (C) Diagram of FLASH mutants used in this study. The GST 
tag is fused N terminally to each protein and is not indicated. The ability of each FLASH protein 
to support processing or bind Lsm11 is indicated. (D) In vitro processing of histone pre-mRNA 
with a limiting amount of mouse nuclear extract (NE) in the absence of any recombinant protein 
(lane 2) or in the presence of 100 ng of various FLASH proteins, as indicated (lanes 3 to 5). Lane 
1 contains the input substrate. (E) Schematic of the assay for isolation of factors that bind to the 
Lsm11/FLASH complex. The N-terminal FLASH (amino acids 29 to 139) fused to GST and the 
N-terminal Lsm11 (amino acids 1 to 168) fused to MBP were incubated with a nuclear extract, 
and interacting proteins were purified on glutathione beads. 
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Figure 7. The Lsm11/FLASH complex binds a subset of factors involved in cleavage and 
polyadenylation. (A) GST-mediated binding of the FΔ51N/Lsm11 complex to glutathione 
(GSH) beads in the absence (lane 2) or in the presence (lane 3) of a HeLa nuclear extract (NE). 
Binding of FΔ51N alone in the presence of the same nuclear extract is shown in lane 4. Proteins 
bound to GSH beads were resolved in an 8% SDS–polyacrylamide gel and stained with silver. 
Proteins in the nuclear extract bound to GSH beads in the absence of recombinant proteins are 
shown in lane 1 (indicated with asterisks). (B) FΔ51N (lane 3), alone or together with Lsm11 
(lane 4), was incubated with a HeLa nuclear extract, and the material bound to GSH beads was 
tested for the presence of CPSF73, CF Im68, CstF50, and COPS5 using specific antibodies. Lane 
2 contains proteins bound to GSH beads in the absence of recombinant proteins, and HeLa NE 
input (20%) is shown in lane 1. (C and D) Proteins of a HeLa nuclear extract (C) or mouse 
myeloma (Mm) nuclear extract (D) bound to GSH beads in the presence of indicated 
recombinant proteins were analyzed by Western blotting using specific antibodies. Coomassie 
blue staining of the two recombinant proteins bound to GSH beads is shown in the bottom 
panels. Lane 2 in each panel shows proteins collected on GSH beads in the presence of Lsm11, 
which is tagged with MBP and does not bind to GSH beads, hence serving as a negative control 
to measure the nonspecific background (see the bottom panels). 
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Figure 8. The LDLY motif in FLASH is required for the interaction of the complex with 
polyadenylation factors. (A and B) HeLa nuclear proteins bound to GSH beads in the presence 
of the indicated Lsm11/FLASH complexes were analyzed using specific antibodies. Lane 2 in 
panel B contains HeLa nuclear proteins bound to GSH beads in the absence of recombinant 
proteins. (C and D) The identity of HeLa nuclear proteins bound to GSH beads in the presence of 
the indicated complexes (lanes 2 and 3) was determined by mass spectrometry. HeLa proteins 
were electrophoretically separated in a 10% SDS–polyacrylamide gel and stained with silver (C). 
Note that the LDLY-4A mutant migrates slower than the wild-type FΔ28N. Lanes 2 and 3 were 
divided into 11 equal sections and treated with trypsin, and the complete proteome of each gel 
section was determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The 
most abundant proteins identified by mass spectrometry were assigned to individual silver-
stained bands (indicated with arrows) and are listed in panel D. Lane 1 in panel C contains HeLa 
nuclear proteins bound to GSH beads in the absence of recombinant proteins, and it was not 
analyzed by mass spectrometry. Column M in panel D shows molecular masses in kDa.  
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Figure 9. Sequences in Lsm11 required for binding the polyadenylation complex by the 
Lsm11/FLASH complex. (A) Amino acid sequence of the N-terminal region of human Lsm11 
(amino acids 1 to 168). The first or last amino acids of various truncations are indicated with 
arrowheads, and the FLASH-interacting region is underlined. (B) Diagrams of Lsm11 
truncations used in the study. The MBP tag is fused N terminally to Lsm11 and is not indicated. 
(C) Binding of 35S-labeled Lsm11 truncations by either GST or FΔ28N tagged with GST, as 
indicated. GST-tagged proteins collected on GSH beads were stained with Coomassie blue 
(bottom panels). (D and E) Polyadenylation factors bound to GSH beads in the presence of the 
indicated FLASH and Lsm11 variants (lanes 3 to 6 in panel D and lanes 3 and 4 in panel E) were 
identified by Western blotting using specific antibodies. The recombinant proteins were stained 
with silver to monitor their recovery on GSH beads (bottom panels). The asterisk in panel E 
indicates a HeLa nuclear protein that nonspecifically binds to GSH beads and comigrates with 
FΔ28N (bottom panel, lane 2). 
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Figure 10. Refined mapping of Lsm11 regions required for binding to FLASH. Binding of 
35S-labeled Lsm11 fragments to GST tagged N-terminal FLASHΔ28N (FΔ28N). Phosphoscreen 
images at top show radiolabeled Lsm11 fragments with 20% input in lane 1, GST control shown 
in lane 2, and FΔ28N in lane 3. Proteins collected on glutathione sepharose beads are shown 
below on Coomassie stained gel.  
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Figure 11. Polyadenylation factors bind to the endogenous U7 snRNP and histone pre-
mRNA. (A) A mouse myeloma nuclear extract was incubated with the anti-U7 oligonucleotide 
(lane 2) or with an unrelated oligonucleotide (lane 3, anti-Mock), both containing a biotin tag at 
the 3’ end. Bound proteins were collected on streptavidin beads and analyzed by Western 
blotting using specific antibodies. (B) The anti-U7 oligonucleotide (lane 2) was used to purify 
the U7 snRNP from a mouse myeloma nuclear extract supplemented with either LDLY-4A (lane 
2) or wild-type FΔ28N (lane 3). Purified proteins were analyzed using specific antibodies. Note 
that the recombinant FLASH is not present in the input nuclear extract. (C) A depiction of the 
61-nucleotide H2a/5m histone pre-mRNA in which 5 nucleotides adjacent to the major cleavage 
site (large arrow) and minor cleavage sites (small arrows) are modified with a 2′-O-methyl 
group. The H2a/5m pre-mRNA contains the upstream stem-loop, the HDE fully complementary 
to the U7 snRNA, and biotin at the 5’ end. (D) The H2a/5m pre-mRNA was incubated with a 
mouse myeloma nuclear extract under control (lane 2) or in the presence of recombinant FΔ28N 
without (lane 3) or with the anti-U7 oligonucleotide (lane 4). Proteins bound to the H2a/5m 
substrate were collected on streptavidin beads and analyzed by Western blotting using specific 
antibodies. FΔ28N is not present in the input nuclear extract, and the band detected in the same 
region in lane 1 is a result of cross-reactivity with an antibody used concomitantly with the anti-
FLASH antibody. (E) Composition of the polyadenylation complex recruited to the U7 snRNP 
and histone pre-mRNA by the Lsm11/FLASH complex. Amino acid regions in FLASH and 
Lsm11 involved in formation of the complex and binding the polyadenylation factors are 
indicated. The interaction between CstF64 and symplekin is mutually exclusive with the 
formation of the CStF complex, (CstF64, CstF77, and CstF50), which is involved in 3’ end 
processing of canonical pre-mRNAs by cleavage and polyadenylation. 
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CHAPTER 3: THE U7 SNRNP AND FLASH ASSOCIATE WITH A DIFFERENT 
SUBSET OF CLEAVAGE AND POLYADENYLATION FACTORS LACKING CPSF30 
AND FIP1 IN DROSOPHILA 
 
INTRODUCTION 
In Chapter 2, I showed bacterially expressed FLASH and Lsm11 N-terminal fragments, two 
proteins unique to histone pre-mRNA 3’ end processing, interact to form a platform that stably 
associates with a subset of polyadenylation factors called the histone pre-mRNA cleavage 
complex (HCC) in mammalian nuclear extracts. The HCC contains all six subunits of CPSF, 
including the endonuclease CPSF73, in addition to symplekin and CstF64. The only proteins in 
the HCC that have been shown to be essential for processing are CPSF73, its catalytically 
inactive binding partner CPSF100, and symplekin. Unlike the larger polyadenylation complex 
required for 3’ end processing of canonical pre-mRNAs, the HCC lacks two subunits of CstF, 
CstF50 and CstF77, and the two cleavage factors CF Im and CF IIm. Interaction between the 
mammalian Lsm11/FLASH complex and HCC is critically dependent on a highly conserved 
LDLY motif in FLASH. The LDLY motif is essential for processing in vitro and mutating these 
amino acids abolishes the ability of FLASH to stimulate processing in mammalian nuclear 
extracts. The HCC associates with the U7 snRNP and is recruited to histone pre-mRNA in a 
FLASH dependent manner. Thus, at least a portion of the native U7 snRNP has a composite 
structure in which FLASH bound to the U7 snRNP through Lsm11 interacts with a subset of 
polyadenylation factors, including the endonuclease. This complex is brought to the histone pre-
mRNA by partial base pairing, thereby behaving as an RNA guided endonuclease.  In this 
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chapter, I show that in Drosophila a unique HCC associates with the U7 snRNP and is recruited 
to histone pre-mRNA. 
 Cleavage of the pre-mRNA yields a mature histone mRNA and a downstream cleavage 
product (DCP), which is degraded exonucleolitycally in the 5’-3’ directon. Degradation of the 
DCP is dependent on the U7 snRNP and is important to release the U7 snRNP from the HDE for 
additional rounds of processing.  The degradation reaction is catalyzed by CPSF73, the 
endonuclease activity can also function as a 5’ to 3’ exoncuclease (Dominski et al 2005). In 
mammals, FLASH does not have a role in DCP degradation, yet here I show it is essential for 
degradation in Drosophila.  
 FLASH is a large 220 kDa protein in mammalian cells and has been shown to interact 
with Ars2 through a domain in its central region. Ars2 was originally identified in a screen 
searching for genes conferring resistance to sodium arsenite in a hamster cell line. In Drosophila, 
Ars2 was shown to be a member of the Cap Binding Complex through an interaction with 
CBP80 and to play a role in the processing of pri-microRNAs to pre-microRNAs (Sabin et al., 
2009; Gruber et al., 2009). Mutations of the Ars2 orthologue in Arabidopsis also show defects in 
microRNA biogenesis (Lobbes et al., 2006). Additionally, it is required for cellular proliferation 
(Gruber et al., 2009) and depletion of Ars2 in mammalian cells results in a small portion of mis-
processed histone mRNA transcripts that are polyadenylated on the 3’ end, suggesting a possible 
involvement in histone pre-mRNA processing. Here I examine whether the interaction between 
FLASH and Ars2 is conserved in Drosophila.  
 In Drosophila the interaction between FLASH and Lsm11 is conserved (Yang et al., 
2009a) and FLASH is required for histone pre-mRNA 3’ end processing in vivo (Burch et al., 
2011). Similar to processing in mammals, CPSF73 is the endonuclease in Drosophila and the 
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only other polyadenylation factors shown to be essential for processing in vivo are CPSF100, and 
symplekin (Wagner et al., 2007). Whether or not there was a complex analogous to the 
mammalian HCC in Drosophila that associated with the U7 snRNP was unknown.  
For this chapter, I prepared large scale Drosophila Kc nuclear extracts that are active in 
3’ end processing to characterize the U7 snRNP and associated complexes. Using a number of 
different protocols and purification approaches, I show the U7 snRNP co-purifies with a set of 
polyadenylation factors similar in composition to the mammalian HCC. The Drosophila HCC 
associates with the U7 snRNP and is recruited to the pre-mRNA in a U7-dependent fashion. 
Recruitment of this composite U7 snRNP to histone pre-mRNA is completely independent of the 
stem-loop or SLBP binding to the stem-loop. I contrast the Drosophila HCC with a larger super 
complex of cleavage and polyadenylation factors immunoprecipitated using an antibody we 
raised against CstF64. Furthermore, I depleted small scale Drosophila S2 cell cultures of FLASH 
by RNA interference and prepared nuclear extracts for in vitro 3’ end processing assays to show 
that the LDLY sequence in mammals is functionally conserved in insects. I use these same 
extracts to demonstrate a critical role for FLASH in Drosophila DCP degradation. Finally, I 
show Ars2 does not interact in a complex with FLASH in Drosophila cells.    
 
 
MATERIALS AND METHODS 
Drosophila nuclear extracts and 3’ end processing. The 106-nt Drosophila H3 pre-mRNA 
used as a substrate for 3’ end processing was generated by T7 RNA polymerase, treated with calf 
intestinal phosphatase (NEB), and labeled at the 5’ end with 32P using T4 polynucleotide kinase 
(NEB). 3’ end processing reactions were carried out in nuclear extracts prepared from either S2 
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or Kc Drosophila cells, as previously described (Dominski et al., 2002; Dominski et al., 2005b). 
Unless otherwise indicated, the extracts were prepared from freshly harvested cells. The cells 
were grown at room temperature in the serum-free D-22 medium (US Biological) using spinner 
flasks. 
 
Synthetic RNAs 
The following RNAs (written in the 5’–3′ orientation) were used in this study: 
-Biot-dH3 pre-mRNA (63-mer): 
(Bi)(18S)(18S)CUCUAUAAUCGGUCCUUUUCAGGACCACAAACCAGAUUCAAUGAGA
UAAAAUUUUCUGUUGCC 
-Biot-dH3ΔSL (47-mer): 
(Bi)(18S)(18S)CUCUAUAAUCACAAACCAGAUUCAAUGAGAUAAAAUUUUCUGUUGC
C 
-Biot-mH2a pre-mRNA (62-mer): 
(Bi)(18S)(18S)CUCCCAAAAAGGCUCUUUUCAGAGCCACCCACUGAAUCAGAUAAAG
AGUUGUGUCACGGUAG 
-Biot-SL (31-mer): 
(Bi)(18S)(18S)GUGCCAAAAAGGCUCUUUUCAGAGCCACCCA 
-Biot-αU7 (20-mer): 
mCmAmAmAmGmAmGmAmAmUmAmAmAmAmAmUmUmUmUmC(18S)(18S)(Bi) 
  
70 
 
-Biot-αMock (17-mer): 
mAmAmAmGmAmGmCmUmGmUmAmAmCmAmCmUmU(18S)(18S)(Bi) 
-αU7 (17-mer): 
mCmAmAmAmGmAmGmAmAmUmAmAmAmAmAmUmU 
-WT SL (31-mer): 
GUGCCAAAAAGGCUCUUUUCAGAGCCACCCA 
-Mut SL (31-mer): 
GUGCCAAUUAGCCUCUUUUCAGAGGCACCCA 
where (Bi) biotin; (18S) 18-atom spacer; and (m) 2′-O-methyl group. The Biot-dH3ΔSL RNA 
was synthesized by IDT. The remaining RNAs were ordered from Dharmacon. 
RNAi in Drosophila S2 cells. For preparation of nuclear extracts from RNAi-depleted cells, a 
total of 106 Drosophila S2 cells were plated in serum-free SF900 medium (GIBCO) and treated 
daily with 10 µg of double-stranded (ds) RNAs against selected Drosophila genes. After 5 d of 
treatment, cells were collected and used to prepare small-scale nuclear extracts. Each preparation 
yielded ∼100 µL of a nuclear extract. For analyzing the expression of GFP reporters, Drosophila 
S2 cells were plated as described above and treated with dsRNA for 48–72 h. Following the 
treatment, cells were transfected with appropriate GFP reporter plasmids, as described (Wagner 
et al., 2007; Burch et al., 2011) and 24 h later viewed on an Olympus IX81-ZDC inverted 
fluorescence microscope. 
Degradation of Drosophila DCP. Degradation reactions were carried out in nuclear extracts 
prepared from Drosophila S2 cells (see above). Extracts were incubated with 5’ end labeled DCP 
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substrate for 120 minutes in the presence of 10mM EDTA and reactions stopped by treating 
mixtures for 1 h with 0.5mg/mL of proteinase K. Products were diluted in a 7M urea gel and 
resolved on 8% polyacrylamide 7M urea gels.  
Mutagenesis and protein expression. Mutations in the N-terminal fragment of Drosophila 
FLASH (amino acids 1–178) were generated using PCR and appropriately altered 
oligonucleotide primers. Drosophila FLASH fused N-terminally to glutathione S-transferase 
(GST) was expressed in bacteria from the pET-42a vector. Drosophila Lsm11 (amino acids 1–
153) fused N-terminally to maltose binding protein (MBP) was expressed in bacteria from the 
pDEST566 vector. Both recombinant proteins were purified on nickel beads (QIAGEN) using 
the His-tag present in each protein. 
Binding of Drosophila nuclear proteins to Drosophila Lsm11/FLASH complex. The 
Drosophila Lsm11/FLASH complex was formed by mixing 100 pmol of each recombinant 
protein in 100 µL of buffer D (100 mM KCl, 20 mM HEPES at pH 7.9, 20% glycerol, 0.2 mM 
EDTA at pH 8, 0.5 mM DTT). All the subsequent steps were carried out as described previously 
(Yang et al., 2013), with the exception that 100 µL of Drosophila nuclear extracts from either Kc 
or S2 cells was used instead of mammalian nuclear extracts. 
Formation of processing complexes and purification of the Drosophila U7 snRNP. 
Processing complexes were assembled in a final volume of 4 mL that contained 3 mL of a 
nuclear extract from Kc cells, 2.5 µg of the 63-nt Biot-dH3 pre-mRNA, 50 µg of yeast tRNA 
(Invitrogen), and 10 mM EDTA. The samples were incubated for 5 min at 22°C followed by 1 h 
of rotation at 4°C. The RNA substrate and associated proteins were bound to streptavidin beads, 
washed several times with buffer D/10 mM EDTA for a total of 1.5 h, and separated on a 
SDS/polyacrylamide gel. A similar approach was used for the single-step purification of the 
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endogenous U7 snRNP with the exception that the Biot-αU7 2′-O-methyl oligonucleotide 
containing biotin at the 3’ end was used instead of the Biot-dH3 pre-mRNA. 
Immunoprecipitations. A single sample typically contained 1 mL of a nuclear extract (∼10 mg 
of total protein) and 3–5 µg of an affinity-purified specific antibody, and it was rotated for 4–14 
h at 4°C. Following incubation, the extract was spun down at 10,000 rpm in a table-top 
microcentrifuge and rotated for 2 h with ∼30 µL of protein A plus agarose beads (Pierce) to 
purify protein complexes bound to the antibody. The beads were washed with buffer D (see 
above) for a total of 2 h, moved to a new tube, and resuspended in an SDS sample buffer. The 
material immobilized on the beads was separated in a single SDS/polyacrylamide gel for analysis 
by silver staining/mass spectrometry or in three or four gels for analysis by Western blotting 
using various antibodies. 
Mass spectrometry. Protein associated with the Drosophila U7 snRNP, Biot-dH3 pre-mRNA, 
or precipitated by specific antibodies was separated on SDS/polyacrylamide gels, excised from 
the gel, treated with trypsin, and identified by LC-MS/MS using the Nano-Acquity LC system 
(Waters) and Orbitrap Velos mass spectrometer (Thermo Electron Corp.), as described (Yang et 
al., 2013). 
Antibodies. Custom-made antibodies against Drosophila Lsm11 and Drosophila CstF50 were 
kindly provided by J. Gall and John Lis, respectively. Antibodies against the N-terminal portion 
of Ars2 (amino acids 1–167 of total 769 residues), full-length Drosophila CstF64 (amino acids 
1–437), and the N-terminal portion of human CF Im68 (amino acids 1–191), all N-terminally 
tagged with 6xHis and GST, were generated in rabbits by Pacific Immunology and affinity-
purified using their respective protein antigens. Antibodies against Drosophila FLASH, CPSF73, 
CPSF100, and symplekin were described previously (Sullivan et al., 2009b; Yang et al., 2009a). 
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RESULTS 
Characterization of Kc nuclear extracts used in biochemical studies on 3’ end processing. 
The 3’ end processing machinery that cleaves replication-dependent histone pre-mRNAs in 
Drosophila shares a number of similarities with the mammalian machinery (Fig. 12A), including 
the essential role played by the interaction of Lsm11 and FLASH (Burch et al., 2011). In 
mammalian cells, these two proteins form a platform that serves to recruit multiple 
polyadenylation factors to the U7 snRNP (Yang et al., 2013). In this study, we used large-scale 
nuclear extracts from Kc cells and several biochemical approaches to determine the role of the 
Lsm11/FLASH interaction and composition of the U7-dependent processing machinery in 
Drosophila. 
In our previous studies on 3’ end processing of histone pre-mRNAs in Drosophila, we 
typically used large-scale nuclear extracts prepared from frozen Kc cells since they had virtually 
the same processing activity as nuclear extracts prepared from freshly harvested cells (Dominski 
et al., 2002; Dominski et al., 2005b). However, closer biochemical analysis revealed that these 
extracts contained significantly reduced levels of two essential processing factors: SLBP and 
FLASH (Fig. 12B, compare. lanes 1 and 2). The reduced level of SLBP was primarily caused by 
its rapid leakage to the cytoplasm during cell thawing. FLASH, in addition to leaking to the 
cytoplasm, was degraded to shorter fragments that are fully functional in 3’ end processing in 
vitro (see below). As a result of leakage, cytoplasmic extracts prepared from frozen cells are 
active in processing, indicating that they contain complete processing machinery. Clearly, 
relatively small amounts of SLBP, FLASH, and other processing factors are sufficient to support 
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robust processing activity of nuclear and cytoplasmic extracts when tested with a limiting 
amount of the dH3 pre-mRNA substrate. 
Since nuclear extracts prepared from freshly harvested Kc cells were highly enriched in 
full-length processing factors, our subsequent biochemical experiments were carried out using 
these extracts. In agreement with our previous results (Dominski et al., 2002, 2005b), 3’ end 
processing of histone pre-mRNAs carried out in these extracts is absolutely dependent on SLBP. 
The presence of 10 µM wild-type stem–loop RNA competitor (WT SL, 500-fold excess over the 
pre-mRNA substrate), which sequesters the entire pool of SLBP in the extract inhibited cleavage 
of the dH3 pre-mRNA, whereas the same amount of a mutant stem–loop RNA (Mut SL) had no 
effect (Fig. 12C, compare lanes 4 and 5). This mutant RNA contains alterations in the 5’-
flanking adenosines and the second base pair of the stem (Fig. 12E) and does not bind SLBP 
(Yang et al., 2009b; Tan et al., 2013). Processing was also efficiently inhibited by 5 µM anti-U7 
2′-O-methyl oligonucleotide (αU7) complementary to nucleotides 5–19 of the Drosophila U7 
snRNA (Fig. 12C, lane 7) and by an antibody directed against the N-terminal portion of 
Drosophila FLASH (Fig. 12D, lane 3). A nonspecific 2′-O-methyl oligonucleotide targeted to 
the first 17 nt of the mouse U7-snRNA (αMock) (Fig. 12C, lane 8) and a nonspecific antibody 
(Fig. 12D, lane 4) did not reduce in vitro 3’ end processing. All these reagents had the same 
effect on processing in Drosophila S2 nuclear extracts prepared from cells grown either in 
monolayers (ML S2) or suspension cultures (Sus S2). We conclude that the essential role of 
SLBP, the U7 snRNP and FLASH in 3’ end processing of histone pre-mRNAs is a universal 
feature of Drosophila nuclear extracts. This conclusion is consistent with the essential role of 
these factors in processing in vivo (Sullivan et al., 2001; Godfrey et al., 2006; Burch et al., 2011). 
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Functional conservation of Drosophila FLASH. A short N-terminal fragment of human 
FLASH encompassing amino acids 52–139 strongly stimulates processing in diluted or poorly 
active mammalian nuclear extracts (Yang et al., 2009a, 2011). This fragment of FLASH tightly 
binds the N-terminal fragment of human Lsm11 (amino acids 1–170), and together they interact 
with a large nuclear complex consisting of multiple polyadenylation factors, including the 
endonuclease CPSF73 (Yang et al., 2013). We refer to this complex as the Histone pre-mRNA 
Cleavage Complex (HCC). By introducing various deletions and mutations into the N-terminal 
fragment of human FLASH, we demonstrated that amino acids 100–135 bind Lsm11, whereas 
amino acids 55–58 with the highly conserved LDLY sequence are required for the recruitment of 
the HCC (Yang et al., 2011). 
Our previous studies in Drosophila cultured cells showed that the region located between 
amino acids 65 and 77 of Drosophila FLASH is essential for processing of histone pre-mRNAs 
in vivo, but its role has not been determined (Burch et al., 2011). This region contains an LDIY 
sequence (Fig. 13A), which is likely the functional counterpart of the LDLY motif in mammalian 
FLASH. Surprisingly, the N-terminal fragment of Drosophila FLASH (FN-ter, amino acids 1–
178) did not stimulate 3’ end processing in Drosophila Kc nuclear extracts (Fig. 13B, lane 4). 
Moreover, a deletion mutant of this fragment lacking the first 77 amino acids (FΔ77), including 
the LDIY motif, did not act in a dominant-negative fashion in vitro (Fig. 13B, lane 5), although 
the equivalent mutant of human FLASH strongly inhibited processing in mammalian extracts 
(Yang et al., 2011). Note that as indicated above, FLASH is an essential component of 
Drosophila processing machinery, and the presence of an anti-FLASH antibody inhibits cleavage 
of the dH3 pre-mRNA in this and all other tested Drosophila nuclear extracts. 
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In contrast to mammalian cells, where FLASH is severely limiting, Drosophila cultured 
cells contain relatively high levels of this protein, either full length or its shorter proteolytic 
fragments, which could be precipitated by specific antibodies and visualized on 
SDS/polyacrylamide gels by Coomassie and silver staining (Fig. 13B). We reasoned that the 
endogenous Drosophila FLASH is in excess to Lsm11 and quantitatively bound to the U7 
snRNP, providing a potential explanation for the failure of the recombinant N-terminal FLASH 
to stimulate processing. To test this possibility, we reduced the endogenous level of FLASH by 
RNA interference (RNAi). Drosophila S2 cells were grown in monolayers for 5 d in the absence 
or presence of double-stranded (ds) RNA against Drosophila FLASH and used to prepare small-
scale nuclear extracts. A nuclear extract from untreated cells contained readily detectable 
amounts of FLASH (Fig. 13C, lane 1) and was proficient for processing of the dH3 histone pre-
mRNA (Fig. 13D, lane 2). Recombinant N-terminal FLASH (FN-ter, amino acids 1–178) 
increased the efficiency of cleavage approximately twofold in this nuclear extract (Fig. 13D, lane 
3; Fig. 2F), whereas the FΔ77 FLASH mutant typically had on average a minor inhibitory effect 
(Fig. 13D, lane 4; Fig. 13F). It is unclear why the FN-ter and FΔ77 FLASH proteins affected 
processing only in the small-scale nuclear extracts from S2 cells and showed no activity when 
added to large-scale nuclear extracts prepared from suspension Kc cells (Fig. 13B, lanes 4, 5). S2 
cells adapted to grow in suspension cultures yielded large-scale nuclear extracts that behave in 
the same manner as Kc nuclear extracts. One possible explanation is that extracts from 
monolayer cells differ from extracts from suspension cells in the abundance of FLASH and other 
processing factors and their accessibility for recombinant FLASH. 
The nuclear extract I prepared from S2 cells treated with dsRNA against FLASH 
contained a significantly reduced level of FLASH (Fig. 13C, lane 2), whereas the amounts of 
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SLBP and the U7 snRNP (Fig. 13C, lane 2), the two other critical processing factors, were 
unchanged. This extract alone poorly processed histone pre-mRNA (Fig. 13D, lane 5), and the 
addition of the recombinant FN-ter protein (amino acids 1–178) increased its activity more than 
fivefold, to a level that was higher than that of the control extract (Fig. 13D, cf. lanes 2 and 7; 
Fig. 13F). The stimulation of the processing efficiency by the N-terminal FLASH was highly 
reproducible and observed with every nuclear extract independently depleted of FLASH (Fig. 
13F). The FΔ77 FLASH (amino acids 78–178) lacking the LDIY mutant was inactive (Fig. 13D, 
lane 6; Fig. 13F). To determine whether the lack of activity is caused by the absence of the LDIY 
motif, I created the LDIY-4A point mutant in which this motif was replaced by four alanines. 
This protein had only a residual activity in processing (Fig. 13E, lane 4; Fig. 13F), demonstrating 
that the LDIY motif in FLASH is critical for 3’ end processing of histone pre-mRNAs in 
Drosophila and supporting the notion that it is a functional counterpart of the LDLY motif in 
mammalian FLASH. 
Based on unpublished reports that a second LDIY motif located between amino acids 45-
48 was capable of rescuing the LDIY-4A mutant in vivo in Drosophila flies, (Deirdre Tatomer et 
al., submitted), I expressed a double mutant fragment of FLASH (amino acids 1-178) with both 
LDIY motifs changed to 4 alanines (LDIY-4A(x2)). N-terminal FLASH (amino acids 1-178) 
clearly rescues 3’ end processing efficiency in FLASH depleted nuclear extracts (Fig. 14C  
compare lanes 2-3, 4-5, and 6-7) while the LDIY-4A mutant rescues only 10-15% of processing  
(Fig. 14C lanes 8-9 compared to lanes 4-5). Surprisingly, in vitro processing assays showed a 
virtual elimination of processing ability in FLASH depleted S2 nuclear extracts when comparing 
the LDIY-4A and LDIY-4A(x2) stimulated reactions (Fig. 14C, compare lanes 8-9 with lanes 
10-11). In light of Deirdre’s unpublished data indicating the single LDIY motif located at amino 
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acids 45-48 is capable of rescuing the fly, this additional result suggests a possible redundant role 
for the first LDIY that although is considerably less efficient in vitro is sufficient to rescue the 
fly in vivo. 
The interaction between a complex of the N-terminal FLASH and Lsm11 and Drosophila 
polyadenylation factors. We next tested whether various recombinant N-terminal FLASH 
fragments (GST fusion) bound to the N-terminal Lsm11 (MBP fusion) can interact with 
polyadenylation factors in Drosophila nuclear extracts, as previously described for the 
mammalian proteins (Yang et al., 2013). The bound proteins were purified on glutathione beads 
and analyzed by Western blotting using antibodies against the three Drosophila polyadenylation 
factors known to be essential for 3’ end processing of histone pre-mRNAs in Drosophila and 
mammalian cells: symplekin, CPSF100, and CPSF73 (Sullivan et al., 2009b). The level of all 
recombinant protein absorbed on glutathione beads was carefully monitored by staining with 
Coomassie Blue. 
Initially, we used small-scale nuclear extracts prepared from untreated and FLASH-
depleted S2 cells since their processing activity was increased by recombinant FLASH. A 
complex of the N-terminal regions of Drosophila FLASH (FN-ter, amino acids 1–178) and 
Lsm11 (amino acids 1–153) interacted with readily detectably amounts of symplekin and 
CPSF100 in extracts from both untreated (Fig. 15A, lane 3) and FLASH-depleted S2 cells (Fig. 
15A, lane 7). Among the interacting proteins we also identified CPSF73, although its detection 
on Western blots was obscured by a bacterial protein present in the preparation of recombinant 
Lsm11 that strongly cross-reacted with the anti-CPSF73 antibody (see Fig. 15C, lanes 3, 4). 
Importantly, the interaction of all these polyadenylation factors was nearly abolished by deleting 
the first 77 amino acids from the FN-ter FLASH (FΔ77) (Fig. 15A, lanes 4, 8). 
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Of multiple large-scale Kc nuclear extracts tested by this approach, only some behaved in 
the same fashion as the small-scale extracts prepared from S2 cells. In these Kc extracts, the FN-
ter/Lsm11 complex, but not the mutant FΔ77/Lsm11 complex, interacted with symplekin, 
CPSF100 (Fig. 15B, compare lanes 4 and 5) and CPSF73 (see also Fig. 15C, lane 3). Consistent 
with our previous results with the mammalian system, the N-terminal FLASH alone was less 
efficient in binding the polyadenylation factors than its complex with Lsm11 (Fig. 15B, compare 
lanes 3 and 4). To determine whether the FΔ77 FLASH mutant complexed with the N-terminal 
Lsm11 is unable to bind the polyadenylation factors primarily due to deletion of the LDIY motif 
rather than any other sequence in the first 77 amino acids of FLASH, we used the LDIY-4A 
mutant. The interaction of the LDIY-4A/Lsm11 complex with symplekin, CPSF100, and 
CPSF73 in the same Kc nuclear extract was significantly reduced (Fig. 15C, compare lanes 3 and 
4), demonstrating that the LDIY motif plays an equivalent function to the LDLY motif in 
mammalian FLASH and is essential for recruiting the CPSF73 endonuclease and other 
polyadenylation factors to the U7 snRNP. 
FLASH is essential for degradation of the DCP after cleavage of histone pre-mRNA. In 
mammalian extracts, degradation of the downstream cleavage product (DCP) released after 
cleavage depends on the 5’ to 3’ exonuclease activity of CPSF73 (Dominski et al., 2005c). The 
DCP contains a HDE and degradation of this cleavage product is U7-dependent. Adding α-
FLASH antibody or mutated fragments of recombinant FLASH lacking the conserved LDLY 
motif to mouse myeloma extracts inhibits 3’ end processing of labeled H2a substrate. But it does 
not inhibit degradation of a separate 5’-labeled DCP under the same conditions, demonstrating 
FLASH is not required for degradation of the DCP in vitro. Furthermore, supplementing the 
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extract with wild type N-terminal FLASH showed no change in degradation efficiency (Yang et 
al., 2011).  
To see if this is the same in Drosophila, I prepared small scale nuclear extracts from 
Drosophila S2 cells. Blocking the interaction between the U7 snRNP and HDE with an anti-U7 
oligo prevented degradation of the DCP in extracts from untreated S2 cells, as expected (Fig. 16, 
compare lanes 2 and 3). Surprisingly, the addition of F-Nter had a stimulatory effect in the 
extract, while adding α-dFLASH antibody clearly blocked degradation of the DCP (Fig. 16, 
compare lane 2 to lanes 4 and 5). In S2 extracts depleted of FLASH using RNA interference, 
degradation of the DCP was reduced significantly compared to the untreated extract (Fig 16, lane 
6 compared to lane 2).  Upon addition of F-Nter, degradation is restored to levels surpassing that 
of the untreated extract (Fig. 16, compare lanes 7 and 2). This effect is at least partially 
dependent on the conserved LDIY motif as changing these residues to alanines reduces the 
stimulatory effect of adding recombinant FLASH (Fig 16, compare lanes 7 and 8). These results 
indicate FLASH is an essential factor for degradation of the DCP in Drosophila.  
In Drosophila Ars2 does not stably associate in a complex with FLASH and is dispensable 
for histone pre-mRNA 3’ end processing. In mammalian cells, FLASH interacts with Ars2, 
and this interaction is required for S-phase progression, expression of replication-dependent 
histone mRNAs, and efficient localization of FLASH to Histone Locus Bodies (HLBs) 
(Kiriyama et al., 2009). In addition, Ars2 is essential for cell proliferation (Gruber et al., 2009), 
and depletion of Ars2 from human cells increases the number of aberrant replication-dependent 
histone mRNAs that end with a poly(A) tail (Gruber et al., 2012), suggesting that Ars2 may 
cooperate with FLASH in U7-dependent 3’ end processing. 
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I tested whether Drosophila Ars2 and FLASH form a stable complex in Drosophila cells. 
Xiao Yang generated a rabbit antibody against the N-terminal portion of Ars2 to isolate 
complexes containing Ars2 from Kc nuclear extracts and identify interacting proteins by mass 
spectrometry. As determined by Western blotting, the antibody precipitated Ars2 but not FLASH 
(Fig. 17A, lane 3). Mass spectrometry analysis of a large-scale precipitation with the anti-Ars2 
antibody additionally identified large amounts of Cap Binding Protein 80 (CBP80) in the 
precipitate (Fig. 17B). This 80 kDa subunit of the nuclear RNA Cap Binding Complex (CBC) 
and the smaller 20 kDa subunit interact with tagged versions of Ars2 in human (Gruber et al., 
2009) and Drosophila cells (Sabin et al., 2009), and they likely interact with Ars2 in plants 
(Laubinger et al., 2008). The anti-Ars2 precipitate also contained homologs of other mammalian 
proteins, including the helicase Mtr4 (Fig. 4B), shown to exist in a complex with Ars2 in 
mammalian cells (Lubas et al., 2011). However, both Western blotting (Fig. 17A, lane 3; Fig. 
18A, lane 2) and mass spectrometry (Fig. 17B) demonstrated that the antibody against Ars2 
failed to coprecipitate FLASH, suggesting that these two proteins do not form a stable complex 
in Drosophila cells. The anti-Ars2 antibody also did not precipitate Lsm11 (Fig. 18A, lane 2). 
The conclusion that FLASH and Ars2 are not part of the same complex was also supported by a 
reciprocal experiment with anti-FLASH antibodies directed against the N-terminal (Fig. 17A, 
lane 2) and C-terminal regions of Drosophila FLASH. Finally, no Ars2 was detected in the 
material precipitated by an anti-Lsm11 antibody, although this antibody precipitated FLASH 
(Fig. 17A, lane 5). The inability of the anti-FLASH and anti-Ars2 antibodies to coprecipitate 
Ars2 and FLASH, respectively, was highly reproducible and observed for a broad range of 
nuclear extracts, including those prepared from S2 cells grown in monolayers (Fig. 17A, lanes 6–
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9) or in high-volume suspension cultures. Collectively, these results suggest that in Drosophila, 
Ars2 does not interact with FLASH and is not part of the U7 snRNP. 
Since it was possible that Drosophila Ars2 functions in processing of histone pre-mRNAs 
via interacting with a different processing component, we next reduced the endogenous level of 
Ars2 in S2 cells by RNA interference (RNAi) and tested whether this treatment results in in vivo 
production of replication-dependent histone mRNAs that end with a poly(A) tail rather than the 
stem–loop. This phenotype was readily observed in S2 cells depleted of FLASH (Yang et al., 
2009a) and other factors essential for U7-dependent 3’ end cleavage of histone pre-mRNAs in 
Drosophila, including symplekin, CPSF100, and CPSF73 (Wagner et al., 2007; Sullivan et al., 
2009b; Yang et al., 2009a) and was also observed in Ars2-depleted mammalian cells (Gruber et 
al., 2012). Xiao Yang monitored the extent of depletion by Western blotting, using the antibody 
against the N-terminal portion of Ars2 (Fig. 17C). The antibody detects a single band at ∼140 
kDa in the whole cell lysate from untreated S2 cells, and the corresponding band is virtually 
missing in the lysate from S2 cells depleted of Ars2 by treatment with dsRNA (Fig. 17C, lane 6). 
RNAi with dsRNA specific for Drosophila FLASH or a number of proteins unrelated to 3’ end 
processing of histone pre-mRNA had no effect on the abundance of Ars2 in S2 cells (Fig. 17C, 
lanes 2–5). 
Cells depleted of FLASH produced longer polyadenylated dH3 histone mRNA resulting 
from a defect in the U7-dependent 3’ end processing (Yang et al., 2009a) (Fig. 17D, lane 1). 
Importantly, depletion of Ars2 had no visible effect on this process (Fig. 17D, compare lanes 1 
and 6), although it resulted in a noticeable reduction of the overall level of the dH3 mRNA 
relative to the level of Drosophila 7SK RNA, a transcript generated by RNA Pol III. The same 
general reduction in expression of replication-dependent histone mRNAs was previously 
  
83 
 
observed in Ars2-depleted human cells (Kiriyama et al., 2009; Gruber et al., 2012) and is also 
seen in Drosophila S2 cells depleted of mxc (Fig. 17D, lane 3), the Drosophila orthologue of 
NPAT (White et al., 2011). NPAT is specifically required for transcription of histone genes in 
mammalian cells (Ma et al., 2000). 
Since Ars2 may be essential for transcription of histone genes, thereby making it difficult 
to assess its role in 3’ end processing of histone pre-mRNAs in vivo, I prepared nuclear extracts 
from Ars2-depleted S2 cells. In contrast to FLASH-depleted S2 extracts, extracts prepared from 
Ars2-depleted cells were consistently very active in processing the dH3 pre-mRNA, further 
arguing that Ars2 is not a component of the Drosophila U7-dependent processing machinery. 
Nuclear proteins associated with Drosophila FLASH. To better understand the role of FLASH 
in 3’ end processing of histone pre-mRNAs and to identify its binding partners in Drosophila 
nuclear extracts, we carried out a series of immunoprecipitations using antibodies against 
FLASH and other Drosophila processing factors. The antibody against the N-terminal portion of 
Drosophila FLASH efficiently precipitates U7 snRNA (Yang et al., 2009a) and Lsm11 (Fig. 
18A, lane 3), indicating that a substantial fraction of the endogenous U7 snRNP is stably 
associated with FLASH. Consistently, an anti-Lsm11 antibody coprecipitates Drosophila 
FLASH from Kc nuclear extracts (Fig. 17A, lane 5). 
I next investigated whether the endogenous Drosophila FLASH is associated with any of 
the polyadenylation factors known to be components of the mammalian HCC. As shown by 
Western blotting, the anti-FLASH antibody, but not the anti-Ars2 antibody, precipitated two 
polyadenylation factors that are essential for 3’ end processing of Drosophila histone pre-
mRNAs: symplekin and CPSF73 (Fig. 18A, lane 3). To confirm this result and to identify other 
proteins associated with Drosophila FLASH, I scaled up precipitation with the anti-FLASH. In 
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addition to FLASH, silver staining revealed several specific protein bands in the anti-FLASH 
precipitate that were identified by mass spectrometry as Drosophila orthologues of CPSF160 
(CG10120), symplekin (CG2097), CPSF100 (CG1957), and CPSF73 (CG7698), which 
comigrated with the 70 kDa heat shock protein (HSC70, CG4262) (Fig. 5B). The precipitate also 
contained peptides from the Drosophila orthologue of WDR33 (CG1109), although this protein 
was not visible as a separate band on the silver-stained gel. All these proteins were either 
undetectable or detected with very low scores in the anti-Ars2 precipitate (Fig. 18A, lane 2). 
Consistent with FLASH and symplekin forming a common complex, an antibody against 
Drosophila symplekin (Fig. 18C, lane 3), but not a mock antibody directed against an unrelated 
Drosophila protein (Fig. 18C, lane 4), coprecipitated FLASH. 
I carried out additional immunoprecipitation experiments with the anti-FLASH antibody 
and analyzed the precipitated material in higher-percentage gels to look for smaller proteins. 
These experiments failed to identify any additional polyadenylation factors associated with 
FLASH, including the Drosophila orthologue of CPSF30 (CG3642), which based on its amino 
acid sequence is expected to migrate at ∼30 kDa. The analysis did not include the area of the gel 
near the 50 kDa size marker that contained large amounts of the immunoglobulin heavy chain. 
Altogether, these results demonstrate that FLASH and Lsm11 in Drosophila nuclear extracts are 
tightly associated with each other and suggest that they recruit several polyadenylation factors to 
the U7 snRNP. 
Affinity purification of Drosophila U7 snRNP from Kc nuclear extracts. I next affinity-
purified Drosophila U7 snRNP from Kc nuclear extracts using a 2′-O-methyl oligonucleotide 
(Biot-αU7) complementary to the 5’ end of the Drosophila U7 snRNA (Dominski et al., 2005b). 
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This oligonucleotide contains biotin at the 3’ end, allowing adsorption of the associated 
complexes on streptavidin beads. 
I initially carried out a pilot experiment with a small amount of a Kc nuclear extract (500 
µL) and determined that the Biot-αU7 oligonucleotide binds both specifically and efficiently to 
the U7 snRNP. The material purified by this method was highly enriched in Lsm11 and also 
contained readily detectable amounts of FLASH (Fig. 18D, lane 3), confirming that FLASH is an 
integral part of the U7 snRNP. As expected, the material did not contain SLBP, which could be 
specifically purified by the 31-nt Biot-SL RNA, containing the sequence of the stem–loop and 
biotin on the 5’ end (Fig. 18D, lane 4). A nonspecific 2′-O-methyl oligonucleotide 
complementary to the first 17 nt of the human U7 snRNA and tagged with biotin at the 3’ end 
(Biot-αMock) bound neither the U7 snRNP nor SLBP (Fig. 18D, lane 2). Importantly, the 
material purified by the Biot-αU7 also contained detectable amounts of symplekin, CPSF100, 
and CPSF73 but lacked CstF50 (Fig. 18E, lane 2). These results strongly support the conclusion 
from the immunoprecipitation experiments that the Drosophila U7 snRNP associates with 
FLASH and a complex of polyadenylation factors that resembles the mammalian HCC, which 
also lacks the 50 kDa subunit of CStF (Yang et al., 2013). 
To determine whether additional proteins associate with the U7 snRNP, we used larger 
amounts of both the Biot-αU7 and Kc nuclear extract (1.0 µg and 5.0 mL, respectively) and 
analyzed the purified material by mass spectrometry. Nuclear proteins bound to the Biot-αU7 
were collected on streptavidin beads, separated on an 8% SDS/polyacrylamide gel, and 
visualized by silver staining (Fig. 18F, lane 1). Control purification was carried out with the 
Biot-αMock oligonucleotide (Fig. 18F, lane 2). Several clearly visible silver-stained protein 
bands were detected only in the lane containing material bound to the Biot-αU7 oligonucleotide 
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(Fig. 18F, lane 1). These bands and other regions of the gel were analyzed by mass spectrometry 
(Fig. 18F, right panel). The heavily stained band near the top of lane 1 that is completely missing 
in lane 2 was identified as FLASH (Fig. 18F, band 2). The less-intense band migrating 
immediately above FLASH (band 1) was identified as Drosophila CPSF160, whereas the bands 
migrating faster than FLASH were identified as symplekin (band 3), CPSF100 (band 4), WDR33 
(band 5), and CstF64 (band 9) (Fig. 18F). Lane 1 also contained CPSF73, although it was 
masked by massive amounts of another protein identified as the Drosophila orthologue of 
Insulin-like Growth Factor 2 mRNA Binding Protein 1 (IGF2BP1, CG1691). This protein likely 
directly interacts with the Biot-αU7 oligonucleotide (see below). All the polyadenylation factors 
purified by the Biot-αU7 oligonucleotide were undetectable by mass spectrometry in lane 2, 
whereas IGF2BP1 was present in this lane in trace amounts. 
To analyze smaller proteins purified via the Biot-αU7, two-thirds of the same material 
was separated on a 12% SDS/polyacrylamide gel (Fig. 18G, lane 1) and compared with the 
material bound to the Biot-αMock oligonucleotide (Fig. 18G, lane 2). Two silver-stained bands 
were clearly visible at ∼30 and 22 kDa in lane 1, and they were absent from lane 2. These bands 
were identified as Drosophila Lsm11 and SmB, the two largest components of the U7-specifc 
Sm ring, confirming that the Biot-αU7 oligonucleotide is very efficient and specific in purifying 
the Drosophila U7 snRNP. Independent experiments also identified two smaller members of the 
ring in the material purified by the Biot-αU7 oligonucleotide: Drosophila Lsm10 and SmD3. 
The material purified via the Biot-αU7 contained large amounts of two major forms of 
the Drosophila orthologue of Insulin-like Growth Factor 2 mRNA Binding Protein 1 (IGF2BP1) 
and several of its apparent degradation products. The high abundance of IGF2BP1 greatly 
exceeded the amount of Lsm11 and other core U7 snRNP components in the precipitate, 
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suggesting that this protein is not part of the U7 snRNP. Subsequent studies and multiple 
immunoprecipitation experiments with the anti-FLASH antibody support the notion that 
IGF2BP1 directly binds the excess Biot-αU7 oligonucleotide and plays no role in 3’ end 
processing of histone pre-mRNAs. Lane 1 also contained a band migrating at ∼60 kDa that was 
identified as a Drosophila homolog of the mammalian p62 helicase (CG10279). This protein was 
also present in the negative lane, and hence it likely nonspecifically binds 2′-O-methyl 
oligonucleotides. Altogether, the results of both immunoprecipitation and affinity purification 
experiments combined with mass spectrometry demonstrate that Drosophila U7 snRNP has a 
composite structure, and in addition to the core components of its Sm ring contains FLASH and 
at least six polyadenylation factors. 
Characterization of processing complexes formed on histone pre-mRNA in Drosophila 
nuclear extracts. I next tested whether processing complexes formed on Drosophila pre-mRNA 
in Drosophila nuclear extracts contain the same subset of polyadenylation factors that associate 
with the Drosophila U7 snRNP. A 63-nt dH3 pre-RNA containing all necessary processing 
elements (the SL and HDE) and biotin at the 5’ end (Biot-dH3) was incubated for 20 min at 
room temperature with a Kc nuclear extract (750 µL), and factors that bound to this substrate 
were collected on streptavidin beads. To prevent cleavage, which would result in release of the 
U7 snRNP from the complexes, the reaction was supplemented with 0.1% NP-40. This mild 
detergent at low concentrations blocks processing in Drosophila nuclear extracts (Fig. 19A, lanes 
3, 4), as it does in mammalian nuclear extracts (Yang et al., 2009b, 2013). However, processing 
complexes that assembled in the Kc nuclear extract under these conditions, while containing 
FLASH, SLBP, and U7 snRNP (as determined by the presence of Lsm11), lacked detectable 
amounts of polyadenylation factors. Purification of Drosophila U7 snRNP by either the Biot-
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αU7 oligonucleotide (Fig. 19B, lane 3) or anti-FLASH antibody in the presence of NP-40 
demonstrated that this detergent destabilized the interaction between U7 snRNP and 
polyadenylation factors, including symplekin (Fig. 19B, compare lanes 2 and 3). This is the most 
likely cause of the toxicity of NP-40 on 3’ end processing in both Drosophila and mammalian 
nuclear extracts. 
Instead of using NP-40, I significantly shortened the incubation time to capture 
processing complexes at early stages of assembly prior to cleavage of the substrate, in a manner 
similar to methods previously used for canonical pre-mRNAs containing the AAUAAA 
sequence (Veraldi et al., 2000; Shi et al., 2009). After 4–5 min of incubation in a nuclear extract, 
the Biot-dH3 pre-mRNA associated with both SLBP and the U7 snRNP, as determined by the 
presence of Lsm11 (Fig. 19C, lane 3). Thus, at least a fraction of the input RNA remains 
unprocessed under these conditions. The Biot-SL and the Biot-αU7 oligonucleotides bound only 
to SLBP and U7 snRNP, respectively (Fig. 19C, lanes 4, 5), demonstrating that binding of the 
two factors to sites flanking the cleavage site in the Biot-dH3 is specific. We next carried out 
larger-scale experiments, either in the absence or in the presence of various RNA competitors 
(Fig. 19D). Western blots with available antibodies against various processing factors 
demonstrated that the Biot-dH3 pre-mRNA in the absence of RNA competitors assembled into a 
complex containing SLBP, FLASH, the U7 snRNP (as determined by the presence of Lsm11), 
and the three essential polyadenylation factors we assayed: CPSF73, CPSF100, and symplekin 
(Fig. 19D, lane 3). The presence of 2.5 µM αU7 oligonucleotide, which blocks the 5’ end of the 
U7 snRNA and abolishes the recruitment of the U7 snRNP to the substrate, eliminated all these 
proteins except SLBP from the complex (Fig. 19D, lane 6). Thus, the composite U7 snRNP 
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carrying FLASH and polyadenylation factors is directly recruited to histone pre-mRNA through 
the base-pairing interaction between the U7 snRNA and the HDE. 
In the presence of 1 µM WT SL RNA that sequesters SLBP, binding of SLBP to the 
Biot-dH3 pre-mRNA was eliminated. However, the association of the composite U7 snRNP, 
including FLASH and the three polyadenylation factors, with the HDE was unaffected (Fig. 19D, 
lane 4). Note that this concentration of the WT SL competitor is sufficient to block the cleavage 
reaction (Fig. 12C, lane 3), whereas the Mut SL RNA (Fig. 12E) at the same and higher 
concentrations has no effect on 3’ end processing (Fig. 12C, lane 5) and does not prevent binding 
of SLBP to the Biot-dH3 pre-mRNA (Fig. 19D, lane 5). The failure of the WT SL competitor to 
reduce the amount of the U7 snRNP in the complex assembled on the dH3 pre-mRNA was 
unexpected since previous models based on processing in mammalian and Drosophila nuclear 
extracts suggested that SLBP primarily functions by stabilizing the interaction of the U7 snRNP 
with the HDE in histone pre-mRNAs (Dominski et al., 1999, 2005b). 
To confirm this surprising result by a different approach, I assembled processing 
complexes on a derivative of the Biot-dH3 pre-mRNA that lacked 16 nt encompassing the stem–
loop structure. The HDE of this new substrate designated Biot-dH3ΔSL was identical to that in 
the Biot-dH3 pre-mRNA. In addition to the dH3ΔSL RNA, we also used the mouse-specific 
Biot-H2a-614 pre-mRNA (Yang et al., 2009b). This substrate contains the stem–loop structure 
that normally interacts with Drosophila SLBP, but its HDE has only a limited ability to base-pair 
with the Drosophila U7 snRNA. Due to this reduced compatibility between the HDE and the 
Drosophila U7 snRNP, the H2a-614 pre-mRNA is only poorly processed in Drosophila nuclear 
extracts (Dominski et al., 2002, 2005b). 
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As expected, the Biot-dH3ΔSL substrate, in contrast to the Biot-dH3 and Biot-H2a-614 
pre-mRNAs, was unable to bind SLBP from the Kc nuclear extract (Fig. 19E, compare lane 4 
with lanes 2 and 3). Importantly, consistent with our conclusion based on using the stem–loop 
competitor, the absence of the stem–loop structure in the Biot-dH3ΔSL substrate and SLBP in 
the processing complex did not prevent the interaction between the composite U7 snRNP and the 
HDE. Both FLASH and symplekin were detected in processing complexes assembled on the 
Biot-dH3ΔSL, and their amount was comparable to that detected in the complexes assembled on 
the Biot-dH3 pre-mRNA (Fig. 19E, compare lanes 3 and 4). The mouse-specific Biot-H2a-614 
pre-mRNA interacted with the Drosophila U7 snRNP only weakly, consistent with the nature of 
the HDE in this substrate and its inability to form a strong duplex with the U7 snRNA (Fig. 19E, 
lane 2). I conclude that the interaction of the Drosophila SLBP with the stem–loop structure in 
histone pre-mRNA has no major effect on the recruitment of the U7 snRNP to the HDE. 
Preparative scale purification (5.0 mL of Kc nuclear extract per each reaction) was next 
performed to analyze proteins associated with the Biot-dH3 pre-mRNA by mass spectrometry. 
The control reaction contained no RNA competitor, and the two other reactions contained either 
the αU7 oligonucleotide (1.25 µM) to block the Drosophila U7 snRNP or the WT SL RNA (1 
µM) to sequester SLBP in the extract (Fig. 19F). On silver-stained gels, the three samples shared 
several bands, and most of these likely represented proteins nonspecifically bound to streptavidin 
beads and/or excess of the Biot-dH3 RNA. Compared with the control reaction (Fig. 19E, lane 
1), the WT SL RNA competitor resulted in a disappearance of only one major protein band that 
corresponds to SLBP (Fig. 19F, lane 3). The reaction supplemented with the αU7 
oligonucleotide lacked several proteins migrating in the range of ∼50–200 kDa, whereas the 
amount of SLBP was unchanged (Fig. 19F, lane 2), consistent with the Western data. Mass 
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spectrometry identified these proteins (from the largest to the smallest) as CPSF160, FLASH, 
symplekin, CPSF100, WDR33, and CstF64 (Fig. 6F, right panel). Lanes 1 and 3, but not lane 2, 
also contained CPSF73 (band 7), although this polyadenylation factor was masked by an 
abundant protein present in all three lanes. 
The material purified from the Kc nuclear extract via the Biot-dH3 pre-mRNA also 
contained CstF77 (CG17170) (Fig. 19F, lane 1, band 6). Results from mass spectrometry 
analysis suggest that the association of this protein with the Biot-dH3 substrate was only partially 
reduced by the presence of the αU7 oligonucleotide (Fig. 19F, right panel). CstF77 was not 
detected in the material purified by the anti-FLASH antibody or the Biot-αU7 oligonucleotide 
(see above), collectively arguing that this polyadenylation factor associates with the RNA 
substrate in a nonspecific manner. We also note that CstF77 was previously identified as a 
contaminant of the mammalian U7 snRNP affinity-purified from mouse nuclear extracts (Yang 
et al., 2013). 
Mass spectrometry analysis of the remaining gel sections failed to identify any other 
major differences in protein composition between the three lanes. I conclude that the composite 
U7 snRNP containing FLASH and several polyadenylation factors is recruited to Drosophila 
histone pre-mRNA for 3’ end processing. Strikingly, SLBP does not play any detectable role in 
the recruitment of this composite U7 snRNP, although its binding to the stem–loop in histone 
pre-mRNA is absolutely required for cleavage. 
CstF64 as a component of the Drosophila U7 snRNP. The mammalian HCC that interacts with 
FLASH and Lsm11 is composed of symplekin, all CPSF subunits, and CstF64 (Yang et al., 
2013). The two remaining CStF subunits, CstF50 and CstF77, are conspicuously missing from 
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the HCC. The equivalent complex in Drosophila also contains symplekin, most CPSF subunits, 
and CstF64 as the only component of the CStF subcomplex. 
To confirm that CstF64 is part of the Drosophila U7 snRNP and to look more closely at 
its role in 3’ end processing of histone pre-mRNAs in Drosophila, Xiao Yang generated 
antibodies against bacterially expressed full-length protein (amino acids 1–437). The antibody 
recognizes a distinct band on Western blots of Drosophila nuclear extract that migrates at ∼50 
kDa (Fig. 20A, lane 1), consistent with the mobility of CstF64 identified by mass spectrometry. I 
tested the material purified from Kc nuclear extracts via the Biot-αU7 oligonucleotide using the 
anti-CstF64 antibody and confirmed that it indeed contains CstF64 (Fig. 20A, lane 2). CstF64 
was also readily detected in processing complexes assembled on the Biot-dH3 and Biot-dH3ΔSL 
RNAs. Lower amounts of CstF64 were associated with the Biot-mH2a pre-mRNA, consistent 
with the limited complementarity of this mouse-specific substrate to the Drosophila U7 snRNA. 
Thus, consistent with the mass spectrometry results, CstF64 is a stable component of the 
Drosophila U7 snRNP and is recruited together with other polyadenylation factors to histone 
pre-mRNA for 3’ end processing. 
I next tested the ability of the anti-CstF64 antibody to precipitate processing complexes 
from Kc nuclear extracts. Western blotting demonstrated that the anti-CstF64 antibody is very 
efficient in precipitating both CstF64 and CstF50 (Fig. 20B, lane 3), indicating that the antibody 
readily recognizes the entire CStF subcomplex known to consist of these three subunits in 
mammalian cells (Takagaki et al. 1990). Surprisingly, the anti-CstF64 precipitate also contained 
large amounts of CPSF73, CPSF100, and symplekin (Fig. 20B, compare lanes 1 and 3). 
Precipitation of all these polyadenylation factors was blocked by recombinant CstF64 used as the 
antigen to generate the antibody (Fig. 20B, lane 4). Importantly, the anti-CstF64 precipitate 
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contained readily detectable amounts of FLASH (both full-length and numerous degradation 
products) and Lsm11, but not Ars2 (Fig. 20C, lane 3), further confirming that in Drosophila 
nuclear extracts, a fraction of CstF64 exists in a complex with the U7 snRNP. Note that while at 
least 10% of Lsm11 was precipitated by the anti-CstF64 (Fig. 20C, lane 3), <1% of the total 
CstF64 was bound to U7 snRNP (Fig. 20A, lane 2), as expected from the very low amount of U7 
snRNP compared with the high abundance of polyadenylation factors. 
CstF64 as a component of a supercomplex of cleavage and polyadenylation factors. The 
ability of the anti-CstF64 antibody to precipitate a large fraction (∼50%) of symplekin and 
various CPSF subunits (Fig. 20B) suggested that in Drosophila distinct polyadenylation 
subcomplexes may associate to form a macromolecular entity resembling that previously 
described in mammalian cells (Takagaki and Manley, 2000). To identify additional components 
of this hypothetical complex, I separated the precipitated proteins on either 8% (Fig. 20D, E) or 
15% SDS/polyacrylamide gels (Fig. 20F) and analyzed their identity by mass spectrometry. The 
anti-CstF64 precipitate (Fig. 20D, lane 3) but not the control anti-Mock precipitate (Fig. 20D, 
lane 2) contained several proteins that were readily stained with silver. As determined by mass 
spectrometry, the precipitate contained all three subunits of CStF, although CstF64 and CstF50 
were partially masked by the antibody heavy chain and hence not readily visible. I also identified 
all subunits of CPSF in the anti-CstF64 precipitate, including the smallest CPSF30 (CG3642) 
that migrates with the expected mobility of ∼30 kDa (Fig. 20F, lane 1). Precipitation of all these 
proteins was eliminated by blocking the anti-CstF64 antibody with recombinant CstF64 (Fig. 
20E, lane 2; Fig. 20F, lane 3). Among CPSF subunits, WDR33 and Fip1 (CG1078) were 
relatively weakly stained, which may indicate that they are limiting in Drosophila nuclear 
extracts (Fig. 20D, lane 3; Fig. 20E, lanes 1, 3). Note that Fip1 exhibits much slower 
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electrophoretic mobility than its mammalian counterpart (Kaufmann et al., 2004), consistent with 
its significantly larger size (701 amino acids vs. 550 amino acids for human Fip1). 
The anti-CstF64 precipitate also contained significant amounts of the Drosophila 
orthologues of CF Im68 (CG7185) (Fig. 20D, lane 3; Fig. 20E, lane 1) and CF Im25 (CG3689) 
(Fig. 20F, lane 1). In mammalian cells, these two proteins belong to a third subcomplex, CI Im 
(Rüegsegger et al., 1996; Rüegsegger et al., 1998), which was not previously detected in a tight 
association with the subunits of CStF or CPSF in the absence of pre-mRNA substrate. 
Coprecipitation of the CF Im was not affected by pre-treating the nuclear extract with RNase A 
(Fig. 20E, compare lanes 1 and 3; Fig. 20F, compare lanes 1 and 2). 
To confirm this unexpected finding, I tested the precipitate with an antibody generated 
against the first 191 amino acids of human CF Im68. This antibody cross-reacts with the 
Drosophila CF Im68 (Fig. 20G), likely by recognizing the highly conserved N-terminal RRM-
type RNA binding domain. Western blot analysis using this antibody confirmed that the anti-
CstF64 antibody, indeed, coprecipitated CF Im68 (Fig. 20H). Thus, Drosophila nuclear extracts 
contain a large, preassembled 3’ end processing complex consisting of most known 
polyadenylation factors, with the notable exception of the Drosophila orthologues of the two 
subunits of CF IIm, Clp1 and Pcf11 (de Vries et al., 2000). 
 
DISCUSSION 
We recently showed that in mammalian nuclear extracts supplemented with the bacterially 
expressed N-terminal portion of FLASH, a subset of polyadenylation factors that we refer to as 
the Histone Cleavage Complex (HCC) associates with the U7 snRNP. The association depends 
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on the interaction between FLASH and Lsm11, the largest protein of the U7-specific Sm ring 
(Yang et al., 2013). The mammalian HCC contains symplekin, all six CPSF subunits, and 
CstF64, but lacks the two remaining CStF subunits. This composite U7 snRNP, containing the 
CPSF73 endonuclease among other components of the HCC, is subsequently recruited to the 
Histone Downstream Element (HDE) in histone pre-mRNA for the cleavage reaction (Yang et 
al., 2013). FLASH is present at a very low level in mammalian cells and is highly susceptible to 
proteolysis during preparation of nuclear extracts, likely explaining the failure of initial studies to 
detect its association with U7 snRNP and polyadenylation factors (Smith et al., 1991; Pillai et al., 
2001). 
FLASH and U7 snRNP are relatively abundant in a broad range of Drosophila nuclear 
extracts and likely not limiting for 3’ end processing of histone pre-mRNAs in vitro. In this 
study, I took advantage of this fact to partially purify the U7 snRNP from the Drosophila Kc 
nuclear extracts and directly analyzed its proteome by mass spectrometry. My main goal was to 
determine whether Drosophila U7 snRNP associates with the same set of polyadenylation factors 
that form the HCC in mammalian nuclear extracts and whether this association depends on the 
interaction between Drosophila FLASH and Lsm11. 
Drosophila U7 snRNP has a composite structure. I affinity-purified the Drosophila U7 snRNP 
from Kc nuclear extracts via a 2′-O-methyl oligonucleotide complementary to the 5’ end of the 
U7 snRNA. The purified material, in addition to Lsm11 and other proteins of the U7-specifc 
ring, contained readily detectable amounts of endogenous FLASH, confirming that this protein 
indeed constitutes an integral component of the U7 snRNP. The purified U7 snRNP also 
contained several polyadenylation factors. Among them I identified symplekin, four out of six 
CPSF subunits (CPSF160, CPSF100, CPSF73, and WDR33), and CstF64 as the only component 
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of the CStF subcomplex. I confirmed that CstF64 is indeed a component of the U7 snRNP in 
Drosophila by demonstrating that an antibody directed against full-length CstF64 efficiently 
coprecipitates both Lsm11 and FLASH. 
Consistent with FLASH being an integral component of U7 snRNP, the anti-FLASH 
antibody precipitates Lsm11, and the antibody directed against Lsm11 precipitates FLASH. 
Importantly, the anti-FLASH precipitate contained the same polyadenylation factors that were 
identified in the affinity-purified U7 snRNP fraction. Thus, based on using two independent 
purification protocols, I conclude that the Drosophila U7 snRNP has a composite structure, 
consisting of the U7 snRNP core (U7 snRNA and the Sm ring), FLASH, and the Drosophila 
counterpart of the HCC. Compared with the mammalian HCC, the Drosophila HCC seems to 
lack orthologues of two CPSF components: Fip1 and CPSF30. My immunoprecipitation 
experiments with an anti-CstF64 antibody indicate that Fip1 may be present in low levels in 
Drosophila nuclear extracts, and it is possible that this subunit is also underrepresented in the 
HCC and escaped our detection. CPSF30, on the other hand, is readily detectable as a component 
of the Drosophila CPSF complex involved in cleavage and polyadenylation, and its absence in 
the HCC is surprising. Interestingly, RNAi-mediated knockdown of Drosophila CPSF30 in S2 
cells in contrast to knockdown of CPSF160 does not result in codepletion of CPSF73, CPSF100, 
and symplekin, suggesting that CPSF30 may not be an essential component of CPSF in 
Drosophila cells, explaining the absence of this subunit in the HCC (Sullivan et al., 2009b). 
I found no evidence for an association of the Drosophila U7 snRNP with the Drosophila 
orthologue of CF Im68. CF Im68 was recently reported to stably associate with the mammalian 
U7 snRNP (Ruepp et al., 2010), although previous results did not find CF Im68 as part of the 
mammalian HCC and the endogenous U7 snRNP (Yang et al., 2013) or the highly related Heat 
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Labile Factor (HLF) purified from mammalian cells (Kolev and Steitz, 2005). Similarly, this 
study argues that CF Im68 has no role in 3’ end processing of histone pre-mRNAs in Drosophila 
nuclear extracts. 
The composition of the HCC is much different from the composition of a related 
Drosophila complex that functions in cleavage and polyadenylation. This complex consists of 
symplekin, all three CStF subunits, all six CPSF subunits, and the two CF Im subunits of 25 and 
68 kDa. The supercomplex was purified by precipitation with the anti-CstF64 antibody and is not 
disrupted by treatment with RNase A, indicating that its assembly involves multiple protein–
protein interactions rather than binding of individual subcomplexes (CStF, CPSF, and CF Im) to 
a single pre-mRNA molecule. A similar complex was previously described in mammalian 
nuclear extracts (Takagaki and Manley, 2000). 
In 3’ end processing of mammalian histone pre-mRNAs, a critical interaction between 
the HCC and FLASH bound to Lsm11 is mediated by the LDLY motif located in the N-terminal 
region of FLASH (Yang et al., 2013). Recombinant N-terminal FLASH lacking this motif is 
unable to interact with the HCC or to stimulate 3’ end processing in mammalian nuclear extracts. 
It is yet unknown which component of the mammalian HCC directly contacts the LDLY motif, 
although symplekin is the most likely candidate to perform this function. Drosophila FLASH 
contains a highly related motif, LDIY, within its N-terminal region (amino acids 71–74), and our 
previous studies demonstrated that deleting the first 77 amino acids impairs the wild-type 
function of FLASH in processing in Drosophila cultured cells (Burch et al., 2011). I now show 
that recombinant N-terminal FLASH with the LDIY motif being replaced by four alanines is 
unable to restore processing activity of nuclear extracts prepared from S2 cells depleted of the 
endogenous FLASH. I also showed that Lsm11 and this LDIY mutant form a complex that is 
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unable to interact with CPSF73, CPSF100, and symplekin. Thus, the mammalian LDLY and 
Drosophila LDIY motifs are functionally conserved and play a critical role in bringing the HCC 
to the U7 snRNP. 
Degradation of Drosophila DCP is FLASH dependent. Following cleavage to form the 3’ end 
of histone mRNA, the downstream cleavage product is degraded by the 5’ to 3’ exonucleolytic 
activity of CPSF73. Degradation is U7-dependent (Yang et al. 2009), but in mammals, FLASH is 
dispensable for this reaction (Yang et al., 2011). Here I present data that shows FLASH is 
essential for the degradation of the DCP in Drosophila. In Drosophila, histone pre-mRNA 3’ end 
processing always results in cleavage 4 nts after the stem-loop. Repositioning the HDE a 
distance further 3’ of its usual position results in a loss of processing. In contrast, mammalian 
cleavage always occurs a fixed distance 5’ of the HDE, regardless of its position if the duplex 
formed with the HDE is sufficiently strong. Interactions with the U7 snRNP may rigidify and 
position the cleavage site for processing, independent of contributions from the stem-loop or 
SLBP. These same interactions may position the 5’ end of the DCP optimally for CPSF73 
exonuclease activity in mammals. Degradation in Drosophila could require additional factors to 
juxtapose the DCP 5’ end and CPSF73 for initiation. FLASH may fulfill this crucial function.  
Ars2 is dispensable for U7-dependent processing. Previous studies that used a sensitive GFP-
based reporter gene driven by a histone gene promoter (Wagner et al., 2007) and direct analysis 
of histone mRNA 3′ ends (Sullivan et al., 2009b) indicated that only three polyadenylation 
factors are essential for 3’ end processing of histone pre-mRNAs in Drosophila cells: (1) 
CPSF73, which functions as the endonuclease in cleavage and polyadenylation and 3’ end 
processing of histone pre-mRNAs; (2) CPSF100, which is a homolog of CPSF73; and (3) 
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symplekin, which plays an unknown role in processing but likely functions as a scaffold or 
adaptor linking CPSF73 and CPSF100 with the rest of each processing machinery. 
The lack of any essential role in 3’ end processing of Drosophila histone pre-mRNAs for 
CstF64 is surprising. CstF64 directly interacts with symplekin (Takagaki et al., 1990) and plays 
an important role in 3’ end processing of histone pre-mRNAs in human cells (Ruepp et al., 
2011). In addition, our recent studies in mammalian nuclear extracts suggested that CstF64 in 
conjunction with symplekin may directly link the HCC with FLASH bound to Lsm11 (Yang et 
al., 2013). This is further evidence that U7-dependent processing machineries in mammalian and 
Drosophila cells are not identical (Fig. 21) 
Direct analysis of endogenous histone mRNAs in Ars2-depleted S2 cells did not reveal 
any role for Ars2 in 3’ end processing of Drosophila histone pre-mRNAs in vivo. In the absence 
of Ars2, the U7-dependent processing is fully operative, and no replication-dependent histone 
mRNAs with a poly(A) tail accumulate. This is in sharp contrast to depletion of Ars2 in human 
cells, which resulted in redirecting a fraction of nascent histone pre-mRNAs to the cleavage and 
polyadenylation pathway (Gruber et al., 2012). The lack of any major role in 3’ end processing 
of histone pre-mRNAs for Ars2 in Drosophila is supported by our biochemical studies, which 
failed to detect this protein in association with U7 snRNP or any other processing factors known 
to operate on histone pre-mRNA. Overall, our results suggest that the interaction between Ars2 
and FLASH and the role of Ars2 in promoting correct 3’ end cleavage of histone pre-mRNAs are 
specific for higher metazoans (Fig. 21). 
U7 snRNP as an RNA-guided nuclease and the role of SLBP in processing. The composite 
Drosophila U7 snRNP containing FLASH and multiple polyadenylation factors is recruited to 
histone pre-mRNA for 3’ end processing, resembling the situation recently described for 
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mammalian extracts (Yang et al., 2013). An antisense oligonucleotide complementary to the 5’ 
end of the Drosophila U7 snRNA that prevents the interaction between the U7 snRNP and the 
HDE completely eliminates FLASH and the polyadenylation factors from the complex formed 
on histone pre-mRNA. Thus, the U7 snRNA can be considered as a vehicle that identifies a 
target substrate by base-pairing and delivers the endonuclease CPSF73, CPSF100, symplekin, 
and several accessory polyadenylation factors to the site of cleavage. This mode of action is 
highly reminiscent of snoRNAs, which use an RNA-guided mechanism to locate target 
sequences for enzymatic modifications (Kiss et al., 2002). 
In purified fractions of the U7 snRNP and processing complexes, FLASH stains with 
silver significantly stronger than the polyadenylation factors. It is therefore possible that a 
fraction of the U7 snRNP contains FLASH, but not the HCC (Fig. 22). Alternatively, more than 
one molecule of FLASH is required to interact with Lsm11, as suggested (Yang et al., 2013), or 
binding of the HCC to the Lsm11/FLASH complex is relatively weak and partially disrupted 
during purification of the U7 snRNP. 
The most notable difference between the mechanism of 3’ end processing of histone pre-
mRNAs in Drosophila and mammals is that Drosophila processing is absolutely dependent on 
SLBP (Dominski et al., 2002), and cleavage invariably occurs 4 nt after the stem (Fig. 21) 
(Dominski et al., 2005b). These observations suggest that in Drosophila, SLBP and U7 snRNP 
are equally important in determining the site of cleavage. In mammalian processing, SLBP is an 
auxiliary rather than an obligatory factor and functions to stabilize the interaction between 
histone pre-mRNA and the U7 snRNP, which is capable of directing cleavage of the pre-mRNA 
on its own (Streit et al., 1993; Dominski et al., 1999). Consistently, in mammalian nuclear 
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extracts, the site of cleavage is determined by the U7 snRNP (Scharl and Steitz, 1994; Scharl and 
Steitz, 1996). 
An excess of the stem–loop RNA added to Drosophila nuclear extracts results in a 
complete inhibition of in vitro processing due to preventing the interaction between SLBP and 
the stem–loop in histone pre-mRNAs (Dominski et al., 2002). Strikingly, this treatment had no 
effect on the recruitment of the composite Drosophila U7 snRNP to histone pre-mRNA. The 
core U7 snRNP, FLASH, and all the polyadenylation factors that form the HCC, including the 
CPSF73 endonuclease, are present in the processing complex assembled on histone pre-mRNA 
in the absence of free SLBP or on a pre-mRNA that lacks an SLBP binding site. Thus, in contrast 
to a previous model (Dominski et al., 2005b), the most critical role in recruiting the composite 
U7 snRNP to Drosophila histone pre-mRNA is played by the sequence of the HDE. SLBP (and 
hence the stem–loop) is yet indispensable for processing in Drosophila nuclear extracts and may 
function by delivering an unknown essential factor(s) to the U7 snRNP positioned near the 
cleavage site. 
Mass spectrometry did not detect any major differences in the composition of processing 
complexes assembled either in the presence or the absence of Drosophila SLBP. One possibility 
is that the SLBP-interacting factor exists in Drosophila nuclear extracts at a very low 
concentration or its interaction with SLBP is weak or transient and cannot be detected 
biochemically. What could be the nature and function of this factor? It may, for example, 
represent a hypothetical activator of the CPSF73 endonuclease, which was speculated to depend  
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on a structural rearrangement prior to acquiring the catalytic activity (Mandel et al., 2006; 
Dominski, 2010). Alternatively, it may function by bypassing the requirement for CstF64 or 
Ars2 in 3’ end processing in Drosophila. Elucidating the precise role of Drosophila SLBP in 
activating cleavage of histone pre-mRNA is the main focus of our ongoing studies. 
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Figure 12. 3’ end processing of histone pre-mRNAs in Drosophila. (A) Known factors 
involved in 3’ end processing of histone pre-mRNAs in Drosophila. (Black and gray lines) 
Histone pre-mRNA and Drosophila U7 snRNA, respectively. (Vertical lines) Base-pair 
interactions between the two RNAs. In the U7-specifc Sm ring, the two spliceosomal proteins 
SmD1 and SmD2 are replaced by Lsm10 and Lsm11 (indicated with dark gray). Lsm11 binds 
FLASH and in mammalian nuclear extracts these two proteins interact with CPSF73 (the 
endonuclease), CPSF100, symplekin, and other polyadenylation factors that together form the 
Histone pre-mRNA Cleavage Complex (HCC). It is unknown whether the interaction between 
Lsm11 and FLASH functions in the same manner in Drosophila (double arrow) and whether the 
HCC contains any factors in addition to CPSF73, CPSF100, and symplekin, as indicated with the 
question mark. (B) Levels of FLASH, SLBP, and symplekin in nuclear extract prepared from 
frozen (lane 1) or freshly collected Kc cells (lane 2), as determined by Western blotting. (C) 3’ 
end processing of Drosophila histone H3 (dH3) pre-mRNA in a Kc nuclear extract prepared 
from freshly harvested cells in the presence of indicated RNA competitors (lanes 3–8). The input 
alone and processing in the absence of any RNA competitor is shown in lanes 1 and 2, 
respectively. (D) 3’ end processing of the dH3 pre-mRNA in a Kc nuclear extract prepared from 
freshly harvested cells in the presence of indicated antibodies (lanes 3 and 4). The input alone 
and processing in the absence of any RNA competitor is shown in lanes 1 and 2, respectively. 
Inhibition of processing by the αU7 oligonucleotide is shown in lane 5. (E) Nucleotide sequence 
of the wild-type SL (WT SL) RNA. Regions altered in the Mut SL RNA that are essential for 
binding SLBP are underlined. 
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Figure 13. The role of the LDIY motif in FLASH in processing. (A) The amino acid sequence 
of the first 178 residues of Drosophila FLASH. The Lsm11-binding site and the critical LDIY 
motif (replaced with four alanines in the LDIY-4A mutant) are underlined. (Arrow) The start 
point of the FΔ77N deletion mutants. (B) 3’ end processing of the dH3 pre-mRNA in a Kc 
nuclear extract in the presence of 100 ng of indicated recombinant proteins. The input pre-
mRNA and control processing (no protein added) are shown in lanes 1 and 2, respectively. (C) 
The abundance of endogenous FLASH and SLBP in untreated S2 cells (No KD, lane 1) or 
treated with a specific double stranded (ds) RNA (FLASH KD, lane 2), as determined by 
Western blotting using an antibody directed against the N-terminal region of Drosophila 
FLASH. (*) A protein cross-reacting with the antibody that serves as a loading control. (D) 3’ 
end processing of the dH3 pre-mRNA in nuclear extracts prepared from untreated S2 cells (lanes 
2–4) or cells depleted of FLASH (lanes 5–7). Control processing in the absence of any 
recombinant protein is shown in lanes 2 and 5. Processing in lanes 3–4 and 6–7 was carried out 
in the presence of 100 ng of indicated recombinant proteins. (E) 3’ end processing of the dH3 
pre-mRNA in a nuclear extract prepared from S2 cells partially depleted of FLASH. Reactions 
were carried out in the presence of 100 ng of indicated recombinant FLASH proteins (lanes 2–4). 
The control reaction (lane 1) contains no exogenous protein. (F) Statistical analysis of 3’ end 
processing of the dH3 pre-mRNA in small-scale nuclear extracts from untreated S2 cells (left 
panel) and FLASH-depleted S2 cells (right panel). Processing was carried out in the absence of 
any recombinant protein (buffer) or in the presence of indicated variants of FLASH. The P-value  
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was calculated using a paired version of the Student's t-test with a two-tailed distribution. The 
data represent two to four separate processing reactions and three independent nuclear extract 
preparations from untreated and treated S2 cells. Efficiency was measured as a ratio of the final 
processed product to the input (unprocessed + processed). Error bars indicate the standard 
deviation for measured efficiencies. 
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Figure 14. Second conserved LDIY motif located between amino acids 45-48 has a minor 
role in processing efficiency in vitro. (A) The first 178 amino acids of Drosophila FLASH with 
two highly conserved LDIY motifs underlined. Both of these motifs were changed to alanines in 
a double FLASH mutant (LDIY-4A (x2)). (B) Western to identify dFLASH in nuclear extracts 
prepared from S2 small scale cell cultures either in the presence of dsRNA targeting dFLASH 
(lane 2) or without (lane 1). Arrow indicates a cross reacting band between the two nuclear 
extracts. (C) Time course for 3’ end processing of labeled dH3 pre-mRNA in nuclear extracts 
prepared from untreated cells (lanes 2 and 3) or FLASH knockdown cells (lanes 4-11). Labeled 
dH3 in the absence of nuclear extract is in lane 1. Incubations were stopped at 90 or 180 minutes 
respectively. Approximately 100 ng of corresponding recombinant proteins or an equivalent 
volume of extract buffer were added to each reaction as indicated. 
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Figure 15. A complex of the N-terminal FLASH and Lsm11 binds Drosophila 
polyadenylation factors. (A–C) The interaction of indicated recombinant FLASH variants 
bound to the N-terminal Lsm11 with polyadenylation factors in S2 (A) or Kc (B,C) nuclear 
extracts. Nuclear proteins that interact with the Lsm11/FLASH complex were collected on 
glutathione (GSH) beads via the GST tag attached to FLASH and analyzed by Western blotting 
using specific antibodies. Material bound to GSH beads in the absence of recombinant proteins 
was analyzed in lanes 2 and 6 (A) and lane 2 (B,C). Input (15%) of the nuclear extract is shown 
in lane 1 of each panel. The arrows in C indicate a contaminant from the recombinant Lsm11 
protein that cross-reacts with the antibody against CPSF73. 
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Figure 16. U7-dependednt degradation of Drosophila DCP generated during 3’ end 
processing requires FLASH. In vitro degradation assays with 5’ radio-labeled DCP in small 
scale Drosophila S2 nuclear extracts. Labeled DCP substrate at top of gel and degraded 5’ 
monophosphate products at the bottom. Probe alone is in lane 1. Reactions with extracts from 
untreated S2 cells are shown in lanes 2-5. Lane 3 shows U7-dependence of degradation. Lanes 6-
9 show reactions with extracts from cell culture treated by RNAi to deplete FLASH.  
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Figure 17. Analyzing the involvement of Drosophila Ars2 in 3’ end processing of histone 
pre-mRNAs. (A) Immunoprecipitation of Ars2 and FLASH from nuclear extracts prepared from 
freshly harvested Kc cells (lanes 1–5) or S2 cells grown in monolayers (MS, lanes 6–9). The 
antibodies used in the experiment are indicated at the top of each lane. The anti-Mock antibody 
is directed against 3′hExo, a human protein that has no clear homolog in Drosophila. The inputs 
are shown in lanes 1 and 6. (B) Proteins immunoprecipitated by the anti-Ars2 antibody from a 
Kc cell nuclear extract were detected by silver staining and analyzed by mass spectrometry. The 
major identified proteins are listed on the left. (C) Depletion of endogenous Ars2 in S2 cells by a 
specific dsRNA. S2 cells were treated for 5–6 d with dsRNA against various proteins and tested 
for depletion of Ars2 using the anti-Ars2 antibody. CR indicates a protein of ∼70 kDa that cross-
reacts with the antibody and served as a loading control. Mock1 (CG7769) and Mock2 (CG8443) 
are two proteins unrelated to 3’ end processing of histone pre-mRNAs. (D) Northern blot 
analysis of endogenous histone H3 mRNA in S2 cells treated with dsRNAs shown in panel C. 
Species ending with the canonical stem–loop (dH3 SL) migrate as a single band. Polyadenylated 
species are longer and, due to the heterogeneity of the poly(A) tail, migrate as a smear. 
Drosophila 7SK RNA served as a loading control. 
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Figure 18. Composition of Drosophila U7 snRNP. (A) The material precipitated from a Kc 
nuclear extract with the anti-Ars2 (lane 2) or anti-FLASH (lane 3) antibodies was tested for the 
presence of indicated processing factors using specific antibodies. Lane 1 contains 10% of the 
input extract used for immunoprecipitation. CR indicates a protein cross-reacting with the anti-
FLASH antibody. (B) Proteins precipitated with the anti-FLASH antibody from 2.0 mL of a Kc 
nuclear extracts were separated in an SDS/polyacrylamide gel, detected by silver staining, and 
identified by mass spectrometry. (C) Proteins immunoprecipitated from a Kc nuclear extract 
using indicated antibodies were analyzed for the presence of FLASH using the anti-FLASH 
antibody. Mock antibody (lane 4) was directed against a protein unrelated to 3’ end processing of 
histone pre-mRNA (CG9958). Lane 1 contains 2% of the input extract used in 
immunoprecipitation. (D) Binding of processing factors to various RNAs containing biotin for 
subsequent purification on streptavidin Sepharose beads. Lane 1 contains 5% of the input extract 
used in each binding experiment. One of the blots was simultaneously probed with the anti-
FLASH and anti-SLBP antibodies; CR indicates two FLASH degradation products that migrate 
immediately above full-length SLBP. SLBP is virtually undetectable in this lane and highly 
enriched in the material purified by the Biot-SL RNA. (E) The material bound to the Biot-αU7 
oligonucleotide was analyzed by Western blotting for the presence of indicated proteins. Lane 1 
contains 1% of the input extract used in the binding experiment. (F,G) Major proteins bound to 
either the Biot-αMock (lane 1) or Biot-αU7 (lane 2) oligonucleotides were separated in 8% (F) or 
12% (G) SDS/polyacrylamide gels, stained with silver, identified by mass spectrometry, and are 
listed to the right. 
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Figure 19. Composition of processing complexes assembled on the dH3 pre-mRNA. (A) 3’ 
end processing of the dH3 pre-mRNA in a Kc nuclear extract in the presence of indicated 
concentrations of NP40 (lanes 3, 4). The input alone and processing in the absence of NP-40 is 
shown in lanes 1 and 2, respectively. (B) The Drosophila U7 snRNP was affinity-purified from a 
Kc nuclear extract using the Biot-αU7 oligonucleotide either in the absence (lane 2) or presence 
(lane 3) of NP-40 and subsequently probed for the presence of indicated processing factors. Lane 
1 contains 1% of the input extract used for the purification. Lsm11 is virtually undetectable in 
this lane and highly enriched in the material purified by the oligonucleotide. (C) Binding of 
SLBP and Lsm11 to indicated biotinylated RNAs. Lane 1 contains 5% of the input Kc extract 
used in each binding experiment. Lane 2 shows the background binding to streptavidin 
Sepharose beads in the absence of any biotinylated RNA. (D) Binding of processing factors from 
a Kc nuclear extract to the Biot-dH3 pre-mRNA (lanes 3–6), either in the absence of any RNA 
competitor (lane 3) or in the presence of indicated RNAs (lanes 4–6). Lane 1 contains 5% of the 
input Kc extract used in each binding experiment. SLBP and Lsm11 are virtually undetectable in 
this lane and highly enriched in the material purified by the Biot-dH3 pre-mRNA. Lane 2 shows 
the background binding to streptavidin Sepharose beads in the absence of the Biot-dH3 pre-
mRNA. (E) Binding of FLASH, symplekin, and SLBP to indicated biotinylated RNAs. Lane 1 
contains 2.5% of the Kc extract used in each binding experiment. (F) Protein factors from a Kc 
nuclear extract bound to the Biot-dH3 pre-mRNA in the absence of any RNA competitor (lane 1)  
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or in the presence of indicated RNAs (lanes 2, 3). The bound proteins were separated on a 12% 
SDS/polyacrylamide gel and stained with silver. The indicated bands and remaining portions of 
each lane were analyzed by mass spectrometry; the identified processing factors are listed to the 
right. The mass spectrometry results obtained for lane 3 were virtually identical to those obtained 
for lane 1 
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Figure 20. CstF64 is a component of the Drosophila U7 snRNP. (A) Western blot analysis of 
proteins bound to either the Biot-αU7 (lane 2) or Biot-αMock (lane 3) oligonucleotides using an 
antibody directed against full-length Drosophila CstF64. Lane 1 contains 2% of the input extract 
used in the binding experiment. (B) Immunoprecipitation of various polyadenylation factors 
from a Kc nuclear extract with the anti-CstF64 antibody alone (lane 3) or in the presence of the 
competing recombinant protein (lane 4). (*) Recombinant CstF64 bound to the antibody and 
collected on protein A agarose beads. Lane 1 contains 20% of the input extract used for 
immunoprecipitation, and lane 2 contains proteins of the nuclear extract bound to protein A 
agarose in the absence of any antibody. Immunoprecipitated proteins were identified by Western 
blotting using specific antibodies. (C) Immunoprecipitation of various polyadenylation factors 
from a Kc nuclear extract with the anti-CstF64 antibody alone (lane 3) or in the presence of the 
competing recombinant protein (lane 4). Lane 1 contains 10% of the input extract used for 
immunoprecipitation. (D) Proteins immunoprecipitated with the anti-CstF64 antibody (lane 3) or 
an anti-Mock antibody were separated on a 12% SDS/polyacrylamide gel, silver-stained, and 
analyzed by mass spectrometry. Lane 1 contains material bound to protein A agarose in the 
absence of any antibody. (E,F) Proteins precipitated with the anti-CstF64 antibody (lane 1 in 
both panels) or in the presence of the competing recombinant protein (lane 2 in panel E and lane 
3 in panel F) were separated on a 10% (E) or 15% (F) SDS/polyacrylamide gel, silver-stained, 
and analyzed by mass spectrometry. Immunoprecipitation with the anti-CstF64 antibody using 
the nuclear extract pre-treated with RNase A is shown in lanes 3 (E) and 2 (F). (*) The CstF64 
protein competitor bound to the antibody. The recombinant CstF64 used as a competitor is 
additionally shown in lane 4 of panel F. (G) Levels of Drosophila CF Im68 in whole cell lysate 
from untreated S2 cells (lane 1) or cells treated with dsRNA against this factor (CF Im68 KD, 
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lane 2), as determined by Western blotting using an antibody targeted to the N-terminal region of 
human CF Im68. CR indicates two proteins cross-reacting with the antibody that served as a 
loading control. (H) Immunoprecipitation of Drosophila CF Im68 from a Kc nuclear extract with 
the anti-CstF64 antibody (lane 4) or with a nonspecific antibody directed to a protein unrelated to 
3’ end processing (lane 3). The material bound to protein A agarose in the absence of any 
antibody is analyzed in lane 2. Lane 1 contains 10% of the input extract used for 
immunoprecipitation. 
 
  
123 
 
 
 
 
  
124 
 
Figure 21. Major differences in 3’ end processing of replication-dependent histone pre-
mRNAs between mammals and Drosophila. Table identifies differences between 3’ end 
processing of histone pre-mRNA in mammalian and insect cells.  
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Table 1. Differences in 3’ end processing between mammals and Drosophila  
Factor/Function Mammalian Drosophila 
Position of cleavage site Fixed position 5’ of the HDE  Always 4 nts 3’ of the stem-
loop 
Role of SLBP in processing Stabilizes binding of the U7 
snRNP. Dispensable if duplex 
between U7 snRNA 5’ end 
and HDE is sufficient 
Absolutely required 
Composition of HCC All six subunits of CPSF, 
symplekin, and CstF64 
Four subunits of CPSF (Fip1 
and CPSF30 missing), 
symplekin, and CstF64 
Role of CstF64 in processing Possibly essential (Ruepp et 
al. 2011) 
Not essential 
Ars2 and FLASH interaction Yes No 
Role of FLASH in 
degradation of DCP 
Not required  Essential for degradation 
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Figure 22. Potential forms of the U7 snRNP in Drosophila. The core particle consists of the 
U7 snRNA and the U7-specific Sm ring. This form is predominant in mammalian cells. In 
Drosophila cultured cells, most if not all U7 snRNP contains FLASH that interacts with Lsm11. 
As a result of this interaction, at least a fraction of the U7 snRNP assembles with a subset of 
polyadenylation factors (light gray) that form the Histone pre-mRNA Cleavage Complex (HCC). 
CPSF73, CPSF100, and symplekin are essential for 3’ end processing of histone pre-mRNAs in 
vivo, whereas the remaining polyadenylation factors (CPSF160, WDR33, and CstF64) are 
dispensable and may play accessory/regulatory functions. The arrangement of polyadenylation 
factors within the HCC is arbitrary. 
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CHAPTER 4: INTERACTION OF C-TERMINAL FLASH WITH NPAT AND 
IDENTIFICATION OF MINIFLASH 
 
INTRODUCTION 
Nuclear Protein, Ataxia Telangiectaisa locus (NPAT) is a co-activator of histone gene 
transcription. CDK2/cyclinE phosphorylates five epitopes in the C-terminal half of NPAT at the 
G1 to S-phase transition. These modifications are essential for entry into S-phase and efficient 
histone gene transcription (Ma et al., 2000).  The N-terminal half of NPAT contains a LisH 
domain at the N-terminus which contains residues critical to histone gene transcription (Wei et 
al., 2003) and a region that interacts with the histone specific transcription factor HINF-P (Miele 
et al., 2005).  
Chapters 2 and 3 examined the critical regions of N-terminal FLASH in mammals and 
Drosophila and show it is required for histone pre-mRNA 3’ end processing by interacting with 
Lsm11 and the HCC. Replication dependent histone genes are cell-cycle regulated with 
expression limited to S-phase, when there is a need to package newly synthesized DNA into 
chromatin. Upregulation of histone mRNA levels is achieved through a combination of 
transcriptional activation of histone genes coupled with histone pre-mRNA 3’ end processing 
activity. Both NPAT and FLASH contribute to efficient histone gene expression and are stably 
associated with the histone locus body (HLB) (Barcaroli et al., 2006a; Barcaroli et al., 2006b). 
HLBs are nuclear bodies localized near histone gene clusters and enriched in factors critical for 
expression of histone genes. In human and mouse primary cells, four HLBs are visible during S-
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phase and localized to the two histone gene loci on chromosomes 1 and 6 (Zhao et al., 2000). By 
concentrating factors essential to histone gene expression, HLBs unite two distinct processes 
required for histone biogenesis: transcriptional activation of the histone gene and post-
transcriptional processing of the pre-mRNA 3’ end. But the mechanism for localization of NPAT 
and FLASH to the HLB was unknown.  
The C-terminal domain of FLASH (amino acids 1923-1976) is similar in sequence to that 
of an unrelated protein, YARP. YARP is an orthologue of Drosophila MUTE, which also 
localizes to the HLBs (White et al., 2011) and functions as a repressor of histone gene 
transcription (Bulchand et al., 2010). In this chapter, I demonstrate that C-terminal domains of 
FLASH and YARP bind C-terminal NPAT in vitro. When the C-terminal domains of FLASH or 
YARP are fused to an unrelated protein in vivo, the chimeric protein binds C-terminal NPAT. 
Furthermore, the interaction between NPAT with the C-terminal domains of FLASH or YARP is 
sufficient to localize the chimeric protein to HLBs. These results demonstrate a potential 
mechanism by which FLASH is recruited to HLBs for histone pre-mRNA 3’ end processing. .  
Additionally, I conducted a yeast two-hybrid screen using N-terminal Lsm11 (amino 
acids 1-168) with a human universal tissue library that isolated an alternatively spliced form of 
FLASH. This unique splice variant was not previously identified and encompasses the first N-
terminal 138 amino acids shown to be critical for histone pre-mRNA 3’ end processing fused to 
the terminal 52 amino acids shown to interact with NPAT. Named MiniFLASH, it is missing two 
massive internal exons that together account for approximately 1800 amino acids of the protein, 
including the region known to interact with Ars2. This interesting result demonstrates an instance 
where the two extreme ends of FLASH critical for 3’ end processing and HLB localization are 
joined directly.  
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MATERIALS AND METHODS 
Yeast two-hybrid system. The C-terminal region of FLASH (amino acids 1880-1982) was cloned 
into the pGBKT7 vector (Clontech) and used to screen a normalized Mate & Plate™ Library from 
HeLa S3 (Clontech, Cat. # 630479), as suggested by the manufacturer.  Human MiniFLASH was 
isolated by screening normalized Universal Human Mate & Plate™ Library (Clontech, Cat. # 
630480) against full length Lsm11 cloned in pGBKT7 (Yang et al., 2009a).  Yeast diploid cells 
expressing proteins potentially interacting with the bait proteins were initially selected on plates 
lacking histidine and containing 5 mM 3-AT and subsequently tested on plates containing up to 
100 mM 3-AT. 
Antibodies.  The following antibodies were use in this study: mouse monoclonal anti-HA 16B12 
(Covance), mouse monoclonal anti-Myc 9E10 (Santa Cruz Biotechnology), rabit anti-CPSF73 
A301-090A (Bethyl Labolatories), anti-SLBP (Wang et al., 1996), anti-FLASH (Yang et al., 
2009a), sheep anti-mouse IgG NA931V (GE), donkey polyclonal anti-rabbit IgG Na934V (GE), 
goat anti-rabbit IgG labeled with green-fluorescent Alexa Fluor 488 (Life Technologies) and goat 
anti-mouse IgG labeled with red-fluorescent Alexa Fluor 594 (Life Technologies).  
Transient expression of proteins in HeLa cells. The cDNA for human SLBP was extended at 
the C-terminus with a portion of human FLASH that encodes the last 103 amino acids of human 
FLASH (amino acids 1880-1982).  The resultant insert was cloned into pcDNA3/HA downstream 
from the regions encoding three hemagglutinin (HA) tags. This construct (HA-SLBP/F) when 
expressed in HeLa cells yields a fusion protein consisting of three HA tags at the N-terminus 
followed by 234 amino acids of SLBP and the C-terminal portion of FLASH (amino acids 1880-
1982).  We also generated a construct consisting of the HA tag and SLBP but lacking the C-
terminal FLASH (HA/SLBP).  The C-terminal regions of human NPAT (amino acids 1297-1427) 
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and Drosophila mxc (amino acids 1669-1837) were cloned in the pcDNA3/Myc vector 
immediately downstream of a single Myc epitope.  Approximately 106 HeLa cells grown in 
monolayers were co-transfected in the presence Lipofectamine 2000 (Invitrogen) with various 
combinations of constructs expressing the HA and Myc-tagged proteins and 24 hours later 
collected and lysed in NP40 buffer (0.5% NP40, 150 mM NaCl, 50 mM Tris-HCl pH 8, 10 mM 
sodium azide, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride).  The cell lysates were 
supplemented with EDTA to a final concentration of 10 mM and incubated 30 min on ice with 50 
ng of the stem-loop RNA containing biotin at the 5’ end.  Proteins associated with the RNA were 
collected on streptavidin sepharose beads (Sigma), separated in an SDS/polyacrylamide gel and 
analyzed by Western blotting, using anti-HA and anti-Myc antibodies.   
Immunofluorescence.  The HA-SLBP and HA-SLBP/F constructs were transiently expressed in 
HeLa cells and 24 hours later fixed with 3.7% formaldehyde and permeabilized with 0.5% Triton 
X-100. The intracellular localization of the tagged proteins was analyzed by confocal microscopy 
using an anti-HA antibody (Covance) and a Cy3-conjugated goat anti-mouse antibody. Histone 
Locus Bodies were detected with the DH3 monoclonal anti-NPAT antibody (kindly provided by 
E. Harlow) (Zhao et al., 2000) or rabbit polyclonal anti-FLASH antibody (Yang et al., 2009a).  
In vitro protein expression and purification.  Recombinant FLASH, YARP and NPAT proteins, 
each N-terminally fused to glutathione S-transferase (GST), were expressed in bacteria from the 
pET-42a vector and purified on nickel beads (Qiagen) via the His tag present on each fusion 
protein. 35S-labeled proteins were cloned in a vector containing SP6 RNA promoter and expressed 
in rabbit reticulocytes using the Transcription and Translation coupled kit (TnT, Promega), 
according to the manufacturer’s protocol.  
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Analysis of protein-protein interactions by GST pull down assays.  Various combinations of 
two different proteins, one tagged with GST (~5 µg) and the other labeled with 35S (10-15 µl of 
the TnT reaction, depending on the efficiency of labeling) were mixed in 100 µl of buffer D (100 
mM KCl, 20 mM Hepes pH at 7.9, 20% glycerol, 0.2 mM EDTA at pH 8, 0.5 mM DTT) and 
incubated on ice for 30 min. The volume was subsequently increased to 600 µl with buffer D and 
each binding reaction was rotated with 30 µl of glutathione agarose beads (Sigma) at 4oC for 1 
hour. The beads were rinsed several times with buffer D, rotated with the same buffer for additional 
30 min, transferred to a new tube, re-suspended in a SDS sample buffer and bound proteins 
analyzed on an SDS/polyacrylamide gel.  Each gel was initially stained with Coomassie Blue to 
monitor the amount of the GST tagged proteins and subsequently dried and used for 
autoradiography to detect 35S-labeled proteins. 
 
RESULTS 
The C-terminal domains of FLASH and YARP interact with the C-terminus of NPAT.  
Human FLASH is a 220 kDa protein consisting of 1982 amino acids.  Its N-terminal 135 amino 
acids play a critical role in 3’ end processing of histone pre-mRNAs in vitro by forming a 
platform with Lsm11 that recruits the HCC to the U7 snRNP and hence to histone pre-mRNA 
(Yang et al., 2013).  This is the most highly conserved region of FLASH, sharing a weak but 
recognizable homology with its Drosophila orthologue (Yang et al., 2009a; Burch et al., 2011).  
The C-terminal region of FLASH is highly conserved in all vertebrates but displays no similarity 
to the C-terminus of Drosophila FLASH.  Strikingly, a sequence of 55 amino acids highly 
similar to the C-terminal region of FLASH is also present at the end of an unrelated vertebrate 
protein known as YY1 Associated Protein Related Protein 1 (YARP) or Gon4l (Fig. 23B) 
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(Ohtomo et al., 2007; Lu et al., 2010). As part of our interest in understanding the functional 
organization of FLASH, we investigated the role of its C-terminus and potential links between 
FLASH and YARP.  
 FLASH is known to interact through the N-terminal domain with itself (Kiriyama et al., 
2009) and Lsm11 (Yang et al., 2009a) and through a short central motif (amino acids 931-943) 
with Ars2 (Kiriyama et al., 2009).  To identify potential binding partners of the highly conserved 
C-terminal common to FLASH and YARP, Lalitha Kunduru cloned the last 108 amino acids of 
FLASH (Fig. 23C) in the yeast pGBKT7 bait vector (Clontech) and screened this fragment 
against a 2-hybrid library from HeLa cells (Clontech) in the presence of 5mM 3-aminotriazol.  
Among over 10 million diploids screened, fewer than 100 colonies rapidly grew under these 
relatively stringent conditions, with seven colonies containing the same insert encoding only the 
last 16 amino acids of NPAT (Nuclear Protein, Ataxia-Telangiectasia Locus), a known activator 
of histone gene transcription and a stable resident of Histone Locus Bodies (Ma et al., 2000; 
Zhao et al., 1998; Ye et al., 2003; Zhao et al., 2000). The second most frequently identified 
positive clone (4 independent isolates) contained the C-terminal half of Proliferating Cell 
Nuclear Antigen (PCNA), a component of the DNA replication machinery.  Judging from the 
growth rate in the presence of increasing concentrations of 3-AT, the C-terminal region of 
FLASH interacts stronger with NPAT than with PCNA (Fig. 1D). 
 Since NPAT and FLASH are stable residents of HLBs, their interaction detected in yeast 
cells was likely biologically relevant and raised the possibility that YARP may also interact with 
NPAT and could be a new HLB component with a role in histone gene expression.  We used a 
GST pull down assay to determine whether the C-terminal regions of FLASH and YARP directly 
interact in vitro with the C-terminus of NPAT.  The terminal 16-amino acid region of NPAT was 
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cloned downstream of GST in pET42-a (Fig. 1E) and expressed as the GST-Np16C fusion 
protein in bacteria.  The C-terminal regions of FLASH (Fl103C, amino acids 1880-1982) and 
YARP (Ya97C, amino acids 2117-2213) were expressed and labeled with 35S-methionine in 
rabbit reticulocyte lysate using the TnT kit (Promega).  In the pull down assay, consistently more 
than 20% of 35S-labeled Fl103C used in the experiment bound to the GST-Np16C fusion protein 
and retained on glutathione agarose beads (Fig. 1G, top two panels, lane 3).  The corresponding 
domain of YARP also bound to GST-Np16C, although the interaction was less efficient, with on 
average 15% input recovered from glutathione beads (Fig. 1G, top middle panels, lane 2).  In 
contrast, the N-terminal domain of FLASH (GST-F138N, amino acids 1-138) that is involved in 
3’ end processing of histone pre-mRNAs  does not detectably interact with GST-NP16C (Fig. 
1G, top bottom panels, lane 2). 
 To confirm the interaction of the C-terminal NPAT with the C-terminal regions of 
FLASH or YARP, we carried out a reciprocal experiment.  The C-terminal amino acids of 
FLASH (1880-1982) or YARP (2117-2213) were cloned downstream of an N-terminal GST tag 
and expressed in bacteria (GST-Fl103C and GST-Ya97C, respectively).  The C-terminal region 
of NPAT encompassing the last 131 amino acids of NPAT (Fig. 2A) was expressed rabbit 
reticulocyte lysate, yielding 35S labeled NPAT-131C.  In the pull down assay, as much as 20% 
of the input NPAT-131C was consistently bound by GST-Fl103C or GST-Ya97C (Fig. 2B, top 
panel). To determine whether the interaction involves only the last 16 amino acids of NPAT or 
extends to a more upstream sequence, we removed these amino acids from the NPAT-131C 
protein, creating NPAT-Δ16C.  This deletion significantly reduced the interaction with GST-
Fl103C and nearly abolished the interaction with GST-Ya97C (Fig. 2B, middle panel, lanes 3 
and 4, respectively).  Deleting additional 9 amino acids from the end (NpΔ25C) was sufficient to 
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eliminate the interaction with GST-Fl103C (Fig. 2B, bottom panel, lane 3).  We concluded that 
the C-terminal domains of FLASH and YARP interact with a larger than 16 amino acids portion 
of NPAT, and the interaction likely extends to as many as its 25 last amino acids.  In addition, 
these results indicate that the C-terminal domain of NPAT interacts more strongly with FLASH 
than with YARP. 
 To prove that the interaction of NPAT with FLASH or YARP is mediated by the shared 
55-amino acid domain rather than by unique sequences located outside the conserved region, we 
expressed a GST fusion protein linked to the domain of FLASH (GST-Fl54C).  In the GST-pull 
downs assay Np131C interacted with this domain as efficiently as with the longer C-terminal 
FLASH fragment consisting of 103 amino acids (Fig. 2C, lanes 3 and 4).  We synthesized a 
peptide containing the last 25 amino acids of NPAT (Np25C) and tested its ability to compete 
with GST-Np16C in binding 35S-labeled Fl103C (Fig. 2D, lanes 4 and 5).  The interaction of 
GST-Np16C with Fl103C was completely eliminated in the presence of 1 µg and 10 µg of 
Np25C (2 and 20 fold excess of the peptide relative to GST-Np16C, respectively), confirming 
that the 25-amino acid C-terminal region of NPAT alone is capable of strongly interacting with 
the C-terminal domain of FLASH. 
 We also tested the in vitro interaction between the C-terminal regions of FLASH and 
YARP with PCNA.  PCNA is a cofactor of the DNA polymerase delta and plays a key role in 
enhancing the efficiency of DNA synthesis of the leading strand during S-phase (Jonsson and 
Hubscher, 1997).  Its interaction with FLASH could facilitate coupling of histone gene 
expression with DNA replication and other key S-phase events.  The GST pull down assay 
confirmed that full length PCNA (261 amino acids) interacts with the C-terminal FLASH in vitro 
(Fig. 2E, lane 3), although this interaction is significantly weaker than between NPAT and 
  
136 
 
FLASH.  This result is in a good agreement with the data from the yeast two-hybrid screen (Fig. 
1D).  The 54-amino acid domain of FLASH is sufficient for the interaction.  The same domain of 
YARP did not interact with PCNA, indicating that FLASH and YARP in spite of sharing 
significant homology at the C-terminus may interact with both distinct and overlapping partners.  
PCNA is known to bind numerous proteins in vivo (De Biasio and Blanco, 2013; Maga and 
Hubscher, 2003) and further studies are required to determine whether its interaction with 
FLASH has biological significance.  
The interaction between the C-terminal domains of FLASH and NPAT in HeLa cells.  To 
determine whether the C-terminal regions of FLASH and NPAT interact in cells, we constructed 
the HA-SLBP/F clone encoding human SLBP extended at the C-terminus with the last 103 
amino acids of FLASH and at the N-terminus with a 3xHA tag (Fig. 3A).  We also constructed a 
similar clone that lacked the C-terminal FLASH extension, consisting solely of the 3xHA tag at 
the N-terminus followed by full length SLBP (HA-SLBP).   
Since the endogenous NPAT is present in limiting quantities and generally difficult to 
detect by Western blotting, we constructed a clone that expresses the last 131 amino acids of 
human NPAT (amino acids 1297-1427) as a fusion with an N-terminal Myc epitope (Myc-
Np131C).  As a negative control, we used a clone encoding the last 169 amino acids of mxc 
(amino acids 1669-1837, Myc-mxc169C), the Drosophila orthologue of NPAT, which localizes 
to HLBs in Drosophila (White et al., 2011) but shares no recognizable homology with the C-
terminus of human NPAT (Fig. 3A).  Each HA tagged version of SLBP was co-expressed in 
HeLa cells with either Myc-Np131C or Myc-mxc169C.  Approximately 24 hours following 
transfection, HeLa cells were collected, lysed and the SLBP from each lysate was affinity-
purified on streptavidin agarose beads uisng a short RNA containing the stem-loop structure 
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from histone mRNA and biotin on the 5’ end (Biot-SL).  This method of affinity purifying SLBP 
was used by us previously (Dominski et al., 2003) and is efficient and specific.   
The Biot-SL RNA purifies HA-SLBP and HA-SLBP/F, with the efficiency varying 
between experiments from 10 to 40% of the input (Fig. 3C and not shown).  The precipitate also 
contains the endogenous SLBP, which does not react with the anti-HA antibody and can only be 
detected by an anti-SLBP antibody (not shown).  We used anti-Myc antibodies and Western 
blotting to analyze the material purified by the stem-loop RNA. Importantly, HA-SLBP/F but not 
HA-SLBP co-purified with Myc-Np131C, demonstrating that the C-terminal regions of FLASH 
and NPAT form a complex in vivo. As expected, the material did not contain detectable amounts 
of CPSF73 and other proteins of the whole cell lysate, confirming that the RNA-mediated 
purification is very selective.  The specificity of the method was additionally confirmed by 
expressing an HA-tagged protein that lacks SLBP and fails to interact with the SL RNA (see Fig. 
6F, lane 4).  
To test whether the interaction between the C-terminal regions of human FLASH and NPAT is 
specific, we co-expressed HA-SLBP/F with Myc-mxc169C, containing the C-terminal amino 
acids of Drosophila mxc (amino acids 1669-1837).  Whole cell lysates were prepared from HeLa 
cells transiently expressing HA-SLBP/F and Myc-mxc169C and SLBP was purified from each 
lysate by the Biot-SL RNA.  As determined by Western blotting with anti-HA and Myc 
antibodies, the recovered material contained HA-SLBP/F but lacked any detectable Myc-
mxc169C (Fig. 3D, lane 2), demonstrating that these two proteins do not interact.   
We also tested the interaction between HA-SLBP/F and Myc-Np131C using 
immunoprecipiation.  The same lysates were incubated with an anti-SLBP antibody and the 
precipitated material analyzed by Western blotting, using anti-HA and anti-Myc antibodies. 
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Again, the HA-tagged SLBP fused with the C-terminal region of FLASH (HA-SLBP/F) co-
precipitated with Myc-Np131C (Fig. 3E, compare lanes 2 and 4).  Altogether, the in vitro pull 
down experiments and studies in HeLa cells established that the C-terminal portions of FLASH 
and human NPAT make direct contacts with each other.  Previous studies demonstrated that the 
endogenous FLASH and NPAT co-precipitate, but failed to determine whether they interact 
directly or exist in a common complex containing additional proteins (Barcaroli et al., 2006a; 
Kiriyama et al., 2009).  
 
The C-terminal domain of FLASH targets a heterologous protein to HLBs.  SLBP is a 3’ 
end processing factor that tightly binds the highly conserved stem-loop structure in histone pre-
mRNA located upstream of the cleavage site and remains associated with the mature histone 
mRNA following 3’ end processing (Marzluff et al., 2008).  The complex of mature histone 
mRNA and SLBP is ultimately exported from the nucleus for translation.  As a result, in 
mammalian cells SLBP is only transiently associated with histone gene loci and is detected in the 
S-phase cells throughout the nucleoplasm and cytoplasm, displaying no significant enrichment in 
Histone Locus Bodies (Erkmann et al., 2005) (see Fig. 4B).  This is in a sharp contrast to the U7 
snRNP, including its integral components FLASH and Lsm11, which persists in HLBs after each 
round of processing (Liu et al., 2006; Pillai et al., 2001b).   
To investigate the biological role of the interaction between the C-terminal regions of 
FLASH and NPAT, we tested whether SLBP fused with the last 103 amino acids of FLASH is 
concentrated in HLBs.  We transiently expressed HA-SLBP and HA-SLBP/F in HeLa cells and 
used fluorescent confocal microscopy to determine their intracellular localization 24 hours post 
transfection.  Since NPAT is a limiting factor, it was possible that overexpression of HA-SLBP/F 
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would result in its diffused localization throughout the nucleoplasm, hence preventing the 
detection of HLBs.  To ensure expression at a physiological level, HeLa cells were transfected 
with small amounts of plasmid DNA.  Indeed, the steady-state levels of both HA-SLBP and HA-
SLBP/F were comparable to the level of endogenous SLBP (Fig. 4A, lanes 2 and 3).  
HeLa HLBs were stained with an antibody against the N-terminal portion of FLASH and the 
intracellular localization of the HA-tagged SLBP proteins expressed from transfected plasmids 
was analyzed by an anti-HA antibody.  HA-SLBP, differing from the endogenous SLBP only by 
the presence of the HA-tag, was localized predominantly to the nucleoplasm, showing a uniform 
distribution and no detectable foci that would co-localize with HLBs (Fig. 4B).  In contrast, the 
HA-SLBP/F fusion protein localized to distinct nuclear structures and this punctuate pattern of 
staining was coincident with HLBs detected by the anti-FLASH antibody (Fig. 4C). We 
conclude that the C-terminal domain of FLASH that interacts with NPAT functions as a signal 
for localizing/retaining proteins in HLBs.  
 
Intracellular localization of YARP.  The presence of the FLASH-like domain at the C-terminus 
of YARP and its ability to interact with NPAT in vitro suggested that this protein may be a stable 
component of HLBs.  We first tested whether YARP and NPAT interact in vivo.  An HA-tagged 
version of SLBP extended at the C-terminus by amino acids 2117-2213 of YARP (HA-SLBP/Y) 
was transiently co-expressed with Myc-Np131C in HeLa cells and purified from whole cell 
lysate 24 hours post transfection by the Biot-SL RNA. The material collected on streptavidin 
beads in the presence of this RNA was highly enriched in HA-SLBP/Y and contained Myc-
Np131C (Fig. 5A, lane 6), indicating that these two proteins interact in vivo.  As controls, we 
again tested the interaction of Myc-Np131C with the two other SLBP fusion proteins: HA-SLBP 
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and HA-SLBP/F (Fig. 5A, lane 6).  Consistent, with the data presented above, only HA-SLBP/F 
co-purified with Myc-Np131C.  No background amounts of Myc-Np131C were detected in the 
material purified from cells expressing HA-SLBP, confirming that the interaction requires the C-
terminal region of either FLASH or YARP. 
Xiao Yang transfected HeLa cells with low doses of DNA encoding HA-SLBP/Y and 
used confocal fluorescent microscopy to monitor the localization of the transiently expressed 
HA-SLBP/Y in HeLa cells.  As determined by an anti-SLBP primary antibody and a goat anti-
rabbit secondary antibody conjugated to green-fluorescent Alexa Fluor 488, SLBP in addition to 
showing a uniform nucleoplasmic distribution was targeted to a number of much brighter nuclear 
foci.  These foci were coincident with NPAT detected by an anti-NPAT monoclonal antibody 
(Zhao et al., 2000) and stained red with a secondary, anti-mouse antibody conjugated to Alexa 
Fluor 594 (Fig. 5B).  Thus, the C-terminal portion of YARP functions in the same manner as the 
homologous C-terminal portion of FLASH and when appended to a heterologous protein, 
promotes its retention in HLBs.   
 We next analyzed the intra-cellular localization of endogenous YARP and FLASH in 
HeLa cells using the cross-adsorbed and affinity-purified anti-YARP(C) or anti-FLASH(C) 
primary antibodies and a goat anti-rabbit secondary antibody conjugated to green-fluorescent 
Alexa Fluor 488.  HLBs were detected in the same cells using a mouse monoclonal antibody 
against NPAT (Zhao et al., 2000) and stained red with a secondary anti-mouse antibody 
conjugated to Alexa Fluor 594.  The anti-FLASH(C) antibody detected a number of foci in HeLa 
nuclei that perfectly co-localized with the NPAT-stained HLBs (Fig. 5D).  This result is in 
agreement with our previous localization experiments conducted with an antibody directed 
against the N-terminal region of FLASH (Yang et al., 2009a) (Fig. 5E).  Importantly, the anti-
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YARP(C) antibody also stained a number of foci that always co-localized with NPAT.  Based on 
these results we conclude that YARP is a newly identified component of HLBs in mammalian 
cells and its localization is likely mediated by the C-terminal domain that interacts with NPAT.  
In addition to detecting HLBs, the anti-YARP(C) antibody stained the nucleoplasm, excluding 
the nucleolus.  Thus, YARP while enriched in the vicinity of histone gene loci may also bind to 
other regions of chromatin, consistent with its proposed role in controlling expression of various 
genes (see below). 
 
Mini-FLASH, a short form of FLASH is localized to HLBs.  In FLASH, amino acids 100-135 
interact with Lsm11, the largest component of the Sm ring in U7 snRNP (Yang et al., 2009a; 
Yang et al., 2011).  Together they form a platform that recruits Histone pre-mRNA Cleavage 
Complex (HCC), which contains the CPSF73 endonuclease and other polyadenylation factors to 
the U7 snRNP (Yang et al., 2013).  The short N-terminal fragment of FLASH containing the 
binding sites for Lsm11 and the HCC strongly stimulates the activity of nuclear extracts in 3’ end 
processing of histone pre-mRNAs (Yang et al., 2009a; Yang et al., 2011), indicating that these 
two regions mediates all essential processing functions of FLASH in nuclear extracts and that the 
remaining 95% of the protein is dispensable in vitro.  Here, we have determined that the C-
terminal domain of FLASH (amino acids 1895-1982) targets FLASH to HLBs.  Thus, out of 
nearly 2,000 amino acids of FLASH, fewer than 200 residues derived from the opposing N- and 
C-terminal ends may be sufficient to support full processing activity of this protein in vivo.  
 As part of our continued effort to identify proteins interacting with Lsm11, we screened 
several independent cDNA libraries using the yeast two-hybrid system.  In most screens, we 
consistently isolated clones encoding various N-terminal portions of FLASH that included the 
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Lsm11 binding site (amino acids 100-135) (Yang et al., 2009a).  Strikingly, a universal cDNA 
library obtained from a collection of adult human tissues representing a broad range of expressed 
genes and both male and female donors yielded a FLASH variant in which the N- and C-terminal 
regions were directly linked and nearly 1800 amino acids of central part of the protein was 
missing.  Of the 190-amino acid total length of this variant, the first 138 residues and the last 52 
residues originated from the N- and C-terminus of full length FLASH, respectively (Fig. 6A).  
We refer to this protein as MiniFLASH (MiniF).  MiniF is encoded by an alternatively splice 
FLASH mRNA that lacks two internal exons, consisting of over 2,000 and 3,000 nucleotides 
(Fig. 6B).  These exons vastly exceed 150 nucleotides for an average exon and are among the 
largest internal exons in the genome, (Hawkins, 1988; Bolisetty and Beemon, 2012).  
 The N-terminal region of MiniF (amino acids 1-138) contains all sequences necessary for 
3’ end processing and is active in vitro.  We first tested whether MiniF is capable of supporting 
in vitro processing of a model 5’-labeled histone pre-mRNA derived from the mouse histone 
H2a-614 gene (Yang et al., 2009a; Yang et al., 2011).  This 86-nucleotide substrate contains all 
necessary processing sequences and upon cleavage is converted to a 48-nucelotide mature 
product terminated with the terminal stem-loop (Fig. 6C).  The GST-tagged MiniF was 
expressed in bacteria and added to a highly diluted mouse nuclear extract (equivalent of 0.5 µl of 
undiluted extract) that is virtually inactive in processing due to limiting amounts of FLASH (Fig. 
6D, lane 2).  Consistent with our previous reports (Yang et al., 2009a; Yang et al., 2011), the 
GST tagged N-terminal region of FLASH (GST-F138N) stimulates 3’ end processing of a model 
mouse H2a pre-mRNA increasing processing from a nearly undetectable level to 10% (Fig. 6D, 
lane 5).  As expected, the NPAT-interacting FLASH region encompassing amino acids 1880-
1982 (GST-Fl103C) has no effect on processing (Fig. 6D, lane 5).  Importantly, GST-MiniF that 
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contains the same N-terminal region followed by the last 52 C-terminal amino acids of FLASH 
was functional (Fig. 6D, lane 4).  Thus, adding 52 FLASH C-terminal amino acids to the N-
terminal region does not interfere with its ability to function in processing in vitro.  
The last 52 amino acids of MiniF correspond to a truncated NPAT-binding domain that 
lacks the 9-amino acid GEIIILWTR sequence at the N-terminus (Fig. 6A and B).  We tested 
whether this incomplete C-terminal domain is sufficient to interact with the C-terminal NPAT 
and can support proper localization of MiniF to HLBs in vivo.  In the GST pull down assay, 
MiniF compared to Fl103C showed reduced ability to interact with the C-terminus of NPAT 
(Fig. 6E, top panel, lanes 3 and 4), indicating that the missing 9-amino acid region is important 
for the optimal interaction.  Indeed, eight residues of this region are conserved in all known 
vertebrate FLASH and YARP orthologue and represent the N-terminal boundary of the sequence 
similarity between FLASH and YARP (Fig. 1A).  Shortening the C-terminal region of NPAT by 
removing the last 16 amino acids eliminated the interaction with MiniF (Fig. 6E, bottom panel, 
lane 4).  Consistent with the data shown in Fig. 2, the interaction of NPATΔ16 with the entire C-
terminal domain of FLASH was significantly reduced (Fig. 6E, bottom panel, lane 3).  
Altogether, these data indicate that the incomplete C-terminal FLASH domain in MiniF retains 
partial ability to interact with NPAT.  
The fact that human MiniF is generated as a result of alternative splicing and this isoform 
was not present in HeLa cell libraries suggests that it could be expressed in a tissue- or 
developmentally-specific manner and functional in vivo.  To determine whether the incomplete 
C-terminal domain is sufficient to deliver MiniF to HLBs, we transiently expressed a 3xHA 
tagged version of MiniF in HeLa cells and monitored its intracellular localization.  MiniF 
expressed at levels readily detectable by Western blotting and migrated at the expected size of 30 
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kDa (Fig. 6F, lane 3).  HLBs were detected by antibodies against FLASH (which also detects 
MiniF) and stained green, whereas MiniF was detected by anti-HA antibodies and stained red 
(Fig. 6G).  These experiments showed that the HA-tagged MiniF is concentrated in HLBs, 
indicating that when expressed, it may participate in generating mature histone mRNAs in vivo. 
 
DISCUSSION 
Human FLASH, a protein of nearly 2000 amino acids, is essential for U7-dependent 3’ end 
processing of histone pre-mRNAs and resides in Histone Locus Bodies (HLBs) (Yang et al., 
2009a; Ghule et al., 2008; Barcaroli et al., 2006a; Barcaroli et al., 2006b).  Its N-terminal region 
of about 135 amino acids interacts with Lsm11, a component of the U7 snRNP, and together 
these two proteins recruit a subset of polyadenylation factors, including the endonuclease, to 
histone pre-mRNA for 3’ end cleavage (Yang et al., 2009a; Yang et al., 2011).  The N-terminal 
region is also involved in FLASH self-association, whereas a short motif located in the center 
mediates the interaction of FLASH with Ars2, a stable component of the Cap Binding Complex 
(Kiriyama et al., 2009).  The structural and functional organization of FLASH outside these 
regions is poorly characterized.  The 55-amino acid domain located near the C-terminus is 
among the most highly conserved regions in vertebrate FLASH.  Strikingly, a highly similar 
sequence with about 50% identical residues is also present at the end of an unrelated protein 
known as YARP (Yin Yang 1 Associated Protein-Related Protein) or Gon4-like (Gon4l).  
Studies on YARP suggested that it functions as a transcriptional regulator involved in controlling 
critical developmental decisions but provided no information on the role of its C-terminal 
domain (Lu et al., 2010; Lu et al., 2011).   
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The C-terminal domains of FLASH and YARP interact with the extreme C-terminus of 
NPAT.  Using yeast two-hybrid screens, we identified NPAT as a factor that binds the C-
terminal domain of FLASH.  This finding was validated by in vitro GST pull down assays and in 
vivo studies in HeLa cells.  The homologous C-terminal domain of YARP also interacts with 
NPAT.  Strikingly, of nearly 1500 amino acids of NPAT, the region binding the C-terminal 
domains of FLASH and YARP is limited to the last 25-30 amino acids, with as few as 16 
extreme C-terminal NPAT residues being sufficient to mediate a strong interaction in vitro. 
The structures of the C-terminal domains of FLASH and YARP have been determined by 
structural genomic projects and both proteins adopt the same overall fold, consisting of three α-
helices.  This fold structurally resembles the SANT and Myb domains and is referred to as the 
SANT/Myb-like domain.  The Myb domain functions as a DNA recognition module in Myb-
related transcriptional activators (Ogata et al., 1994).  The SANT domain is an essential element 
of many chromatin-remodeling proteins and was named after four proteins that share this 
domain: SWI3, ADA2, N-CoR and TFIIIB (Boyer et al., 2004).  Sequence alignments, 
secondary structure predictions and X-ray crystallography suggest that in spite of structural 
similarities with the Myb domain, the SANT domain is unable to bind DNA and its function 
remains unknown (Horton et al., 2007).  Interestingly, it has been proposed that the SANT 
domain may function as a universal module that interacts with histone tails (Boyer et al., 2004).  
Our studies demonstrated that the related C-terminal SANT/Myb-like domain in FLASH and 
YARP functions in vertebrates as an NPAT-interacting module.  
Strikingly, compared to the FLASH orthologue, all vertebrate YARP orthologues contain 
an insertion of a single amino acid, a glycine that is located at the C-terminal end of helix 2.  The 
absolute conservation of this amino acid suggests that it functionally important for YARP and 
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may provide a critical feature that discriminates this domain from the C-terminal domain of 
FLASH.  The interaction between NPAT and FLASH is significantly stronger than that between 
NPAT and YARP, indicating the FLASH and YARP C-terminal domains in spite of overall 
similarities are not fully equivalent.   
The extreme C-terminal region of NPAT is among the most highly conserved regions of 
NPAT in vertebrates, although based on the sequence analysis and secondary structure prediction 
it does not resemble any known domain.  A similar sequence can be also found at the end of the 
uncharacterized sea urchin Strongylocentrotus purpuratus LOC582916 protein, which based on 
the presence of the Lissencephaly type-1-like homology (Lis-H) motif at the N-terminus likely 
represents the orthologue of NPAT.  The genome of S. purpuratus also encodes the orthologue 
of YARP that ends with a SANT/Myb-like domain.  Thus, the interaction between the C-
terminal region of NPAT and the SANT/Myb-like domain likely arose early in metazoan 
evolution. 
The similarity between vertebrate and Drosophila FLASH is limited to the N-terminal 
region, which interacts with Lsm11 and polyadenylation factors (Yang et al., 2009a; 2013) and 
the C-terminal regions are unrelated (Burch et al., 2011).  The NPAT orthologue in Drosophila 
has been recently identified as mxc (White et al., 2011) and its C-terminus also shares no 
recognizable sequence similarity with the vertebrate NPAT.  Intriguingly, the localization of 
FLASH to HLBs in Drosophila depends on its C-terminal region and the C-terminal region of 
mxc (White et al., 2011; Rajendra et al., 2010).  Thus, the interaction between the C-terminal 
regions of FLASH and NPAT may be a universal feature of all animals, although in Drosophila 
(protostomes) and vertebrates/sea urchins (deuterostomes)  it is mediated by unrelated sequences.  
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This conserved arrangement may be mechanistically essential and critical for the proper function 
of FLASH and NPAT in histone gene expression and HLB biogenesis. 
 
The SANT/Myb-like domain of FLASH and YARP functions as an HLB localization signal.  
What is the role of the interaction between the SANT/Myb-like domain of FLASH and NPAT?  
We showed that the addition of the C-terminal region of FLASH to SLBP converts SLBP from a 
shuttling protein that displays diffused pattern of localization throughout the nucleoplasm and 
cytoplasm into a stable resident of HLBs.  Thus, at least one purpose of this interaction is to 
efficiently accumulate proteins in HLBs.  Theoretically, FLASH might localize to HLBs through 
its interaction with the U7 snRNP, which binds the histone downstream element (HDE) in 
histone pre-mRNA.  However, our studies with a mutant Drosophila FLASH containing the 
Lsm11-interacting N-terminal domain but lacking the C-terminal region indicate that this way of 
localizing FLASH to HLBs in Drosophila cells (Burch et al., 2011)and flies (D. Tatomer, R.J. 
Duronio, Z.D., W.F.M., submitted) is inefficient.  Truncated FLASH has a largely diffused 
distribution in the nucleoplasm of Drosophila cells, explaining the requirement for an alternative 
targeting mechanism (Burch et al., 2011).  The interaction between FLASH and NPAT (or mxc 
in Drosophila) may additionally serve to mobilize the U7 snRNP to HLBs before generation of 
the nascent histone pre-mRNAs and to integrate the transcriptional co-activation function of 
NPAT with the 3’end processing activity of FLASH.  The accumulation of processing factors in 
distinct nuclear structures, likely HLBs, in a manner independent of binding to histone pre-
mRNA was observed in Xenopus oocytes (Abbott et al., 1999; Wu and Gall, 1993) and 
Drosophila embryos  (White et al., 2011; Salzler et al., 2013).  The U7 snRNP is limiting and 
creating its high local concentration in the direct vicinity of histone genes prior to the onset of 
  
148 
 
their transcription may be important to increase the efficiency and fidelity of the correct 3’ end 
processing, preventing undesired processing by cleavage and polyadenylation (Wagner et al., 
2007).  
 
YARP as the orthologue of Drosophila Mute.  Consistent with the presence of the NPAT-
interacting domain, Xiao Yang demonstrates that endogenous YARP localizes to HLBs in HeLa 
cells.  YARP throughout most of its length shares significant similarity with Drosophila Mute, a 
component of HLBs in Drosophila cells (Bulchand et al., 2010; White et al., 2011), suggesting 
that these two proteins may be functional counterparts.  It has been suggested that the C-terminal 
region of Mute also contains the SANT/Myb-like domain (Bulchand et al., 2010), although it 
displays only a weak similarity to the C-terminal regions of vertebrate YARP and FLASH.  It is 
unknown whether this degenerate SANT/Myb-like domain is responsible for targeting Mute to 
HLBs and whether it directly interacts with mxc.  Clearly, the C-terminal region of Drosophila 
FLASH does not resemble the Mute SANT/Myb-like domain and likely operates as an HLB-
targeting signal trough a different mechanism.  
Deficiency of Mute affects Drosophila muscle development, hence Mute is also referred 
to as “Muscle wasted” (Bulchand et al., 2010).  Mutations in Mute result at the molecular level in 
an increased accumulation of histone mRNAs in fly embryos (Bulchand et al., 2010).  This 
observation supports the possibility that one of the functions of Mute is to repress transcription 
of histone genes (Bulchand et al., 2010). It has been shown that YARP forms a complex 
consisting of the multifunctional transcriptional factor Ying Yang 1 (YY1), the transcriptional 
co-repressor Sin3a and histone deacetylase 1 (HDAC1), which functions as a transcriptional 
repressor that commits B cell progenitors to B lymphopoiesis (Lu et al., 2011).  Interestingly, 
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virtually all metazoan replication-dependent histone genes contain elements that bind YY1 (Last 
et al., 1999; Eliassen et al., 1998; Palko et al. 2004).  Thus, YARP through the interaction with 
YY1 may recruit HDAC1 to these genes to negatively regulate their transcription, as postulated 
for Mute.   
Both YARP and Mute are likely versatile transcriptional factors and in addition to 
regulating histone genes may affect expression of multiple genes, including those essential for 
development (Bulchand et al., 2010; Kiriyama et al., 2009; Liu et al., 2007).  Some of these other 
functions of YARP and Mute may be executed by their various splice variants and paralogues.  
The human genome contains for example a gene encoding a YARP homologue, YY1 Associated 
Protein (YY1AP) that was generated as a result of partial duplication of the YARP gene during 
evolution of anthropoids (Ohtomo et al., 2007; Kuryshev et al., 2006).  YY1AP corresponds to 
the central part of YARP (amino acids 601-1338) and the two regions share nearly 100% 
sequence identity, consistent with the evolutionarily recent duplication event.  YY1AP also binds 
YY1 (Wang et al., 2004)but lacks the SANT/Myb-like domain and is therefore unlikely to 
localize to HLBs. 
MiniF is a splicing variant of FLASH.  FLASH is encoded by multiple exons with a potential 
to generate multiple splice variants.  However, sequencing data based on RNA from cultured 
cells or human tissues provides no indication of extensive alternative splicing of FLASH pre-
mRNA. To our surprise, by screening a cDNA library constructed on mRNA isolated from a 
mixture of human tissues we identified a number of independent clones encoding a short form of 
FLASH that we refer to as MiniFLASH (MiniF).  MiniF consists of only 190 amino acids and 
results from skipping two extremely large internal exons and an in-frame fusion of exons 
encoding the N- and C-terminal regions.  The first 138 amino acids of MiniF derive from the N-
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terminus of FLASH and we previously demonstrated that this region contains all elements 
necessary for 3’ end processing of histone pre-mRNAs in vitro (Tang et al., 2009a; 2013; 2011).  
The remaining 52 amino acids of MiniF correspond to the C-terminus of FLASH and encompass 
almost the entire SANT/Myb-like domain. This incomplete domain retains some ability to 
interact with NPAT and is sufficient to localize MiniF to HLBs, the site of histone pre-mRNA 
processing in vivo.  
The composition of MiniF, combining the two external FLASH domains required for 
processing and HLB localization, suggests that it may at least partially substitute for full length 
FLASH in generating mature histone mRNAs in vivo.  This interpretation is supported by our 
recent studies in Drosophila.  The processing and HLB localization domains in Drosophila 
FLASH are also located in the N- and C-terminal regions, respectively.  We engineered an 
artificial Drosophila FLASH variant by directly linking the terminal domains and deleting most 
of the protein body of nearly 550 amino acids. This artificial Drosophila MiniF restores virtually 
all phenotypic and molecular defects resulting from the deficiency of the endogenous full length 
FLASH in Drosophila tissue culture cells (Burch et al., 2011) and whole animals (D. Tatomer, 
R.J. Duronio, Z.D., W.F.M., submitted). 
Exons, in contrast to introns, are typically short, encoding on average less than 50 amino acids 
(Hawkins, 1988).  This limited length facilitates the mechanism of exon definition by promoting 
direct interaction between factors bound to the flanking splice sites (Eliassen et al., 1998; 
Robberson et al., 1990).  Long exons tend to be skipped and their recognition frequently requires 
an active mechanism, involving a subset of specific RNA binding proteins that interact with 
exonic splicing enhancers (Bolisetty and Beemon, 2012).  FLASH pre-mRNA contains two of 
the longest exons in the mammalian geneome.  It is unknown whether their skipping and 
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generation of MiniF is an aberrant process or a result of a highly regulated alternative splicing 
specific for some tissues or developmental stages.  The central region of mammalian FLASH 
deleted from MiniF due to exon skipping consists of nearly 1,800 amino acids and plays a 
largely unknown role.  Parts of this region may control apoptosis (Imai et al.) and transcription of 
selected genes (Alm-Kristiansen et al., 2008), two processes previously linked to FLASH.  A 
short 13-amino acid motif located between amino acids 931-943 that is missing in MiniF 
interacts with Ars2 (Kiriyama et al., 2009).  Ars2 exists in a tight complex with Cap Binding 
Proteins of 20 and 80 kDa and its interaction with FLASH may co-ordinate transcription of 
histone gens with maturation of the 5’ and 3’ ends of histone mRNAs.  Indeed, a mutant FLASH 
lacking the Ars2-intercating motif is inefficient in supporting proliferation and cell cycle 
progression of human pharyngeal carcinoma-derived KB cells, suggesting that MiniFLASH may 
only be partially proficient in vivo (Kiriyama et al., 2009).  Clearly, the absence of this motif and 
other functional domains may also liberate MiniF from tight regulatory constrains, potentially 
resulting in important consequences for cell metabolism and phenotype. 
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Figure 23.  1. The C-terminal regions of FLASH and YARP interact with NPAT.  A.  A 
diagram of human FLASH consisting of 1982 amino acids. Positions of the conserved N- and C-
terminal domains are indicated with gray boxes.  B. Comparison of the amino acid sequences of 
the C-terminal domains of FLASH (top, amino acids 1895-1976) and YARP (bottom, amino 
acids 2123-2203).  Conserved amino acids are shown in the middle. C.  Sequence of the last 103 
amino acids of human FLASH, with the C-terminal domain shared with YARP being underlined.  
D.  The yeast two-hybrid screen identifies NPAT and PCNA as potential interactions of the 
FLASH C-terminal region that encompasses the last 103 amino acids.  Growth of yeast cells 
expressing the C-terminal region of FLASH and either the last 16 amino acids of NPAT (left 
vertical row) or full length PCNA (right vertical row) in the presence of increasing concentration 
of 3-amino triazol (3-AT).  E.  Sequence of the last 16 amino acids of human NPAT fused to the 
N-terminal GST (GST-N16).  F.  Sequence of 97 amino acids of human YARP that are located 
near the C-terminal end and contain the C-terminal domain shared with FLASH (underlined).  G.  
GST pull down assay to analyze in vitro interaction of 35S-labeled C-terminal regions of FLASH 
(FL103C) or YARP (YA97C) with the last 16 amino acids of NPAT fused to GST (GST-N16).  
35S-labeled N-terminal region of FLASH (F138N, amino acids 1-138) and GST alone were used 
as negative controls.  The amount of each GST protein purified on glutathione beads was 
monitored by staining the gel with Coomassie Blue (bottom panels).  Note that GST alone 
migrates higher than GST-N16 due to containing random amino acids at the C-terminus from 
translating the multiple cloning site present in the pET42a vector. 
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Figure 24. 2.  The C-terminal domain shared by FLASH and YARP is sufficient for the 
interaction with NPAT.  A.  Sequence of the last 131 amino acids of human NPAT (Np131C).  
The 16-amino acid extreme C-terminal region cloned in the yeast two-hybrid screen and capable 
of interacting with C-terminal regions of FLASH and YARP is underlined.  The last amino acids 
of the truncated NpΔ16C and NpΔ25C proteins are indicated with vertical arrows.  B.  GST pull 
down assay to analyze in vitro interaction of 35S-labeled Np131C or its truncated versions 
(NpΔ16C and NpΔ25C) with the C-terminal regions of FLASH (GST-Fl103C) or YARP (GST-
Ya97C), each fused to the N-terminally located GST.  GST alone (lane 2) was used as a negative 
control.  The amount of each GST protein purified on glutathione beads was monitored by 
staining gels with Coomassie Blue and was equal in each lane (not shown).  C.  GST pull down 
assay to analyze the interaction of 35S-labeled Np131C with GST-Fl103C or its shorter version 
containing only the 54-amino acid region of homology with YARP (GST-Fl54C).  The amount 
of each GST protein purified on glutathione beads was monitored by staining the gel with 
Coomassie Blue (bottom panel).  D. GST pull down assay to analyze competition between GST-
Np16 (final concentration 2 µM) and two different amounts, as indicated, of the Np25C 
oligopeptide in binding 35S-labeled Fl103C.  GST alone (lane 2) was used as negative control.  
The amounts of the GST-Np16 and GST proteins purified on glutathione beads were monitored 
by staining the gel with Coomassie Blue (bottom panel).  E and F.  GST pull down assay to 
analyze in vitro interaction of 35S-labeled full length PCNA with GST-Fl103C, GST-Ya97C or 
GST-Fl54C, as indicated at the top of each lane.  GST alone (lane 2 in both panels) was used as a 
negative control.  The amount of each protein purified on glutathione beads was monitored by 
staining the gel with Coomassie Blue (bottom panel in F and not shown).   
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Figure 25. 3.  The C-terminal regions of FLASH and NPAT interact in HeLa cells.  A. A 
schematic representation of FLASH and NPAT clones transiently expressed in HeLa cells.  B.  
Nucleotide sequence of the Biot-SL RNA used to purify SLBP.  C.  Myc-Np131C was co-
expressed in HeLa cells with either HA-SLBP (lanes 1-2) or HA-SLBP/F (lanes 3-4).  SLBP was 
affinity-purified by the Biot-SL RNA from whole cell lysates prepared from transfected HeLa cells 
and the precipitated material tested for the presence of the transiently expressed HA- and Myc-
tagged proteins (lanes 2 and 4).  Lanes 1 and 3 contain 30% of the material used for purification.  
Myc-Np131C co-purified by virtue of interacting with HA-SLBP/F is indicated with an arrow.  A 
protein cross-reacting with the anti-Myc antibody (indicated with an asterisk) served together with 
CPSF73 as a control to measure the extent of nonspecific background present in the purified 
material.  D. Myc-mxc169C was co-expressed in HeLa cells with Ha-SLBP/F and the interaction 
between these two proteins tested as described in panel C.  A protein cross-reacting with the anti-
Myc antibody is indicated with an asterisk.  E.  Myc-Np131 was co-expressed in HeLa cells with 
either HA-SLBP (lanes 1-2) or Ha-SLBP/F (lanes 3-4).  SLBP was precipitated by an anti-SLBP 
antibody and the precipitated material tested for the presences of the transiently expressed HA- 
and Myc-tagged proteins (lanes 2 and 4). A protein cross-reacting with the anti-Myc antibody is 
indicated with an asterisk 
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Figure 26. 4.  The C-terminal regions of FLASH targets SLBP to HLBs in HeLa cells. A.  
The HA-tagged versions of SLBP (HA-SLBP) or SLBP extended at the C-terminus by the last 
103 amino acids of FLASH (HA-SLBP/F) were transiently expressed in HeLa cells and their 
levels compared relative to the endogenous SLBP using an anti-SLBP antibody.  B.  
Immunofluorescence of HeLa cells transiently expressing HA-SLBP.  HLBs were detected using 
a rabbit antibody against the N-terminal FLASH and stained green.  HA-SLBP was detected 
using a mouse anti-HA antibody and stained red.  Nuclei were visualized with DAPI.  The top 
image includes three cells of which only two were transfected and express HA-SLBP. A 
magnified image of an independent transfected HeLa cells is shown at the bottom.  C.  
Immunofluorescence of HeLa cells transiently expressing HA-SLBP/F (see above for details). 
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Figure 27. 5.  YARP is a component of HLBs in HeLa cells.  A.  Myc-Np131C was co-
expressed in HeLa cells with either HA-SLBP (lanes 1-2), HA-SLBP/F (lanes 3-4) or HA-
SLBP/Y (lanes 5-6).  SLBP was affinity-purified by the Biot-SL RNA from whole cell lysates 
prepared from transfected HeLa cells and the precipitated material tested for the presence of the 
transiently expressed HA- and Myc-tagged proteins (lanes 2, 4 and 6).  Lanes 1, 3 and 5 contain 
15% of the material used for purification. Proteins cross-reacting with the anti-Myc antibody are 
indicated with asterisks.  C.  A fraction of SLBP in HeLa cells transiently expressing HA-
SLBP/Y localizes to HLBs.  SLBP was detected by an anti-SLBP antibody and stained green.  
HLBs were detected using a mouse monoclonal antibody against NPAT and stained red 
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Figure 28. 6.  Identification of human MiniFlash (MiniF).  A.  The amino acid sequence of 
190-amino acid human MiniF.  The incomplete C-terminal domain is underlined and the missing 
GEIIILWTR sequence is shown below.  B.  The exon/intron organization of the Open Reading 
Frame of human FLASH.  The number of amino acids (AA) encoded by individual exons 1-9 of 
FLASH and those spliced together in MiniF are shown at the bottom.  The MiniF cDNA results 
from skipping of the two large exons 6 and 7, as depicted by dashed lines, and in-frame linking 
of the N- and C-terminal exons.  The highly conserved GEIIILWTR sequence of the C-terminal 
domain of FLASH that is encoded by the end of exon 7 and hence missing in MiniF is indicated.  
C.  GST-pull down assay to analyzed the interaction between MiniF and the C-terminal region of 
NPAT.  Proteins shown at the top of lanes 2-5 were bacterially expressed as fusion with GST, 
incubated with 35S-labeled Np131C or NpΔ16, and the amount of each radioactive protein 
absorbed on glutathione beads was determined by autoradiography.  As determined by 
Coomassie Blue staining, the amount of GST proteins in each lane was comparable (not shown).  
Lane 1 contains 20% of each radioactive protein used in the experiment.  D. Transient expression 
of HA-MiniF in HeLa cells was compared to expression of HA-SLBP/F.  As expected, only HA-
SLBP/C can be purified by binding to the stem-loop RNA containing biotin at the 5’ end (Biot-
SL).  F.  Immunofluorescence of HeLa cells transiently expressing HA-MiniF.  Localization of 
HA-MiniF was detected by a mouse anti-HA antibody and stained red.  HLBs were detected by 
an antibody against the N-terminal FLASH and stained green.  Nuclei were visualized by 
staining with DAPI. 
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CHAPTER 5: SUMMARY 
  
In metazoans, 3’ end formation of RD histone mRNA is a critical step in the upregulation of 
histone gene expression in S-phase. This step accounts for a significant portion of the cell-cycle 
dependent increases in mRNA levels. Histone pre-mRNA 3’ end processing is U7-dependent and 
occurs by a single endonucleolytic cleavage between two sequence elements in the 3’-UTR, a 
conserved stem-loop structure and a histone downstream element (HDE) 3’ of the cleavage site. 
SLBP binds the stem-loop and the HDE recruits the U7 snRNP via partial base pairing with the 
U7 snRNA 5’ end. Binding of SLBP to the stem-loop is somewhat dispensable in mammals if 
the duplex formed between the HDE and U7 snRNP is sufficiently strong, but absolutely 
essential for 3’ end processing in Drosophila. In mammals, cleavage occurs 4-5 nts 3’ of the 
stem-loop while this distance is always 4 nts in Drosophila. 
 Chapter 2 shows that a unique subset of polyadenylation factors, including the 
endonuclease, stably associates with FLASH and the U7 snRNP in mammalian extracts. This 
complex is named the histone pre-mRNA cleavage complex (HCC) and is recruited to histone 
pre-mRNA in a U7 dependent fashion. Chapter 2 also identifies the region of human Lsm11 that 
binds FLASH and examines the elements of Lsm11 required to isolate the HCC in vitro. Chapter 
3 characterizes the HCC in Drosophila and demonstrates the functional conservation of elements 
in Drosophila FLASH required for processing. Additionally, I examine the role of FLASH in 
Drosophila downstream cleavage product (DCP) degradation. Chapter 4 shows an interaction 
between the C-terminal regions of FLASH and NPAT is sufficient to localize FLASH to HLBs 
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in mammalian cells. I also describe a splice variant of FLASH that contains the N-terminal 
region necessary for 3’ end processing fused directly to the extreme C-terminus required for 
binding NPAT.  
Biochemical isolation and identification of the HCC. Histone pre-mRNA 3’ end processing is 
U7-dependent. Although CPSF73 is known to be the endonuclease required for cleavage, 
precisely how it is recruited to histone pre-mRNA was unknown. Based on available literature, it 
was hypothesized the unique 170 N-terminal amino acids of Lsm11 were essential for 
recruitment of additional 3’ end processing factors. N-terminal Lsm11 forms a tight complex 
with FLASH, a processing factor identified in our lab and whose N-terminal region is critical for 
histone pre-mRNA 3’ end processing. Both of these proteins are unique to U7-dependent 
processing. By forming a stable Lsm11/FLASH complex, we hoped to biochemically isolate 
additional processing factors that depend on this interaction in vitro.  
Dr. Dominski devised a single step biochemical purification strategy using the critical 
regions of N-terminally tagged recombinant Lsm11 (amino acids 1-168) and FLASH (amino 
acids 29-139) to form a stable complex and identify factors that associate with this platform in 
mammalian nuclear extracts. This approach successfully isolated the known histone pre-mRNA 
processing factors CPSF73, CPSF100, and symplekin in addition to a number of polyadenylation 
factors not previously associated with histone pre-mRNA 3’ end processing. Western and mass 
spectrometry analysis of the material that co-purified with the Lsm11/FLASH complex revealed 
a distinct subset of polyadenylation factors. The newly identified complex is unique to histone 3’ 
end processing and is collectively named the histone pre-mRNA cleavage complex (HCC). The 
HCC contains all six CPSF subunits, symplekin and CstF64. Conspicuously missing are the 
other subunits of CstF, CstF50 and CstF77. Mutational analysis showed the interaction between 
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the Lsm11/FLASH complex and HCC depends on a highly conserved LDLY motif (amino acids 
55-58) in FLASH. The HCC resembles the HLF complex purified and described by Nikolay 
Kolev and Joan Steitz with the exception of CstF77. But this was the first time a biochemical 
purification protocol relying on factors unique to histone 3’ end processing was able to isolate 
the HCC. 
I mapped the regions of human N-terminal Lsm11 necessary for interacting with FLASH 
and determined amino acids 19 to 55 of Lsm11 are required to form a tight complex. While N-
terminal Lsm11 (amino acids 1-168) or N-terminal FLASH (amino acids 28-139) are 
individually capable of interacting weakly with components of the HCC, together they form a 
stable platform for efficient binding of the HCC. In FLASH, the essential residues are in the 
highly conserved LDLY motif, while in Lsm11 the region required for cooperative binding of 
the HCC is not as clearly defined but lies between amino acids 66 and 130. These results indicate 
elements of both FLASH and Lsm11 are required for recruitment of the HCC and it is only upon 
forming a Lsm11/FLASH complex that a repositioning of critical domains occurs and a robust 
interaction with the HCC is possible. One of the significant questions remaining to be answered 
is what factor(s) make direct contact with the conserved LDLY motif.  
 The association of the HCC and FLASH with the endogenous U7 snRNP was shown in a 
single step purification of the snRNP from nuclear extracts using a biotinylated oligonucleotide 
complimentary to the 5’ end of U7 snRNA.  These studies revealed the composite nature of the 
U7 snRNP. Adding recombinant FLASH to the mixture modestly enhanced the ability of the U7 
snRNP to interact with the HCC in HeLa extracts, suggesting FLASH may be limiting in these 
extracts. Using a biotinylated H2a pre-mRNA, I was able to demonstrate the entire composite U7 
snRNP is recruited to histone pre-mRNA in a U7-dependent manner. The techniques developed 
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in these investigations were useful in my subsequent efforts to characterize the U7 snRNP in 
Drosophila. 
Drosophila HCC contains a different set of polyadenylation factors. I identified a Drosophila 
HCC that is similar in composition to the mammalian one. The Drosophila HCC contains 
symplekin, CstF64, and four subunits of CPSF (CPSF73, CPSF100, CPSF160, and WDR33). 
Unlike the mammalian HCC, the Drosophila complex does not include CPSF30 or Fip1. As in 
vertebrates, the HCC stably associates with the U7 snRNP and the larger complex can be isolated 
from nuclear extracts as a composite structure in a single step purification using an anti-U7 
oligonucleotide. CPSF73, CPSF100, and symplekin are the only members of the HCC essential 
for 3’ end processing. The exact role of the remaining members of the HCC in processing is not 
clear.  
While cleavage of Drosophila histone pre-mRNA depends on binding of SLBP, 
recruitment of the composite U7 snRNP to the pre-mRNA does not require SLBP binding nor 
the stem-loop structure itself. This was demonstrated in vitro using a SLBP stem-loop oligo 
competitor to sequester SLBP in the presence of biotinylated Drosohphila H3 pre-mRNA or a 
biotinylated H3 pre-mRNA in which the stem-loop had been removed. Under both conditions, 
the composite U7 snRNP containing the HCC was recruited to the pre-mRNA. These results 
suggest SLBP binding of the stem-loop serves an additional role in 3’ end processing not related 
to recruitment of the composite U7 snRNP. Additional investigations into SLBPs processing role 
could better elucidate the mechanisms behind activation of the endonuclease.  
Drosophila HCC differs from a larger super complex specific to cleavage and 
polyadenylation. Curiously, CstF64 is the only subunit from CstF found in the HCC. CstF50 
and CstF77 do not co-purify with the complex. Using an antibody raised against CstF64, I 
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conducted immunoprecipitation experiments with Drosophila Kc extracts. A large 
macromolecular complex co-precipitated with CstF64. This complex contained the six subunits 
of CPSF, both subunits of CF Im, symplekin, and all three subunits of CstF, including CstF50 and 
Cst77. CF IIm was the only cleavage and polyadenylation factor not detected, although it is 
possible that it co-purified in undetectable, sub-stoichiometric amounts. Treating the extracts 
with RNase A did not disrupt the complex, indicating protein-protein interactions are primarily 
responsible for its formation.  
This was the first time that a large complex containing this set of cleavage and 
polyadenylation factors was isolated. The HCC contrasts sharply with the super complex of 
polyadenylation factors. The absence of CstF50 and CstF77 in the HCC, but inclusion in the 
polyadenylation complex, suggests a complexity in the connectivity between subunits. This 
could partially be explained by the mutually exclusive binding of symplekin by CstF64 and 
CstF77.  
Functional elements of FLASH required for 3’ end processing are conserved in Drosophila. 
Drosophila Lsm11 and FLASH also form a tight complex. In mammalian FLASH, a LDLY 
motif located at amino acids 55-58 is critical for histone pre-mRNA 3’ processing and 
recruitment of the HCC. I examined the corresponding LDIY motif (amino acids 71-74) in 
Drosophila FLASH and showed a similar dependence. To examine the role of the LDIY motif in 
processing, I prepared small scale nuclear extracts from Drosophila S2 cells depleted of FLASH 
by RNA interference. In vitro 3’ end processing assays with 5’ radio-labeled H3 pre-mRNA 
showed the depleted extracts had minimal processing activity compared to extracts prepared 
from untreated cells. Adding bacterially expressed Drosophila FLASH (amino acids 1-178) to 
depleted extracts not only restored processing, but stimulated it to levels exceeding that of non-
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depleted extracts. In contrast, an N-terminal fragment of FLASH with the conserved LDIY motif 
(amino acids 71-74) mutated to alanines severely limited the ability of the recombinant protein to 
stimulate processing in vitro. The stimulatory effect of the mutant FLASH was approximately 5-
10% of that seen with the wild type fragment in depleted extracts. Unpublished data from 
Deirdre Tatomer indicated another conserved LDIY motif (amino acids 45-48) is sufficient for 
viability when combined with the LDIY to AAAA mutation at amino acids 71-74. While the 
LDIY motif at amino acids 71-74 is primarily responsible for 3’ end processing in vitro, 
Deirdre’s result demonstrated a redundant role for the minor LDIY motif in vivo. My subsequent 
experiments showed mutating both conserved LDIY motifs (amino acids 45-48 and 71-74) to 
alanines completely abolished the ability of recombinant FLASH to restore processing in 
depleted extracts.  
I also showed the LDIY motif (amino acids 71-74) has a role in recruiting 
polyadenylation factors known to participate in histone pre-mRNA 3’ end processing. In Kc 
nuclear extracts, bacterially expressed Drosophila Lsm11 (amino acids 1-153) bound to FLASH 
(amino acids 1-178) interacts with a complex containing the endonuclease CPSF73, CPSF100, 
and symplekin. These factors co-purify with a Lsm11/FLASH complex in a LDIY (amino acids 
71-74) dependent manner. Western analysis of the purified material showed changing these 
residues to alanines severely hinders the ability of the Lsm11/FLASH complex to interact with 
these essential processing factors. Despite the LDIY mutation, there are trace amounts of 
CPSF73, CPSF100, and symplekin that co-purify with the Lsm11/FLASH LDIY71AAA mutant. 
The minor LDIY motif (amino acids 45-48) could play a redundant role in binding these factors 
though with far less efficiency. Additional pull down experiments using a Lsm11/FLASH 
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complex containing the double mutant of FLASH could help clarify whether the minor LDIY 
(amino acids 45-48) has a contribution to recruiting processing factors 
FLASH is required for DCP degradation in Drosophila. Degradation of the downstream 
cleavage product (DCP) in mammals is U7-dependent and does not require SLBP. The DCP is 
degraded in the 5’ to 3’ direction exonucleolitically by CPSF73, the endonuclease in histone and 
canonical pre-mRNA 3’ end processing (Yang et al., 2009a). In vitro degradation assays using 
mouse nuclear extracts with a 5’ radio-labeled DCP show FLASH is not required for 
degradation. The addition of purified anti-FLASH antibody does not disrupt normal degradation 
nor does adding recombinant N-terminal FLASH stimulate the reactions. In contrast, I 
demonstrated an essential role for FLASH in Drosophila DCP degradation.  
 To check whether Drosophila FLASH participates in the degradation reaction, I 
conducted in vitro degradation assays comparing nuclear extracts from untreated S2 cells and 
FLASH depleted S2 cells. In extracts that were not depleted, degradation proceeded in a U7-
dependent fashion. Blocking the interaction between the HDE and 5’ end of the U7 snRNA 
inhibited the reaction. Adding N-terminal recombinant FLASH to the extract resulted in a 3-4 
fold increase in degradation of the DCP. Adding purified anti-FLASH antibody to the extracts 
completely inhibited activity.  
FLASH depleted extracts showed only residual degradation activity, substantially lower 
than their untreated counterparts. Degradation activity in the depleted extracts was restored to 
levels surpassing extracts containing endogenous FLASH upon addition of N-terminal 
recombinant FLASH. Mutating the conserved LDIY motif (amino acids 71-74) resulted in a 
reduction of degradation rescue by approximately 50% compared to the addition of wild type N-
terminal FLASH. This loss of activity is less severe than that seen in 3’ end processing assays 
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where changing the LDIY causes a 90% reduction of FLASH activity. It is possible the minor 
LDIY motif (amino acids 45-48) is more important for DCP degradation than it is for 3’ end 
processing but this needs to be tested. 
The different requirements for FLASH in DCP degradation between mammals and 
insects could be related to the ability of mammalian Lsm11 to weakly interact with the HCC on 
its own, without binding FLASH. This weak interaction may be sufficient to recruit CPSF73 to 
the DCP for exonucleolytic activity. In Drosophila, retention of HCC after 3’ end processing 
likely requires the continued interaction between Lsm11 and FLASH. The added contribution of 
FLASH may stabilize the interaction of the U7 snRNP with the HCC in a manner that promotes 
the switch from endo- to exonucleolytic mode for DCP degradation.  
 An interaction between C-terminal FLASH and NPAT localizes FLASH to HLBs. A 55 
amino acid domain located near the C-terminus of human FLASH (amino acids 1923-1975) is 
highly conserved in vertebrates and shares 50% sequence identity with a C-terminal domain of 
an unrelated protein, YARP. The shared region is predicted to contain three α-helices with an 
overall fold that resembles SANT and Myb domains, hence named the SANT/Myb-like domain. 
YARP is an orthologue of the Drosophila protein Mute. In Drosophila, Mute acts as a regulator 
of histone gene transcription and localizes to HLBs (Bulchand et al. 2010).  
Lalitha Kunduru conducted a yeast two-hybrid screen using the C-terminal 103 amino 
acids of FLASH, which includes the SANT/Myb-like domain, with a HeLa S3 library and 
identified NPAT as a binding partner of FLASH. NPAT is a constitutive member of HLBs and 
co-activator of histone gene transcription. It is required for the G1 to S-phase transition (Ma et 
al., 2000) and is essential for histone gene transcription (Zhao et al., 2000). Using deletion 
analysis and peptide competitors, I showed the SANT/Myb-like domain near the C-terminus of 
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FLASH interacts with the C-terminal 25 amino acids of NPAT in vitro. The SANT/Myb-like 
domain is conserved in YARP but the interaction with NPAT is weaker.. 
SLBP remains associated with histone mRNA after 3’ end processing and thus 
immunofluorescent staining for endogenous SLBP in HeLa cells shows a diffuse pattern 
throughout the nucleus and cytoplasm. Appending the last 103 amino acids of FLASH to the C-
terminus of SLBP in vivo results in localization of the chimeric protein to HLBs. A similar 
pattern was observed when SLBP was extended with the C-terminal region of YARP (amino 
acids 2117-2213).  
MiniFLASH is a splice variant of FLASH that joins two regions essential for histone 
biogenesis. Mammalian FLASH is a large protein of 1982 amino acids that is encoded by 9 
exons. Yet there is no published data to indicate the existence of alternatively spliced FLASH 
variants. I conducted a yeast two-hybrid screen using N-terminal Lsm11 with a human universal 
tissue library and identified a FLASH splice variant containing the N-terminus fused directly and 
in frame to the C-terminus. Comprising only 190 amino acids, this variant was named 
MiniFLASH. Surprisingly, it includes the first 138 amino acids shown to be essential for histone 
pre-mRNA 3’ end processing in vitro and the C-terminal 52 amino acids required for binding 
NPAT and localizing FLASH to HLBs. The splice variant consists of exons 1-5 spliced to exons 
8 and 9. The two largest exons, 6 and 7, have been skipped.  
Fusing the extreme N- and C-terminal domains of FLASH into MiniFLASH may have 
biological relevance in vivo. In Drosophila, FLASH is 844 amino acids and essential for viability 
(Burch et al., 2011). In a mutant fly deficient for endogenous FLASH, a Drosophila MiniFLASH 
composed of the N- and C-termini rescues viability and molecular defects, including mis-
processing of histone pre-mRNA, despite lacking 550 internal amino acids (Tatomer et al. 
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Submitted). This suggests MiniFLASH can at a minimum compensate for full length FLASH’s 
role in the biogenesis of histone mRNA in Drosophila. The regulatory consequences of 
removing such a large internal portion of the protein are not entirely clear. In mammalian cells, 
cell-cycle progression and cellular proliferation were shown to be dependent on an interaction 
between the internal region of FLASH and Ars2. But human MiniFLASH does not include the 
region of FLASH that binds Ars2. Interestingly, I showed Drosophila FLASH and Ars2 do not 
interact or associate in a complex together, suggesting this interaction is not critical in 
Drosophila. Identification of MiniFLASH has provoked new ideas regarding FLASH as a 3’ end 
processing factor and, in our lab, has led to fresh investigations regarding the potential biological 
significance of this splice variant.  
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